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         ABSTRACT 
 
There are multiple factors that may impact on the outcome of a patient with 
subarachnoid haemorrhage (SAH).  As well as the acute injury, these include the 
mode of treatment: surgical clipping (SC) or endovascular coiling (EVC); the 
complications and durability of investigations and treatment and the delayed 
ischaemic processes/cerebral vasospasm. The International Subarachnoid Aneurysm 
Trial (ISAT) demonstrated a significant reduction in the rate of death or dependency 
for patients treated with EVC rather than SC but ISAT did not address certain issues 
that remain controversial.  This research focuses on some of the reasons for the ISAT 
findings and investigates areas that were not specifically investigated in the trial 
including the role of EVC of middle cerebral artery (MCA) aneurysms; cognition 
and the brain injury incurred through SC and EVC of anterior communicating artery 
(ACOM) aneurysms; the interaction between SC and EVC and the physiological 
derangement of the patient; the potential use of non-invasive imaging only in the 
investigation of more benign perimesencephalic subarachnoid haemorrhage 
(PMSAH); endovascular treatment of severe vasospasm and finally, the follow-up 
necessary for adequately coiled aneurysms.  
The findings of this thesis suggest that EVC is a suitable first line treatment 
for MCA aneurysms; that the injury sustained by brain regions heavily involved with 
cognition is significantly greater in patients with ACOM aneurysms treated with SC; 
that clinical outcomes in patients with more severe physiological derangement are 
superior for coiled patients; that invasive imaging may be unnecessary in patients 
with PMSAH; that endovascular treatment of vasospasm results in low rates of 
cerebral infarction and may negate its clinical impact; and finally that long term 
follow-up of adequately occluded coiled aneurysms is probably not necessary. 
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GLOSSARY OF TERMS 
 
ACA, anterior cerebral artery 
ACOM artery, anterior communicating artery 
APACHE II, Acute Physiology and Chronic Health Evaluation II score 
ATENA, Analysis of Treatment by Endovascular Approach of Nonruptured 
Aneurysms (study) 
aVSP, angiographic vasospasm 
BA, basilar artery 
BRAT, Berrow Ruptured Aneurysm Trial 
CARAT, Cerebral Aneurysm Rerupture After Treatment 
CBF, cerebral blood flow 
CI, confidence interval 
CLARITY, Clinical and Anatomical Results in the Treatment of Ruptured 
Intracranial Aneurysms 
CT, computed tomography 
CTA, CT angiography 
DSA, digital subtraction angiography 
EVC, endovascular coiling 
FLAIR, Fluid-attenuated inversion recovery 
GCS, Glasgow Coma Scale 
GOS, Glasgow Outcome Score 
HELPS, HydroCoil Endovascular Aneurysm Occlusion and Packing Study 
IA, intra-arterial 
ICA, internal carotid artery 
ISAT, International Subarachnoid Aneurysm Trial 
ISUIA, International Study of Unruptured Intracranial Aneurysms 
MCA, middle cerebral artery 
MRA, magnetic resonance angiography 
MRI, magnetic resonance imaging 
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mRS, modified Rankin Scale  
NCCT, non-contrast CT 
NPV, negative predictive value 
OR, odds ratio 
PCA, posterior cerebral artery 
PCOM artery, posterior communicating artery 
PMSAH, perimesencephalic subarachnoid haemorrhage 
RAH, recurrent artery of Heubner 
TBA, transluminal balloon angioplasty 
TCD, transcranial Doppler  
SAH, subarachnoid haemorrhage 
SC, surgical clipping 
VA, vertebral artery 
WFNS, World Federation of Neurosurgical Societies 
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INTRODUCTION AND SUMMARY OF RESEARCH 
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1.1 Subarachnoid haemorrhage  
1.1.1 Definition 
Subarachnoid haemorrhage (SAH) describes extravasation of blood into the 
subarachnoid space (the cerebro-spinal fluid-filled area lying between pia mater 
deeply and arachnoid membrane more superficially).  This can be as a result of head 
trauma or can be spontaneous and in the latter case an underlying neurovascular 
abnormality is commonly identified.  Spontaneous SAH was first described in detail 
in the British medical literature in the late 19
th
 century (Bramwell, 1886) and, by the 
1920’s there was considerable understanding of the clinical and pathological features 
of the condition (Symonds, 1924).  
 
1.1.2 Aetiology 
When spontaneous, SAH usually lies within the cisterns at the base of the 
brain and most commonly results from the rupture of a cerebral aneurysm, a focal 
abnormal dilatation in the wall of a cerebral artery. Indeed, aneurysmal SAH 
accounts for approximately 85% of all SAH, whilst perimesencephalic haemorrhage 
(which may have a venous origin and represents a distinct clinic-radiological entity) 
accounts for approximately 5% (van Gijn et al, 2001, Flaherty et al, 2005). There are 
a number of other pathological processes that can result in spontaneous SAH 
including dural arteriovenous fistula, arteriovenous malformations, cavernous 
angiomata, reversible cerebral vasoconstriction syndrome, vasculitis, venous 
sinus/cortical vein thrombosis and amyloid angiopathy. In these cases, there may be 
a distinct clinical course and the SAH is usually of a more peripheral distribution and 
often present in combination with intra-parenchymal haemorrhage (reviewed by 
Mortimer et al, 2013).  
Although a minority of aneurysms may be the result of an arterial dissection (and 
in that instance are usually fusiform), the vast majority are saccular in morphology.  
A systematic review of 68 studies, which reported on 83 study populations and 1450 
unruptured aneurysms in 94, 912 patients from 21 countries, estimated that the 
overall prevalence of saccular aneurysms was 3.2% (95% CI 1.9–5.2) in the general 
population (Vlak et al, 2011). 
15 
1.1 Cerebral Aneurysms 
1.2.1 Pathophysiology of cerebral aneurysm formation 
It is likely that aneurysm formation is a result of a complex interaction 
between inherent and environmental factors.  Family history, connective tissue 
disease and smoking predispose to aneurysm formation (Ronkainen et al, 1997; 
Raaymakers, 1999; Wardlaw et al, 2000; Juvela et al, 2001; Kissela et al, 2002). 
Arteriosclerosis and hypertension may be associated (Hokari et al, 2014) and 
developmental deficiency of the media and internal elastic lamina has also been cited 
as an aetiological factor (Crawford et al, 1959).   
Aneurysm formation most commonly occurs at outer curvatures, 
bifurcations, or branching points of cerebral arteries; points that have been shown to 
suffer the highest wall shear stress (Kulcsar et al, 2011).  In turn, this stress may 
induce pathological vascular remodeling of the vessel transmitted by endothelial 
cells (Resnick et al, 2003) and vessel wall inflammation which appears to be a 
dominant mechanism in cerebral aneurysm formation and has been the subject of a 
considerable body of aneurysm research (reviewed by Chalouhi et al, 2013a).  
Indeed, there is evidence that patients with unruptured aneurysms treated with 
aspirin, a cyclooxygenase 1 and 2 inhibitor have a lower risk of hemorrhage than 
those who have never used aspirin (Hasan et al, 2011).  
The most common locations for aneurysm formation are the anterior 
communicating artery, middle cerebral artery bifurcation, posterior communicating 
artery and ophthalmic artery origins, the terminal basilar artery and origins of the 
posterior inferior cerebellar arteries (van Gijn et al, 2007). 
 
1.2.2 Aneurysm rupture 
In the International Study of Unruptured Intracranial Aneurysm Investigators, 
a multicentre cohort study of unruptured aneurysms, the overall rate of rupture was 
0.5% per year (Wiebers et al, 2003) but there is a large body of opinion that this may 
be an under-estimation. There are factors that increase the risk of rupture for an 
individual aneurysm. Features that have been shown to predispose to aneurysm 
rupture include female sex, current smoking, hypertension, larger aneurysm size, the 
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aneurysm location and morphology including the presence of a daughter sac or high 
aspect ratio (height divided by neck diameter) as well as aneurysm growth (Ujiie et 
al, 2001; Villablanca et al, 2013; Korja et al, 2014, Murayama et al, 2016).   
A number of scoring systems have been developed to assess the risk of 
aneurysm rupture on a per aneurysm basis (Greving et al, 2014; Etminan et al, 
2015).  Factors that merit firm consideration for treatment include aneurysm size 
≥7mm, young patient age, change in the size or configuration of the aneurysm, and 
the presence of a daughter sac, or associated symptoms. Factors that may support 
intervention over observation are posterior circulation aneurysm location, 
anterior/posterior communicating artery aneurysm location, active smoking, 
hypertension, previous SAH, history of familial SAH, and high aspect ratio. 
The overall incidence of aneurysmal SAH is approximately 9 per 100 000 
person‐years but varies significantly by region, with rates doubled in Japan and 
Finland and far lower in South and Central America. The incidence is higher in 
women and increases with age, though the gender distribution varies with age. At 
young ages, incidence is higher in men, while after the age of 55 years, the incidence 
is higher in women (de Rooij et al, 2007).  
 
1.2.3 Complications of aneurysm rupture and SAH 
Aneurysm rupture and SAH is almost always accompanied by sudden onset 
(‘thunderclap’) headache which may be followed by a focal neurological deficit such 
as limb weakness and/or a reduction in the level of consciousness, coma or death 
(Schwedt et al, 2006).   SAH carries a mortality of 11% prior to seeking medical 
attention (Hijdra et al, 1987a). As well as the impact of the primary haemorrhagic 
injury, early ischaemic brain injury (Wartenberg et al, 2011), hydrocephalus and 
rebleeding may complicate SAH in the early stages.  In addition to the latter two 
conditions, non-neurological complications and delayed cerebral ischaemia may 
complicate the subacute phase. 
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1.2.3.1 Clinical and radiological grading systems 
There are more than forty grading scales, either historical or in use that have 
been applied to patients with aneurysmal SAH.  Rosen & Macdonald (2005) have 
undertaken an extensive review of this subject. In principle, the contemporary 
approach is to clinically grade patients on the basis of their level of consciousness 
(adjudged using the Glasgow coma scale, (GCS)) and whether they exhibit a focal 
neurological deficit. The most commonly used grading system is the World 
Federation of Neurosurgical Societies (WFNS) scale (table 1.1); another that is often 
used in research emanating from the United States is the Hunt and Hess grading 
system though this is less commonly used in the United Kingdom. There is evidence 
that initial neurological grade impacts on eventual functional outcome (Rosen et al, 
2004) and as such this is likely an approximate measure of the acute neurological 
injury. 
 
Grade GCS Focal neurological deficit 
1 15 Absent 
2 13–14 Absent 
3 13–14 Present 
4 7–12 Present or absent 
5 <7 Present or absent 
 
Table 1.1 The World Federation of Neurological Societies Grading scale for aneurysmal 
SAH. 
Non-contrast computed tomography is usually the first line imaging modality 
employed to assess these patients.  The extent of primary haemorrhage can be graded 
using a number of systems but the most commonly quoted scales are the Fisher 
grade (Fisher et al, 1980) and modified Fisher grade (Frontera et al, 2006) which 
take into account the thickness of the basal SAH on axial images and the presence of 
intracerebral or intraventricular haemorhage (tables 1.2. and 1.3).  
18 
 
Fisher grade CT findings 
1 No haemorrhage evident. 
2 Subarachnoid haemorrhage less than 1mm thick. 
3 
Subarachnoid haemorrhage more than 1mm thick. 
4 
Subarachnoid haemorrhage of any thickness with intra-ventricular 
haemorrhage (IVH) or parenchymal extension. 
 
Table 1.2 The Fisher Grade for CT imaging distribution of SAH. 
 
Modified Fisher grade CT findings 
0 No SAH or IVH 
1 Focal or diffuse, thin SAH with no IVH 
2 Focal or diffuse, thin SAH with IVH 
3 Focal or diffuse, thick SAH with no IVH 
4 Focal or diffuse, thick SAH with IVH 
 
Table 1.3 The Modified Fisher Grade (thin SAH is < 1mm thick and thick SAH is 
>1 mm in depth). 
The modified Fisher grade was developed to include patients with thick 
cisternal blood and concomitant intraventricular or intraparenchymal haemorrhage. 
Additionally, the risk of developing angiographic vasospasm progressively increases 
with each level of the modified Fisher grade, whereas the risk was highest for Grade 
3 and then decreased for Grade 4 while using the original Fisher scale (Frontera et al, 
2006). 
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1.2.3.2 Rehaemorrhage 
Risk of acute rehaemorrhage is greatest in the first 24 hours; approximately 
4% of aneurysms will rebleed during this time and if an aneurysm is left untreated 
there is a 40% chance of rebleeding in the following 4 weeks, with about an 80% 
chance of death or disability (Hijdra et al, 1987a; Kassell et al, 1990; van Gijn et al, 
2007). In an assessment of 40 (6.9%) of the 574 patients who had suffered 
rehaemorrhage during the course of their treatment, rebleeding was associated with a 
markedly reduced chance of survival with functional independence (modified 
Rankin Scale score ≤4; OR, 0.08; 95% CI, 0.02-0.34) at 3 months (Naidech et al, 
2005).  Larger aneurysm and poorer neurological grade were risk factors for 
rehaemorrhage.   
 
1.2.3.3 Early ischaemic brain injury 
This is a concept that is receiving increasing attention.  In a recent 
observational study, acute ischaemic injury was seen in 60% of patients undergoing 
diffusion weighted magnetic resonance imaging at days 0-3 post SAH (Frontera et 
al, 2015).  Ischaemic lesions could be the result of a hypoxic ischaemic injury 
(Wartenberg et al, 2011; Frontera et al, 2015) or possibly acute vasospasm as a result 
of aneurysm rupture.  Early ischaemic injury is associated with poor acute 
neurological status after SAH, is more common in patients of poor grade and can 
predict future ischaemia and worse functional outcomes (Frontera et al, 2015).  
 
1.2.3.4 Hydrocephalus 
Up to 20% of patients suffer post SAH hydrocephalus (Suarez-Rivera et al, 
1998), defined as ventricular dilatation that ultimately results in an elevation of 
intracranial pressure (Woernle et al, 2013).  This most commonly occurs in patients 
with greater haemorrhagic loads/Fisher grades and those with intraventricular 
haemorrhage.  This is managed with external ventricular drainage which itself can be 
complicated by infection or haemorrhage.  Approximately 20-30% of patients will 
go on to require permanent cerebrospinal fluid diversion with shunt placement (Lu et 
20 
al, 2012; Woernle et al, 2013).  Controversy exists about whether open 
microsurgical methods serve to reduce shunt dependent hydrocephalus compared 
with endovascular techniques but the most recent evidence suggests that there is no 
difference in shunt dependency among patients treated by either technique (Zaidi et 
al, 2015). 
 
1.2.3.5 Non-neurological complications 
SAH can also be complicated by non-neurological abnormalities. Common 
non-neurological complications of SAH include anaemia, hypertension, cardiac 
arrhythmia, fever, electrolyte changes, pulmonary oedema, pneumonia, hepatic 
dysfunction, renal dysfunction, and thrombocytopenia (Solenski et al, 1995).
 
Pneumonia, sepsis, fever, anaemia, and hyperglycaemia independently predict poor 
outcome and death (Wartenberg et al, 2006).
 
Medical complications are linked to 
severity of presenting grade (Solenski et al, 1995).
 
  
 
1.2.3.6 Delayed cerebral ischaemia 
Post haemorrhage arterial vasospasm and the delayed ischaemic process was 
recognised in the 1950’s (Fletcher et al, 1959).  Delayed cerebral ischaemia refers to 
a clinical phenomenon occurring at days 3-10 post onset of SAH, characterised by a 
new focal neurological deficit or reduction in the level of consciousness. These 
patients are at risk of cerebral infarction which is strongly associated with poor 
outcome (Furgusson & Macdonald, 2007; Vergouwen et al, 2011b).  Angiographic 
cerebral vasospasm refers to a pathophysiological phenomenon which contributes to 
the delayed ischaemic process in which the proximal cerebral arterial luminal 
diameter is reduced secondary to smooth muscle contraction in response to the 
presence of subarachnoid haemorrhage (figure 1.1).   
An additional mechanism of delayed ischaemia, cortical spreading depression 
has also been demonstrated in a cohort of SAH patients (Woitzik et al, 2012). The 
use of nimodipine as a prophylactic treatment and intravascular volume 
expansion/hypervolaemia, haemodilution and induced hypertension as rescue 
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treatments (triple-H) was established in the 1980’s (Kassell et al, 1982; Allen et al, 
1983).  A systematic review of eight prospective randomised trials including 1514 
patients designed to assess the efficacy of prophylactic nimodipine (Liu et al, 2011), 
concluded that nimodipine reduced the rate of delayed cerebral ischaemia by 38% 
and the rate of cerebral infarction by 48%.  Conversely, the evidence for the use of 
triple-H therapy remains sparse despite relatively widespread acceptance. A 
systematic review of triple-H therapy components suggested that induced 
hypertension was the most effective at improving cerebral blood flow (Dankbaar et 
al, 2010).   
 
Figure 1.1 Frontal projection left internal carotid artery angiogram at day 2 post ictus 
immediately post coiling (left) and day 6 post ictus (right) performed to investigate an acute 
right hemiparesis and aphasia.  The coiled aneurysm is labelled with an arrowhead. The 
immediate post coiling appearances demonstrate a normal left M1 MCA calibre and at day 6 
show severe left M1 MCA (arrow) and A1 ACA vasospasm. 
 
 
Endovascular approaches to treating this condition were fist applied in the 
1980’s also (Higashida et al, 1989).  Transluminal balloon angioplasty (TBA) and 
chemical angioplasty using papaverine were the initial methods employed.  The use 
of the latter agent has now largely been superseded by other vasodilators, most 
commonly verapamil, with safer side-effect profiles (Bulsara et al, 2015).    
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1.2 Prognosis 
1.2.1 Outcome scales 
The Glasgow Outcome Scale (GOS) and modified Rankin Scale (mRS) are 
the most commonly used systems for measuring the degree of disability or 
dependence in activities of daily living in patients who have suffered SAH.  The 
GOS is a five-point scale (table 1.4) and was originally developed to assess outcome 
after traumatic brain injury (Jennett et al, 1981).  This has largely been superseded 
by the mRS (table 1.5) that was developed to assess outcome, principally following 
stroke (van Swieten et al, 1988) and encompasses a seven-point scale.  In many 
studies, favourable outcomes are dichotomised as GOS scores of 4 and 5 or 5 alone 
and mRS scores of 0-2 or 0-3.  
 
 
Table 1.4 The Glasgow Outcome Score. 
 
 
 
 
 
Score Definition 
1 Death. 
2  Persistent vegetative state. Patient exhibits no obvious cortical function.    
3  Severe disability. Conscious but disabled.  Patient depends upon others for 
daily support due to mental or physical disability or both.    
4  Moderate disability.  Disabled but independent.  Patient is independent as 
far as daily life is concerned.  The disabilities found include varying degrees 
of dysphasia, hemiparesis, or ataxia, as well as intellectual and memory 
deficits and personality changes.    
5  Good recovery. Resumption of normal activities even though there may be 
minor neurological or psychological deficits. 
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Score Definition 
0 No symptoms. 
1 No significant disability. Able to carry out all usual activities, despite some 
symptoms. 
2 Slight disability. Able to look after own affairs without assistance, but 
unable to carry out all previous activities. 
3 Moderate disability. Requires some help, but able to walk unassisted. 
4 Moderately severe disability. Unable to attend to own bodily needs without 
assistance, and unable to walk unassisted. 
5 Severe disability. Requires constant nursing care and attention, bedridden, 
incontinent. 
6 Death. 
 
Table 1.5 The modified Rankin Scale. 
 
1.2.2 Factors impacting on patient outcome 
Recent studies of in-hospital mortality for SAH suggest that this lies in the 
order of 20% and has fallen since the 1980s (Rincon et al, 2013; Lantigua et al, 
2015), likely due to advances aneurysm treatment and in critical care.  Nevertheless, 
up to 30% of the survivors exhibit significant morbidity and will depend on others 
for activities of daily living and of those patients who survive the acute phase non-
disabled, many suffer cognitive impairment (Hijdra et al, 1987a). As many as a third 
in the International Subarachnoid Aneurysm Trial (ISAT) cohort suffered cognitive 
imparirment (Scott et al, 2010). 
Established patient risk factors for death or dependency include poor clinical 
grade at presentation, older age, aneurysm rebleeding, large aneurysm size, early 
ischaemic brain injury, cerebral oedema and intraventricular haemorrhage (Claassen 
et al, 2002; Naidech et al, 2005; Rosen et al, 2004; Wartenberg et al, 2011; Lantigua 
et al, 2015).  Mode of aneurysm treatment and treatment complications, 
physiological derangement, complications of invasive imaging with digital 
subtraction angiography, cerebral vasospasm and the delayed ischaemic process and 
long term imaging follow-up all have implications for early patient outcome and/or 
longer term well-being (Ruigrok et al, 2000; Molyneux et al, 2002; Vergouwen et al, 
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2011; Ferns et al, 2011a; Lantigua et al, 2015).  These factors are the subject of this 
thesis and will be discussed in turn.   
 
1.3 Aneurysm treatment modality 
1.4.1 A brief history of aneurysm treatment 
In the 1930’s, the first neurosurgical procedures to protect aneurysms from 
rehaemorrhage were performed in Edinburgh, UK and Baltimore, USA with clipping 
of aneurysms first successfully performed by Dandy in 1937 (Dandy, 1938) and, 
with microsurgery first employed to aid clipping in the 1970’s (Krayenbühl et al, 
1972).  Endovascular occlusion of aneurysms first employed detachable balloons in 
the 1980s (Scialfa et al, 1983) but in the early 1990s, the first use of electrolytically 
detachable platinum coils, the mainstay of aneurysm treatment today in most 
institutions, was described by Guglielmi (Guglielmi et al, 1991).  The first of a 
number of land-mark publications as a result of the ISAT trial of 2143 patients, 
comparing endovascular coiling with microsurgical clipping was published in 2002 
(Molyneux et al, 2002).   
Since the development of simple coiling techniques, endovascular treatment 
options evolved.  Balloon-remodelling and stent-assisted coiling are adjunctive 
treatments that allow endovascular occlusion of more complex aneurysms (Pierot et 
al, 2009). In the last ten years both luminal and intra-aneurysmal flow diverters have 
been developed and although the evidence for their use is still building, they do aid 
occlusion of aneurysms with difficult morphology and further add to the 
neurointerventionalist’s armamentarium.  
 
1.4.2 Controversies 
The mode of aneurysm treatment and complications of treatment are 
significant factors which may impact on functional and cognitive outcomes 
(Molyneux et al, 2002, Scott et al, 2010, Ayling et al, 2015).  Broadly, arguments 
for the continued use of clipping in the context of SAH are that there is a perceived 
higher chance of complete long-term occlusion, lower risk of rehaemorrhage and 
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improved ability to fully treat aneurysms of more complex morphology (Johnston et 
al, 2008).  Conversely, coiling is less invasive, is associated with fewer peri-
operative complications (Ayling et al, 2015) and lower levels of biochemical 
markers of brain injury (Shim et al, 2012) but critics of the technique cite incomplete 
occlusion as a major flaw, suggesting that in the long term there may be an increased 
risk of rebleeding and complications associated with further treatment.   
The results of ISAT have gone some way to satisfying this concern.  This 
trial randomised patients with aneurysms that were deemed suitable for both surgical 
clipping and endovascular coiling. At 1 year there was an absolute 6.9% reduction in 
the rate of death or dependency for patients treated with coiling rather than clipping 
(Molyneux et al, 2002).  In longer term follow-up of 1003 patients at 10 years 
(Molyneux et al, 2015), 435 (82%) patients treated with endovascular coiling and 
370 (78%) patients treated with surgical clipping were independent (mRS 0-2; OR 
1.25; 95% CI 0.92-1.71).  Patients in the endovascular treatment group were more 
likely to be alive and independent at 10 years than were patients in the neurosurgery 
group (OR 1.34, 95% CI 1.07-1.67).  Although there was a small increased risk of 
rebleeding in the coiling group, this did not translate to a significantly worse clinical 
outcome when compared with that of the surgically treated group.  Patients were 40-
times more likely to die from another cause than from the treated aneurysm. 
After the initial ISAT results there was a shift in the treatment of aneurysms 
in the UK and coiling became the dominant modality.  In 2006, an audit of 
subarachnoid haemorrhage treatment in the UK demonstrated that 85% of patients 
treated for ruptured aneurysms had coiling (Royal College of Surgeons, 2006).   
There was much criticism of the trial, particularly from neurosurgeons in the 
United States.  The study was designed to randomise aneurysms for which the 
treating clinicians had equipoise.  A principle criticism is that only 20% of eligible 
patients with SAH were enrolled into the study and as a result there is considerable 
bias in terms of the population included and that there is a significant proportion of 
aneurysmal SAH patients to whom the ISAT results do not apply.   
As a result, a more recent study from the Berrow institute (the Berrow 
Ruptured Aneurysm Trial, BRAT) aimed to answer whether the results of clipping 
and coiling differed if randomisation occurred at an early stage, soon after diagnosis 
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of SAH (McDougall et al, 2012).  This study was initially constructed as a pilot and 
as a result was always underpowered. A total of 725 patients were screened, with 
472 assigned to coiling or clipping either by alternating fashion or by lottery for the 
last 100 patients. ‘Right of first refusal’ and crossover were allowed but results were 
presented in an intent-to-treat analysis. There was a 38% cross-over rate from 
clipping to coiling and a large proportion (12%) of patients without an aneurysm 
who did not undergo either treatment were also included, making the results 
somewhat difficult to interpret. Indeed, whether this can still be interpreted as a 
randomised trial is questionable. Initial results at 1 year showed a 10% reduction in 
death or disability (mRS >2) in the coiling group.  In a post hoc analysis of the 3-
year outcome data (Spetzler et al, 2013) in which those patients without an aneurysm 
were excluded, the authors concluded that for anterior circulation aneurysms there 
was no difference in outcomes for clipping and coiling and that clipping should be 
considered a more appropriate treatment due to the risks associated with retreatment, 
completeness of obliteration, and subsequent SAH risk.   
A subsequent 6-year outcome analysis was interpreted in a similar way 
(Spetzler et al, 2015), though independent analysis of the results (Macdonald et al, 
2015) highlighted that poor outcomes were observed in 41% of patients (72 of 174) 
who underwent clipping versus 35% of patients (57 of 162) who underwent coiling, 
with an absolute risk reduction for coiling of 6% and a relative risk reduction of 
17%. This is very similar to the results of ISAT.  Nevertheless, the authors stand by 
their interpretation of the results, and also suggest that scientific data from well-
designed trials is less important than an individual operator’s talent (McDougall & 
Spetzler, 2015). 
In some quarters, the optimal treatment option for anterior circulation 
aneurysms therefore remains a subject of debate and two topics are of particular 
importance.  Firstly, middle cerebral artery aneurysms lie in an anatomical location 
traditionally felt most suitable for surgical clipping and routine use of coiling here 
remains contentious.  The results of a study assessing a coil-first policy would be 
intriguing.  Secondly, although functional outcomes (measured using the mRS or 
GOS) may not be dissimilar, it has been reported that coiling is associated with 
better cognitive outcomes than clipping among patients whose level of dependence 
lies within the traditional ratings of independence (mRS 0-2 or GOS 5) (Hutter & 
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Gilsbach, 1993; Mavaddat et al, 1999; Hadjivassiliou et al, 2001; Scott et al, 2010).  
Despite lying within this range, patients may suffer cognitive deficits that prevent 
them from working and participating in other activities (Al-Khindi et al, 2010).   
Therefore, it is possible that there might be a much larger difference in 
outcomes between clipping and coiling but that functional outcome scales are 
insensitive to it.  A study assessing the anatomical reasons for a difference in 
cognition at a defined location would be of value. 
 
1.5 Endovascular treatment of middle cerebral artery aneurysms 
Ruptured middle cerebral artery (MCA) aneurysms represented only 303 
(14.1%) of the 2143 enrolled patients in ISAT (Molyneux et al, 2002) and of all 
aneurysm locations assessed in ISAT there was least difference in functional 
outcome between clipping and coiling at the MCA location (Molyneux et al, 2005).  
Many specialists consider this anatomical location an indication for surgical 
clipping: the location aids surgical access, and in some cases, surgery facilitates 
haematoma evacuation.  There is also a perceived increased risk for coiling in terms 
of thrombo-embolism and infarction at this site because these aneurysms are often 
wide-neck and have branches arising from the neck (Ausman et al, 1997, Regli et al, 
1999).  Recently, several surgical series have been published that demonstrate 
excellent clinical results with low rates of morbidity and mortality (Morgan et al, 
2010, van Dijk et al, 2011; Choi et al, 2012; Rodrıguez-Hernandez et al, 2013) and 
this practice has extended to treatment of unruptured aneurysms.  
As practice in the United Kingdom has shifted in many institutions to a coil-
first policy, there is a need for assessment of clinical outcomes using this approach to 
analyse how this compares to the results in ISAT and also those of recent surgical 
series.  A retrospective analysis was therefore undertaken of a prospectively acquired 
data base including 295 patients with 300 saccular MCA aneurysms treated using 
endovascular coiling at a regional neuroscience centre between November 1996 and 
June 2010 (Mortimer et al, 2014).  This is described in detail in Chapter 2.  Of the 
total, 244 (80.7%) ruptured aneurysms were treated. The technical failure rate was 
4.3% (13 patients). Complete occlusion or neck remnant was achieved in 264 
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(91.4%). Complications included rupture in 15 patients (5%), thromboembolism in 
17 patients (5.7%), and early rebleeding in 3 patients (1%). Overall permanent 
procedural-related morbidity and mortality were seen in 12 patients (7.8%). Of the 
ruptured aneurysms, 189 (79.4%) had a favourable clinical outcome (GOS 4–5). A 
total of 33 patients (13.6%) died. On initial angiographic follow-up, aneurysm 
remnant was seen in 18 aneurysms (8.1%). A total of 13 patients (4.3%) were 
retreated.  
These results compare very favourably with that of the best published 
surgical series (Morgan et al, 2010, van Dijk et al, 2011; Choi et al, 2012; 
Rodrıguez-Hernandez et al, 2013).  They are also in line with the results published in 
other smaller endovascular series and ISAT which suggests that they are 
reproducible (Molyneux et al, 2002; Iijima et al, 2005; Quadros et al, 2007; Oishi et 
al, 2009; Suzuki et al, 2009; Bracard et al, 2010) and that although the approach was 
different to ISAT (treating all-comers as opposed to just those aneurysms with more 
favourable morphology for coiling), clinical outcomes, complications, anatomical 
results and retreatment rates were in line with published benchmarks for aneurysms 
at all locations (Molyneux et al, 2002; Cognard et al, 2011).  Therefore, although the 
conservative view is that surgery should remain the treatment of choice of ruptured 
MCA aneurysms, except when there are extenuating comorbidities or overriding 
patient preferences, the results suggest that for the range of ruptured MCA 
aneurysms, at least equivalent clinical outcomes to the best surgical series can be 
obtained by use of conventional endovascular techniques.  
The use of adjunctive devices such as stent placement or balloon remodelling 
was very infrequent in this series, and intra-aneurysmal flow diverters were not used. 
Adjunctive devices have been used in 20.4% of other published MCA series 
(Brinjikji et al, 2011a),
 
with the aim of obtaining complete occlusion to minimize the 
risk for subsequent haemorrhage (Johnston et al, 2008).  A critical appraisal of the 
available literature has suggested that balloon assistance, which increases the range 
of lesions that can be treated has a very similar safety profile to coiling without 
remodelling (Pierot et al, 2012b).  Stent assistance has also been used successfully in 
large series of MCA aneurysms (Johnson et al, 2013a).  Stents allow more complete 
treatment of more complex lesions and may lower recurrence. However, there are 
reservations regarding procedural safety in patients with ruptured aneurysms.  
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Intra-aneurysmal flow diverters now represent an additional treatment option 
for wide-neck bifurcation aneurysms. Pierot et al (2013)
 
treated 34 ruptured and 
unruptured MCA aneurysms with the Woven Endobridge (WEB) device, a first 
generation intra-aneurysmal flow diverter.  Adequate occlusion (total occlusion or 
neck remnant) was observed in 83.3% of aneurysms with an acceptable safety 
profile; mortality rate of the treatment was 0.0% and morbidity rate was 3.1% 
(intraoperative rupture with an mRS of 3 at 1-month follow-up).  It is likely 
therefore, that new devices will further increase the range of endovascular options 
for aneurysms at this location and are potential avenues for future research into the 
optimal strategy for these lesions. 
 
1.6 Brain injury following treatment of anterior communicating artery 
aneurysms 
Approximately 50% of the patients treated in ISAT suffered SAH as a result 
of ruptured anterior cerebral artery (ACA) or anterior communicating artery 
(ACOM) aneurysms.  Minimal differences in the rate of poor functional outcome or 
death assessed using the modified Rankin Scale were demonstrated between clipping 
and coiling for aneurysms at this location (27.5% v 24.6%) (Molyneux et al, 2005). 
Nevertheless, patients may suffer significant cognitive impairment despite 
favourable functional outcome scores (Hutter & Gilsbach, 1993; Mavaddat et al, 
1999; Hadjivassiliou et al, 2001, Scott et al, 2010)
 
and it has been recognised for 
some time that surgical clipping may be associated with greater rates of cognitive 
impairment than coiling for aneurysms treated at this location (Chan et al, 2002; 
Fontanella et al, 2003; Proust et al, 2009).  Various patterns of neuropsychological 
impairment can occur (Böttger et al, 1998). 
  
Injuries to the basal forebrain and the fornix specifically have been 
implicated in resulting in memory impairment (Damasio et al, 1985; Phillips et al, 
1987; Abe et al, 1998; Wright et al, 1999; Hashimoto et al, 2000; Mugikura et al, 
2014; Meila et al, 2015). 
 
The basal forebrain contains a number of important structures including the 
nucleus accumbens, substantia innominata, nucleus basalis of Meynert, and medial 
septal-diagonal band of the Brocca complex (Fujii, 2008).  Basal forebrain lesions 
have been linked to the occurrence of amnesia and/or confabulation in a number of 
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case reports and series (Damasio et al, 1985; Phillips et al, 1987; Böttger et al, 1998; 
Abe et al, 1998; Goldberg et al, 1999; Wright et al, 1999; Hashimoto et al, 2000)
 
and a functional imaging study has also suggested that the basal forebrain is likely to 
play a role in episodic memory recall (Fujii et al, 2002).  The medial septal-diagonal 
band of the Brocca complex region is likely to be an important interface within the 
so-called septohippocampal system (Böttger et al, 1998).
   
Bilateral basal forebrain 
lesions do produce more severe memory deficits (Böttger et al, 1998).  The fornix is 
a compact fiber bundle connecting the hippocampus with the hypothalamus and a 
number of other structures including the septal area of the basal forebrain.  It is an 
important constituent of the Papez circuit and is involved in the formation and 
consolidation of declarative memories (Meila et al, 2015).  Diffusion-weighted MRI-
proven infarction limited to the fornices has been reported in conjunction with acute 
onset of amnesia, suggesting that an isolated injury to this structure may be critical 
(Mugikura et al, 2014).  Injuries to other vulnerable structures including the corpus 
callosum and caudate nucleus have also been implicated in resulting in neuro-
behavioural sequelae (Mendez et al, 1989; Kasow et al, 2000).
 
Caudate nucleus 
lesions may result in depression, agitation, abulia, neglect (right-sided lesions), 
memory disturbance (particularly if bilateral), dysarthria, aphasia (left-sided lesions), 
movement disorders (ballistic, choreatiform), or motor weakness. (Kumral et al, 
1999).
 
Structures within the basal forebrain, basal ganglia, and limbic system are 
vulnerable to injury during neurovascular procedures, probably through occlusion of 
ACA or ACOM artery complex perforating branch vessels, notably the recurrent 
artery of Heubner (RAH) or subcallosal artery (Mugikura et al, 2014; Meila et al, 
2015). 
 
Following treatment of ACOM artery aneurysms, a detailed radiological 
investigation into the rates and distribution of injury to the above structures is 
required to assess whether surgical treatment is associated with greater rates of 
injury; a potential cause of inferior cognitive outcomes in the surgical group.  
A retrospective dual-centre radiological investigation was undertaken of a 
consecutive series of patients with ruptured and unruptured ACOM aneurysms 
treated between January 2011 and October 2014 (Mortimer et al, 2016a).  This is 
described in detail in Chapter 3.  Sixty-six patients treated with clipping were 
compared with 93 patients treated with coiling.  Post-treatment CT or MRI showed 
32/66 (48.5%) patients in the clipping group suffered treatment-related injury (31 
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ischemic, 1 haemorrhagic) compared with 4/93 (4.4%) patients in the coiling group 
(3 ischemic, 1 haemorrhagic) (p<0.0001).  For patients with subarachnoid 
haemorrhage, the multivariate OR for infarction for clipping over coiling was 24.42 
(95% CI 5.84 to 102.14), p<0.0001.  The most common site of infarction was the 
basal forebrain (28/66 patients, 42.4%), with bilateral infarction in four patients. 
There was injury of the septal/subcallosal region in 12/66 patients (18%).  
Clipping of ACOM aneurysms was clearly associated with significantly 
higher rates of structural injury than coiling, and this may be a reason for superior 
cognitive outcomes in patients treated with coiling in previously published studies.  
Chan et al (2002)
 
studied 18 patients who had undergone treatment for ruptured 
ACOM aneurysms, half with clipping and half with coiling; 33% of the clipped 
patients showed severe impairment of memory and executive function whereas no 
coiled patient demonstrated this impairment.  
Fontanella et al
 
(2003)
 
assessed 37 consecutive WFNS grade I or II patients 
who underwent treatment of ACOM aneurysms within 48 h of rupture; 20 of 37 
were treated with clipping and 17 were treated with coiling.  Both groups were 
compared with 16 angiogram-negative patients with SAH and 18 normal controls. 
All patients were neurologically intact at discharge and were independent at 6-month 
follow-up after SAH.  Surgically treated patients showed a significant worse 
performance on the logical memory and on the frontal lobe executive functions 
compared with controls, while the endovascular group and the angiogram-negative 
group showed a significant decrease only in the literal fluency score.  Furthermore, 
the surgical group showed a significant impairment in using grammatical and 
syntactical rules to produce sentences.  Proust et al (2009)
 
studied 36 clipped and 14 
coiled patients at 14-month follow-up. They found no difference in executive 
dysfunction although there was a significant impairment of verbal memory in the 
clipped group.  
This raises the question of how to optimally treat these patients and this is 
one factor which may sway a decision towards endovascular approaches, and 
possibly the use of adjunctive techniques such as stent-assisted coiling for more 
complex lesions.  A systematic review of stent coiling at all locations in patients with 
SAH who were managed with dual antiplatelet therapy demonstrated clinically 
significant intracranial haemorrhagic complications in 27 (8%) of 339 patients, 
including 9 (10%) of 90 patients known to have had ventricular drain-related 
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haemorrhages.  Clinically significant thromboembolic events occurred in 16 (6%) of 
288 patients (Bodily et al, 2011).
 
 Perhaps a trial comparing more aggressive 
endovascular approaches (e.g. using stents or even flow diversion) with clipping for 
less favourable aneurysms, particularly for locations such as this, would be 
worthwhile.  Such a study should include neuropsychological testing as part of the 
outcome measures.   
 
1.7 Physiological derangement and choice of treatment modality 
Although there was little reference to physiological derangement or medical 
comorbidity or complications in either ISAT or BRAT studies, there is increasing 
recognition that these factors are significant contributors to poor outcome after SAH 
(Wartenberg et al, 2006; van der Bilt et al, 2009, Lantigua et al, 2015).  
Physiological derangement and medical complications are more common in poorer 
grade patients (Enblad & Persson, 1997).  Only 4.4% of patients recruited into ISAT 
were of poor clinical grade (WFNS 4 or 5).  The results of ISAT may therefore not 
directly apply to poor-grade patients. A recent multicentre prospective observational 
study demonstrated that after adjustment for baseline characteristics there was no 
significant difference in outcomes for coiling or clipping in this patient group (Zhao 
et al, 2015).   
Severity of illness scoring systems have shown better correlation with poor 
outcomes in SAH patients than acute neurological grading (Gruber et al, 1999) and 
there is little evidence regarding the interaction of treatment modality and presenting 
physiological derangement rather than neurological grade in isolation.  In 
comprehensive centres, the decision on whether to clip or coil an aneurysm is often 
based on the morphology and location of the aneurysm.  An alternative approach is 
to subject an acutely unwell patient to the least stressful procedure (namely an 
endovascular coiling), if even just to protect the aneurysm dome in the short term in 
order that they may recover to undergo a further protective procedure if required 
(Waldau et al, 2012).   
The Acute Physiology and Chronic Health Evaluation II (APACHE II) 
scoring system is widely used in many intensive care units and allows approximate 
prognostication based on a score from 0 to 71 for clinical and biochemical markers 
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of physiological function (Knaus et al, 1985).  This has been validated in the SAH 
population (Lantigua et al, 2015).  An assessment of how physiological
 
derangement 
interacts with treatment approach is required to answer whether the physiological 
condition of the patient should influence mode of treatment in the sickest patients. 
An exploratory analysis of prospectively collected trial data was therefore 
undertaken, comparing the outcomes of sixty-nine patients treated with clipping to 
sixty-six treated with coiling (Mortimer et al, 2016b).  This is described in detail in 
Chapter 4.  More profound physiological derangement (APACHE II score >15) was 
the strongest predictor of poor outcome in the overall cohort (OR 17.80, 95% CI 
4.78 to 66.21, p<0.0001). For those with more deranged physiology (APACHE II 
score>15; 59 patients), WFNS grade ≥4 (OR 6.74, 1.43 to 31.75) and surgical 
clipping (OR 6.33, 1.27 to 31.38) were significant predictors of poor outcome 
(p<0.05).  Favourable outcome (mRS 0-2) was seen in 11% of surgical patients 
compared with 38% of coiled patients in this subgroup. The results indicated an 
advantage for coiling in the more profoundly physiologically deranged subgroup.  
On multivariate analysis both poor grade and clipping were predictors of poor 
outcome. Furthermore, functional outcome differences by treatment modality for the 
WFNS grades 1–2 patients with high APACHE II scores tended to significance 
(favourable outcomes for clipping were seen in 30% and in 56% for coiling in this 
subgroup). Perhaps this did not reach significance as the study was underpowered. 
A number of authors have attempted to explain superior outcomes for coiling 
based on lower rates of cerebral vasospasm.  We did not see a significantly increased 
rate of angiographic vasospasm in the clipped patients yet clipped patients did have 
significantly increased total norepinephrine dose, ventilated days, and hospital stay 
(p<0.05).  A large Canadian multicentre study demonstrated that clipped patients 
more commonly suffered medical complications, such as urinary tract infection, 
pneumonia, cardiorespiratory arrest, and seizures, and that these complications were 
linked to poor outcome (Vergouwen et al, 2011c).   
It is therefore plausible that patients undergoing a more invasive procedure 
may require more inotropic support, more time ventilated, and more time in hospital.  
They could therefore take much longer to recover and are therefore more at risk of 
nosocomial infection and other medical complications.  The results also raise the 
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question of whether more profoundly sick patients should undergo a coiling as 
opposed to a clipping procedure. 
 
1.8 Invasive imaging in patients with perimesencephalic subarachnoid 
haemorrhage 
Perimesencephalic subarachnoid haemorrhage (PMSAH) accounts for 
approximately 5% of SAH and represents a distinct clinic-radiological entity 
characterised by haemorrhage centred on the perimesencephalic cisterns, aneurysm 
negative angiographic investigation and a more benign clinical course (van Gijn et 
al, 1985; Rinkel et al, 1991a; Rinkel et al, 1991b; Brilstra et al, 1997; Flaherty et al, 
2005; Greebe et al, 2007). An aneurysm is likely responsible for this pattern of 
haemorrhage in less than 1% of cases and CT angiography (CTA) with modern 
systems are highly sensitive for aneurysm detection (Westerlaan et al, 2011; Kalra et 
al, 2015).   
CTA is now commonly performed prior to digital subtraction angiography 
(DSA) to aid treatment planning through aneurysm identification and 
characterisation.  The traditional approach to investigating patients with SAH also 
includes mandatory use of DSA, the gold standard angiographic modality.  A review 
of the literature has demonstrated that the average risk of permanent neurological 
complications from DSA in patients with perimesencephalic haemorrhage was 
0.74% (95% CI, 0.09% to 2.7%) (Ruigrok et al, 2000).  This is a higher rate than 
seen in two subequent very large series of all consecutive DSA procedures 
performed in 19,826 (Kaufmann et al, 2007) and 2,899 patients (Willinsky et al, 
2003). The permenant neurological complication rate was 0.14% and 0.5% 
respectively. The relative increased risk in PMSAH patients could relate to age. 
Nevertheless, current European and American guidelines are ambiguous as to the 
need for invasive imaging with DSA in this setting and the majority of previous 
studies are of a relatively low number of patients (Connolly et al, 2012; Steiner et al, 
2013).  There is a need for an assessment of the diagnostic yield of DSA in the face 
of a negative CTA in a large cohort of patients with strictly defined PMSAH to 
elucidate the negative predictive value of CTA in this population and to guide 
whether DSA is a necessary investigation in the majority of cases. 
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The negative predictive value (NPV) of CTA was assessed in a series of 72 
patients with PMSAH treated at a regional neuroscience centre over a 9-year period 
(Mortimer et al, 2016c). This is described in detail in chapter 5.  A PMSAH pattern 
defined as blood centred anterior to the midbrain and/or pons within the pre-pontine 
or interpeduncular cistern with possible quadrigeminal or ambient cistern extension; 
possible extension into the basal parts of the Sylvain fissures but not the lateral 
sylvian fissures; possible extension to the cisterna magna but not centred on the 
cisterna magna; and possible extension into the fourth ventricle and occipital horns 
of the lateral ventricles.  
Of 72 patients, one patient showed a potentially significant finding on DSA 
that was not demonstrated on initial CTA (NPV 98.61% (95% CI 92.47% to 
99.77%)).  However, when cisterna magna extension was excluded from the 
definition of PMSAH, no false negative CTAs in 56 patients were encountered (NPV 
100% (95% CI 93.56% to 100.00%)).  The NPV of normal CTA for an arterial 
abnormality in patients with PMSAH is high and our results therefore question the 
role of invasive imaging and certainly imply that if a prospective study is required to 
fully evaluate this then this would be safe and feasible.  
 
1.9 Delayed cerebral ischaemia, cerebral vasospasm and endovascular    
approaches to prevent delayed infarction 
Cerebral infarction is strongly associated with poor outcome following SAH 
(Furgusson & Macdonald, 2007; Vergouwen et al, 2011b).  In the context of SAH, 
infarction could be the result of the acute injury, complications of the aneurysm 
securing procedure or the delayed ischaemic process.  For decades it has been 
assumed that the latter results from the development of cerebral vasospasm (Graham 
et al, 1983), detected angiographically as luminal narrowing of the proximal cerebral 
arteries.  The dominant factor determining the development of vasospasm is the 
presence of thick subarachnoid clot adjacent to the proximal cerebral arteries 
(Inagawa, 2015).  Angiographic vasospasm is an independent predictor of poor 
outcome following SAH (Vergouwen et al, 2011a).  An association between 
vasospasm in the development of delayed infarction is supported by the results of 
radiological studies that suggest that the majority of delayed infarcts occur in 
association with vasospasm, (Crowley et al, 2011; Brown et al, 2013) and that there 
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is a correlation between vasospasm severity and the incidence of infarction. The 
majority of vasospasm-related infarcts are associated with severe vasospasm, 
(Weidauer et al, 2007; Crowley et al, 2011; Inagawa et al, 2014) which results in the 
most severe perfusion deficits (Dankbaar et al, 2009; Vatter et al, 2011; Dhar et al, 
2012). Of patients with severe vasospasm, 50–100% develop cerebral infarction 
compared with 3–5% of patients without significant vasospasm (Weidauer et al, 
2007; Crowley et al, 2011; Inagawa et al, 2014).  Severe vasospasm is associated 
with poor cognition, worse patient-relevant outcomes, and greater inpatient 
healthcare resource use (Macdonald et al, 2012). 
More recently, the role of vasospasm in delayed ischaemia has been brought 
into question largely secondary to the finding that the trial drug clazosentan has been 
shown to improve rates of vasospasm but this did not translate into improved 
functional outcomes whereas nimodipine has been shown to improve clinical 
outcomes without an impact on vasospasm (Petruk et al, 1988; Feigin et al, 1998; 
Macdonald et al, 2008; Macdonald et al, 2011).   
 There are many potential reasons for a failure in correlation between 
reductions in the incidence of vasospasm but not in rates of poor outcome in the 
clazosentan trials.  First, poor grade patients who suffer a more significant acute 
neurological injury are those who are more likely to suffer the most severe 
vasospasm and therefore detecting differences with current outcome measures would 
probably require very large trials or alternative outcome measures.  Second, only 
severe vasospasm may result in significant reductions in cerebral blood flow so as to 
result in infarction and the inclusion of those with moderate vasospasm may dilute 
the treatment effect.  Third, vasospasm is likely to exert its clinical impact through 
infarction: factors such as age (Danière et al, 2014) govern the impact of infarct size 
on functional outcome.  Furthermore, the eloquence of the infarct area will result in 
variable functional impact.  Fourth, the systemic side effects of the treatment may 
have resulted in poor outcome through alternative mechanisms (medical 
complications) in the treatment arm. Lastly and importantly, rescue treatments such 
as endovascular intervention and systemic hypertension may have been effective in 
preventing a poor outcome in patients in the placebo arm.  
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 Some authors also question the correlation between vasospasm and the 
presence of clinical symptoms, the former approximately twice as common as the 
latter (Vergouwen et al, 2011a).  It is true that some patients with evidence of 
vasospasm are clinically asymptomatic or do not show overt clinical deterioration.  
This may be because moderate degrees of vasospasm that are not necessarily 
haemodynamically significant are included in analyses.  In many studies, non-
invasive measures of vasospasm with limited accuracy, sensitivity and specificity 
have also been used.  Furthermore, current measures of vasospasm severity often do 
not incorporate collateral flow or perfusion information or the eloquence of ischemic 
parenchyma, perhaps best assessed through combining angiographic and perfusion 
imaging.  Moreover, patients have variable haemodynamic reserve and respond 
differently to flow limitation; clues to this can be gleaned from the ischemic stroke 
literature.  Hakimelahi et al (2014) have recently reported that patients with ICA or 
proximal MCA occlusions demonstrated a wide range in diffusion-weighted infarct 
volumes within 30 hours of occlusive stroke onset; there was no correlation between 
infarct volume and time from stroke onset.  The observations suggest that highly 
variable cerebral perfusion via the collateral circulation may primarily determine 
infarct growth dynamics, and this has implications for patients with significant 
vasospasm.  
An intriguing possibility for this lack of correlation is that an alternative 
mechanism of delayed ischemia exists that may occur alone or in combination with 
proximal vasospasm.  It has been demonstrated that infarction can occur 
independently of severe cerebral vasospasm (Vergouwen et al, 2011a), and 
spreading depolarization with cortical ischemia may represent one mechanism that 
could account for this.  Woitzik et al (2012) have demonstrated in a series of 13 
patients that the number of spreading depolarizations in patients suffering delayed 
ischemic neurological deficits was significantly higher than in those without, when 
proximal vasospasm was minimised through treatment with nicardipine beads.  
Importantly though, just as vasospasm does not necessarily result in 
infarction, this process occurred without subsequent infarction in 6 of 10 patients on 
follow-up CT or MRI and the infarcts that were demonstrated in this series were 
small.  Spreading depolarization with vasoconstriction also occurs in the ischemic 
penumbra of stroke patients (Strong et al, 2012), raising the possibility that this 
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process could be triggered or compounded by the sustained ischemia of proximal 
vasospasm with the two mechanisms acting as a ‘dual hit’ (Strong & Macdonald, 
2012).  Of note, the incidence of spreading depolarizations is similar in patients with 
and without proximal vasospasm, (Dreier et al, 2006; Woitzik et al, 2012) 
suggesting that the spreading depolarization is not triggered by proximal vasospasm.  
When spreading ischemia was demonstrated in the absence of severe proximal 
vasospasm, infarcts were small (Woitzik et al, 2012).  In contrast, it has been 
demonstrated that patients can develop large infarcts in the presence of proximal 
vasospasm (Mortimer et al, 2015a).  Is it possible that perfusion deficits due to 
proximal vasospasm could increase the severity of spreading ischemia and expand 
infarcts?  Experimental evidence suggests that spreading ischemia is intensified by a 
decline in cerebral perfusion pressure, while increasing perfusion pressure can 
reverse the spreading ischemic process to an almost normal spreading hyperaemic 
response to depolarizations (Drier et al, 2000; Sukhotinsky et al, 2010).   
 If it is assumed that both spreading ischemia and proximal vasospasm act in 
concert, perhaps with the latter augmenting the former, the rationale for treatments 
that increase proximal luminal diameter including endovascular treatments may 
therefore be to improve cerebral perfusion and limit the impact of a microvascular 
process such as spreading ischemia.  This may be most relevant in instances where 
medical measures employed to improve flow (i.e. therapeutic hypertension) cannot 
overcome severe proximal stenoses and where collateral flow is limited.  The 
Poiseuille equation states that flow is directly proportional to the pressure gradient 
and radius to the fourth power and inversely proportional to the fluid viscosity and 
vessel length.  This formula forms the basis for hypertensive treatment in the 
intensive care unit but also for attempts to improve flow through an increase in 
vessel diameter.  While flow will increase with a change in pressure, it will increase 
markedly with a change in vessel diameter. 
Endovascular methods are most commonly employed as ‘rescue’ procedures.  
This has been shown to be effective in case series but neurological improvement is 
maximal if treatment is performed early and delayed treatment is probably futile.  
The use of prophylactic TBA undertaken prior to development of vasospasm has also 
been investigated in a multicentre randomised trial (Zwienenberg-Lee et al, 2009).  
Although there were significant reductions in the rate of patients requiring rescue 
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therapy in the treatment arm and possible outcome benefits in the good grade 
patients, overall clinical outcome was not significantly improved.  An alternative 
approach is to screen for vasospasm at or just before the time when the majority of 
patients develop symptoms.  The goal of this practice is to identify those patients 
with significant vasospasm who may benefit from treatment prior to development of 
symptoms or who are at risk of silent infarction as they are clinically too difficult to 
clinically assess.  One system employs angiographic surveillance for cerebral 
vasospasm at days 5–7 post ictus, at or just before the time point that most patients 
become symptomatic, with subsequent endovascular treatment and multiple 
procedures where necessary based not only on symptomology but also on 
radiographic features.  An assessment of the safety and efficacy of this approach is 
required. 
Studies encompassing both retrospective (Mortimer et al, 2015b) and 
prospective data (Mortimer et al, 2015c) were undertaken.  This is described in detail 
in Chapters 6 and 7 respectively.  In the former, the clinical and radiological 
outcomes of 57 WFNS grade 1-5 patients with severe vasospasm treated using this 
intensive endovascular regime were investigated (Mortimer et al, 2015b).  The mean 
number of procedures/patient was 6, range 2-13.  Mean verapamil dose administered 
to the ICA was 14 mg and VA was 12 mg.  Thirty-one patients underwent TBA 
(52.6%).  The rate of proximal vessel infarction was 3/45 (6.7%) for patients 
presenting < 72 hours.  Rates of favourable outcome (mRS 0-2) were 16/19 (84.2%) 
for WFNS grades 1-2, 12/19 (63.2%) for grades 3—4 and 5/19 (26.3%) for grade 5 
patients. Delayed presentation >72 hours was the only factor on multivariate analysis 
to significantly predict vasospasm related infarction (OR 19.3 (3.2-116.6) P = 
0.0012).  Large vasospasm related infarct (OR 19.0 (1.7-216.4) 0.0179) and poor 
WFNS grade (OR 6.6 (1.3-33.9) P = 0.0233) were significant predictors of poor 
outcome on multivariate analysis.  
In a second study (Mortimer et al, 2015c) which involved an exploratory 
analysis of prospectively acquired data, the clinical outcomes of 63 WFNS grade 1–2 
patients with minimal vasospasm were compared to those of 17 WFNS grade 1–2 
patients with severe vasospasm treated with induced hypertension and endovascular 
therapy.  For those with severe vasospasm, 8/17 patients (47%) underwent TBA with 
a total of 15 procedures.  Seventeen patients underwent verapamil chemical 
40 
angioplasty with a total of 67 procedures.  The mean total dose of verapamil that any 
one patient received at each procedure was 20.3±2.3 mg (range 5-40 mg). Functional 
outcomes were available in 62 and 16 patients, respectively.  Rates of favourable 
outcome did not differ significantly between the two groups. For patients with 
treated severe vasospasm, 90 day mRS 0-2 was seen in 15/17 (88.2%) and GOS 4–5 
was achieved in 16/17 (94.1%).   
The results of both studies suggest that the rates of infarction for patients 
with severe vasospasm treated using this protocol are relatively low compared to 
literature benchmarks; rates of infarction in other studies documenting severe 
vasospasm range from 46-81% (Weidauer et al, 2007; Cowley et al, 2011; Inagawa 
et al, 2014).  Additionally, functional outcomes are encouraging and were not 
dissimilar to those patients who did not suffer vasospasm with good initial 
presenting grade.  Complication rates were low but this regime is labour intensive.  
Furthermore, there is a danger that employing this approach could result in invasive 
imaging and unnecessary treatments in the group of patients who can withstand 
relatively severe vasospasm without detriment.  Other centres employ non-invasive 
methods of vasospasm detection including transcranial Doppler (TCD) and/or a 
combination of CT angiography and CT perfusion.  This may be the optimal 
approach, particularly in those patients who are sedated and difficult to assess 
clinically but TCD is operator dependant and CT techniques incur use of radiation, 
though with modern systems perfusion imaging can be acquired using a more 
acceptable radiation dose.   
The results of these studies are encouraging but the realm of vasospasm 
intervention remains relatively evidence-light and the literature contains many 
studies with variable indications for treatment and variable treatments and, the 
disease itself is heterogeneous and there are many other factors which could 
potentially impact on outcome.  There is an on-going randomised controlled trial 
assessing the use of intra-arterial verapamil versus a cocktail of intra-arterial 
vasodilators, including verapamil, nicardipine and nitrates (Chen, 2015).  The doses 
of drugs used in this trial are relatively low compared to that published in other 
series including the present studies.  There is much work to be done on identifying 
the optimal dosage and duration of action which could employ the use of animal 
models.  An additional area of research is the study of the effect of intra-arterial 
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agents on other mechanisms of delayed ischaemia such as cortical spreading 
depression, a topic that has thus far received little attention due to the difficulty of 
measuring the latter process non-invasively.   
 
1.10 The need for long term follow-up of coiled aneurysms      
Aneurysm recurrence following coil occlusion is well recognised (Ferns et al, 
2009).  Intuitively this is investigated to allow retreatment of recurrent aneurysms 
that may pose a risk of rehaemorrhage.  A number of studies have demonstrated an 
inverse relationship between the degree of occlusion and the risk of rerupture 
(Johnston et al, 2008; Sherif et al, 2012).  This risk is dominant in the acute phase 
and it is unlikely that a high risk persists after a treated aneurysm has stabilised.  
There is little consensus regarding which aneurysms should be retreated and 
there is little consensus regarding how long aneurysms should be followed with 
imaging to assess for recurrence.  This is now commonly performed with magnetic 
resonance angiography (MRA) rather than DSA but long-term follow-up may be 
linked to anxiety/depression so could be detrimental (Ferns et al, 2011a). 
Furthermore, the results of analyses by other groups suggest that the majority of 
recurrences are identified on early follow-up at 6 months (Sluzewski et al, 2003, 
Ferns et al, 2011b).  There is therefore a need for analysis of the rate of late 
recurrence in aneurysms that appear adequately occluded at initial 6-month follow-
up.  An additional question that requires investigation is whether with improving coil 
and angiographic technology rates of later recurrence are falling. 
 A retrospective analysis of aneurysms treated at a neuroscience centre 
between 1995 and 2010 was undertaken (Mortimer et al, 2015d).  This is described 
in detail in Chapter 8. Four hundred and thirty-seven patients with 458 adequately 
occluded aneurysms at 6 months had mean long-term follow-up of 31 months; 57 
(12.4%) were large (≥10 mm) and 104 (22.7%) were wide-necked (>4 mm). Nine 
aneurysms (2%) showed significant late anatomical deterioration whereby 
retreatment was considered or undertaken.  The risk was greater for large aneurysms 
(≥10 mm) (OR 15.61, 95% CI 3.79 to 64.33, p=0.0001) or wide-necked aneurysms 
(>4 mm) (OR 12.70, 95% CI 2.60 to 62.13, p=0.0017).  Of those aneurysms that 
were completely occluded at 6 months, 16 (5.5%) showed deterioration to small neck 
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remnant on late follow-up, but none of these aneurysms required retreatment.  All 
remain adequately occluded. 
 The 1996–2005 cohort, (197 patients with 198 aneurysms) and 2006–2010 
cohort, (241 patients with 260 aneurysms) were compared. The rate of significant 
recurrence was 3.5% in cohort 1 and 0.8% in cohort 2 (p=0.0345).  The rate of 
retreatment was also significantly lower in cohort 2 (p=0.0221).  It was speculated 
that this coincided with the introduction of a biplane unit and 3D rotational 
angiography that could have improved assessment of the aneurysm neck and local 
anatomy and also the introduction of next generation coil technology including 360 
(Boston, now Stryker) and Axium 3D (eV3/Covidien) coils.  Although we did not 
formally assess packing density, complex-shaped platinum coils have been shown to 
increase packing density (Wakhloo et al, 2007). 
 The results therefore suggest that at 6-month follow-up, adequately occluded, 
small, narrow-necked aneurysms may not need further imaging evaluation.  
Furthermore, the results suggest that the rate of late re-opening may be lower in 
patients treated with more contemporary coil technology.  It should be remembered 
that the degree of occlusion is being used as a surrogate for risk of rebleeding.  There 
is some evidence that the degree of occlusion is related to rebleeding risk (Johnston 
et al, 2008; Sherif et al, 2013) but the risk of rehaemorrhage beyond the first year is 
low and lies between 0.11%
 
and 0.21% per year (Johnston et al, 2008; Molyneux et 
al, 2009).  Conceivably, if only adequately occluded aneurysms are included in this 
analysis, the rate of delayed rebleeding would be lower than this.  The very low 
incidence of aneurysm rebleeding therefore questions the validity and cost-
effectiveness of performing routine long-term follow-up imaging of small, narrow-
necked intracranial aneurysms completely obliterated after 6-12 months. 
 
1.11 Conclusion 
The results of this research suggest that a pragmatic imaging approach to 
subarachnoid haemorrhage may well be justified.  In both the initial investigation of 
perimesencephalic haemorrhage, where non-invasive imaging may well suffice and, 
in post-coiling follow-up imaging, where a single episode may be all that is required 
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following adequate coiling, this may well be the case.  The results of a large 
consecutive series of middle cerebral artery aneurysms suggest that the endovascular 
approach to treating the lesions (often regarded as the most favourable for surgical 
clipping) is justified.  Furthermore, the differences in cognitive outcome following 
clipping or coiling of aneurysms are now well established and the results of a 
detailed post procedural imaging analysis suggest that this is likely due to differences 
in local ischaemic brain damage.  The results of this work also suggest that the more 
physiological derangement there is in a patient with SAH, the less outcomes favour a 
surgical approach.  An additional finding is that an aggressive endovascular 
approach to delayed cerebral ischaemia may result in low rates of delayed infarction 
and equivalent rates of favourable outcome when compared to patients of similar 
grade without vasospasm. 
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2.1 Abstract 
2.1.1 Background 
There is controversy as to the best mode of treating MCA aneurysms. We 
report the results of a large endovascular series of patients treated at our centre.  
 
2.1.2 Materials and methods 
This study was a retrospective analysis of a prospectively acquired data base. 
All patients with saccular MCA aneurysms treated between November 1996 and 
June 2012 were included. World Federation of Neurosurgical Societies grade, 
aneurysm site, size, and aneurysm neck size were recorded, along with clinical 
outcome assessed with the Glasgow Outcome Scale and radiographic occlusion 
assessed with the Raymond classification at 6 months and 2.5 years.  
 
2.1.3 Results 
A total of 295 patients with 300 MCA aneurysms were treated including 244 
ruptured aneurysms (80.7%).  The technical failure rate was 4.3% (13 patients).  
Complete occlusion or neck remnant was achieved in 264 (91.4%).  Complications 
included rupture in 15 patients (5%), thromboembolism in 17 patients (5.7%), and 
early rebleeding in 3 patients (1%).  Overall permanent procedural-related morbidity 
and mortality were seen in 12 patients (7.8%).  Of the patients with ruptured 
aneurysms, 189 (79.4%) had a favourable clinical outcome (Glasgow Outcome Scale 
score, 4–5). A total of 33 patients (13.6%) died.  On initial angiographic follow-up, 
aneurysm remnant was seen in 18 aneurysms (8.1%). A total of 13 patients (4.3%) 
were retreated.  
 
2.1.4 Conclusion 
Our experience demonstrates that endovascular treatment of MCA aneurysms 
has an acceptable safety profile with low rates of technical failure and retreatment. 
Therefore, coiling is acceptable as the primary treatment of MCA aneurysms.  
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2.2 Introduction 
The International Subarachnoid Aneurysm Trial (ISAT) demonstrated an 
absolute 6.9% reduction in the rate of death or dependency at 1 year for patients 
treated with endovascular coiling (EVC) (Molyneux et al, 2002).  ISAT did not, 
however, address the specific issue of patients with MCA aneurysms, who 
represented only 303 (14.1%) of the 2143 enrolled patients.  This has resulted in 
controversy as to the best mode of treatment of aneurysms at this location.  Surgical 
clipping remains the standard treatment in many institutions.  The anatomic location 
aids surgical access, and in some cases, surgery facilitates haematoma evacuation.  
There is also a perceived increased risk for EVC at this site because these aneurysms 
are often wide-neck and have branches arising from the neck (Ausman et al, 1997, 
Regli et al, 1999).  Recently, several surgical series have been published that 
demonstrate excellent clinical results with low rates of morbidity and mortality 
(Morgan et al, 2010, van Dijk et al, 2011; Choi et al, 2012; Rodrıguez-Hernandez et 
al, 2013).  Therefore, we analysed the strategy at our institution where EVC is the 
first-line therapy for aneurysm treatment at any location and focused on the more 
controversial MCA aneurysms. 
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2.3 Materials and methods  
2.3.1 Patient population  
This was an observational, prospectively collated study of 295 consecutive 
patients referred to our institution for endovascular treatment of ruptured and 
unruptured MCA aneurysms.  All patients underwent primary EVC during a 15.5-
year period (between November 1996 and June 2012).  All patients with SAH were 
considered for EVC as the primary treatment technique when a consultant 
interventional neuroradiologist was available.  Elective cases were discussed at our 
institutional neurovascular multidisciplinary meeting.  Patients with fusiform or 
dissecting aneurysms and those treated with primary parent vessel occlusion were 
excluded from this study. Patient information, aneurysm characteristics, details of 
treatment, and clinical course were entered prospectively into a data base and 
subsequently analysed.  
SAH was confirmed by cranial CT or lumbar puncture and CSF analysis. Of 
those with unruptured aneurysms, 21 patients with 23 aneurysms had previous SAH 
and delayed treatment of additional MCA aneurysms or SAH that was clearly the 
result of another aneurysm, with the additional MCA aneurysm treated in the same 
procedure.  Thirty-two patients with 33 MCA aneurysms diagnosed incidentally 
were also treated.  
 
2.3.2 Endovascular procedure  
All procedures were performed by consultant interventional neuroradiologists 
(S.A.R., M.D.B., and A.J.M. with 5, 3, and 20 years of endovascular experience 
when they started coiling patients within the study period, respectively).  EVC was 
performed by use of conventional techniques with the patients under general 
anaesthesia and systemic heparinisation.  A bolus of 3000–5000 IU of heparin was 
followed by continuous infusion via the catheter flushing system at a concentration 
of 5 IU/mL.  The aim was to place coils sequentially into the aneurysmal sac to the 
point of angiographic occlusion.  Most coils deployed were bare platinum (Boston 
Scientific, now Stryker, Kalamazoo, Michigan; Micrus, now Codman Neurovascular, 
Raynham, Massachusetts; ev3, now Covidien, Dublin, Ireland).  After diagnostic 
angiography, the aneurysm was selectively catheterised with a microcatheter by use 
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of standard techniques, through a guide catheter positioned in the internal carotid 
artery.  
Where necessary, balloon remodelling (12 cases primary treatment, 4 cases 
retreatment) and stent-assisted coil embolization (1 case primary treatment, 1 case 
retreatment) were used for the treatment of wide-neck aneurysms. Intravenous 
aspirin (500 mg) was used as a prophylaxis to prevent thromboembolic 
complications in both ruptured and unruptured aneurysms, administered after initial 
coil deployment when a degree of protection had been attained.  Intravenous aspirin 
was also administered if a stent was deployed.  Technical failure was defined as an 
attempted embolization procedure during which coils could not be deployed safely. 
Any procedural or other subsequent complication was recorded in addition to any 
deterioration in the patient’s neurologic status after the procedure.  Craniotomy and 
haematoma evacuation or decompressive hemicraniectomy were performed to 
manage haematoma/herniation, after coil embolization.  
 
2.3.3 Aneurysms treated  
The aneurysm responsible for haemorrhage was identified by blood 
distribution on CT, aneurysm appearance, and vasospasm distribution.  This 
aneurysm was treated first.  Additional aneurysms were treated during the same 
procedure or after recovery from haemorrhage.  If it was not possible to clearly 
identify the ruptured aneurysm, all possible candidates were treated initially, and 
aneurysms were classified as ruptured.  If contralateral aneurysms were treated at a 
later date, these were classified as unruptured.  
 
2.3.4 Clinical and radiologic follow-up  
Clinical outcome was independently obtained for all at a 3 to 6-month clinic 
visit with a specialist neurovascular nurse practitioner and was assessed by use of the 
Glasgow Outcome Scale (GOS).  Each patient was scheduled to undergo either 
cerebral angiography (before 2004: 48 patients) or MRA (since 2004: 174 patients) 
at 6 months after treatment and then at approximately 30 months after initial 
treatment.  If early recurrence was anticipated, initial follow-up was obtained earlier.  
If recurrence was demonstrated on MRA, formal conventional angiography was 
performed.  
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The degree of aneurysm occlusion was assessed on immediate post 
embolization angiography and on follow-up angiography.  Angiographic and MRA 
outcomes were determined by the treating physician and were classified according to 
the Raymond classification.  An aneurysm was considered stable on follow-up if 
there was no increase in contrast filling on angiography or flow on MRA.  
Retreatment was considered in persistent or evolving aneurysmal remnants.  
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2.4 Results 
2.4.1 Patient population and aneurysm characteristics 
Of the 295 patients, 196 (66.7%) were women and 98 (33.3%) were men.  A 
total of 244 ruptured aneurysms in 242 patients and 56 unruptured aneurysms in 53 
patients comprised the study cohort.  The mean age of the patients in the ruptured 
cohort was 53.9 years; for the patients in the unruptured cohort, it was 52.7 years 
(table 2.4.1.1). For the 242 patients with SAH, World Federation of Neurosurgical 
Societies (WFNS) and Fisher grading is shown in table 2.1.  
A total of 264 aneurysms (88%) were located at the main MCA branching 
point; 23 (7.7%) were positioned proximal to this location, and 13 (4.3%) were 
positioned more distally.  There were 232 aneurysms (77%) that were small (10 mm) 
and 64 (21%) that were large (11–24mm).  Giant aneurysms constituted 1.3% of the 
cohort (4 cases), and 93 aneurysms (31%) were wide-neck (4 mm).  Twenty patients 
(8.3%) with SAH (other than those subsequently referred for clipping after a failed 
attempt at coiling) went on to have a craniotomy and haematoma evacuation or 
hemicraniectomy.  
Surgical data were available from 2000–2012; 51 patients with ruptured 
aneurysms underwent primary surgical clipping.  A total of 36 patients were treated 
with primary clipping because of either lack of availability of an interventional 
neuroradiologist or if the patient was being treated by a vascular neurosurgeon (most 
aneurysms were clipped before 2003).  Eight aneurysms were clipped because of 
anatomic considerations after angiography.  
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CHARACTERISTIC Unruptured Ruptured 
Number of patients 
(n=295) 
53 242 
Number of aneurysms 
(n=300) 
56 244 
Mean (SD) age (y) 52.7 (9.6) 53.9 (12.4) 
Median (IQR) age (y) 55.0 (13.5) 53.0 (17) 
Age range (y) 29-72 21-84 
No of females 38 (73.1%) 158 (65.3%) 
WFNS Scale  
1 - 136 (56.2%) 
2 - 38 (15.6%) 
3 - 25 (10%) 
4 - 21 (8.6%) 
5 - 22 (9.1%) 
Fisher Grade  
1 - 11 (4.5%) 
2 - 20 (8.3%) 
3 - 104 (42.6%) 
4 - 108 (44.6%) 
 
Table 2.1 Descriptive data for the study population. 
 
 
In 13 cases, the patients were treated with clipping after attempted coiling. In 
the same period, 16 patients with unruptured MCA aneurysms were treated with 
elective primary clipping.  The indications were patient choice or difficult 
aneurysmal morphologic features. 
 
2.4.2 Procedural success  
Initial coiling results are summarised in table 2.2.  Technical failure was seen 
in 13 aneurysms (5 unruptured and 8 ruptured), equating to 4.3% of treated 
aneurysms. These patients went on to have microsurgical clipping. A total of 215 
aneurysms were completely occluded on initial conventional angiography (71.7%), 
and neck remnant was seen in 59 patients (19.7%), resulting in a rate of satisfactory 
occlusion of 91.4%.  An aneurysmal remnant was seen in 9 patients (3%). In 2 
patients, a complication precluded EVC. 
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Initial angiographic 
result 
 
Unruptured 
N=56 
Ruptured 
N=254 
Total 
N=300 
Complete occlusion 28 187 215 (71.7%) 
Neck remnant 17 42 59 (19.7%) 
Aneurysm remnant 3 6 9 (3.0%) 
Technical failure 5 8 13 (4.3%) 
Complication 
precluding coiling 
1 1 2 (0.7%) 
Missing data 1 1 2 (0.7%) 
 
Table 2.2 Initial coiling results. 
 
2.4.3 Complications  
Complications and clinical outcome are summarised in table 2.3.  The 
technical complication rate was 12.9%, including aneurysmal perforations and 
thromboembolic events with either silent or transient symptoms.  The overall 
permanent procedural-related morbidity rate was 3.8% (11 patients) and mortality 
rate was 4% (12 patients), equating to a permanent morbidity and mortality rate of 
7.8% (23 patients).  Of those patients who experienced a technical complication, 26 
(68.4%) of 38 had a favourable outcome (GOS, 4 or 5).  
When unruptured aneurysms were considered separately, 1 patient had 
transient arm weakness that fully resolved and 1 patient (1.8%) died as a result of 
aneurysmal perforation, but no other permanent complications were encountered.  
 
 
Complication Aneurysm 
rupture 
Thromboembolic Early 
rebleed 
 
Other Total 
Total number 15 (5.0%) 18 (6%) 3 (1.2%) 2 (0.7%) 38 (12.9%) 
Clinically 
silent 
6 6  2 14 (4.7%) 
GOS 5 7 10  2 19 
GOS 4 5 2   7 
GOS 1 3 6 3  12 (4%) 
 
Table 2.3 Complications and subsequent clinical outcomes. 
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2.4.3.1 Aneurysmal perforation 
Fifteen patients (5% of procedures) had intra-procedural aneurysmal 
perforations. In 10 patients, the perforation occurred during coil insertion.  In 1 
patient, the perforation was secondary to remodelling balloon inflation; in another 
patient, perforation was secondary to contrast injection before intervention.  When 
rupture occurred, heparin was reversed immediately with protamine; coiling 
continued to limit the extent of haemorrhage and occlude the aneurysm; and 
measures were used, if necessary, to reduce intracranial pressure via ventricular 
drainage of CSF. Six ruptures were clinically silent.  Three patients died after 
rupture; 12 had an independent outcome (GOS, 4–5). 
 
2.4.3.2 Thromboembolic events   
Eighteen patients (6% of procedures) experienced thromboembolic 
complications. These were managed by intravenous aspirin and abciximab and 
induced hypertension.  Of these thromboembolic complications, 6 were clinically 
silent and 3 were transient. Twelve patients were independent (GOS, 4–5), and 6 
patients died.  
 
2.4.3.3 Rebleeds 
Three patients (1.2%) experienced early rebleeds. All occurred within 24 
hours of the procedure, and 3 patients died.  
 
2.4.3.4 Other complications  
Coil protrusion was noted in 2 patients with no clinical sequelae. 
 
2.4.4 Clinical outcome 
Of the patients with ruptured aneurysms, 79.8% had a favourable clinical 
outcome (GOS, 4–5).  A total of 33 patients (13.6%) died (table 2.4).  One of 53 
patients with an unruptured aneurysm died as a result of procedural rupture and was 
the only patient who experienced a permanent change in neurologic status as a result 
of the procedure.  Of the patients who underwent a craniotomy or craniectomy for 
management of haematoma or mass effect, 8 (40%) of 20 achieved a clinical 
outcome of GOS 4.  The mortality rate was 45% in this subgroup. 
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Clinical outcome Patients 
 
GOS 5 170 (70.3%) 
GOS 4 23 (9.5%) 
GOS 3 15 (6.2%) 
GOS 2 0 
GOS 1 33 (13.6%) 
Missing data 1 (0.4%) 
 
Table 2.4 Clinical outcomes for patients with ruptured MCA aneurysms. GOS, Glasgow 
Outcome Score. 
2.4.5 Anatomic outcome 
Initial follow-up (mean, 7 months; range, 3–17 months) was available in 219 
patients.  Allowing for those patients who died, follow-up was available in 84%.  
Reasons for no follow-up included a dead or severe outcome in 38 patients, 
advanced age in 12 patients, microsurgical clipping as a definitive treatment in 13 
patients, patient choice in 7 patients, and unknown reasons in 6 patients.  Medium- to 
long-term follow-up (mean, 35 months; range, 18–108 months) was available in 158 
patients.  Twenty-two patients were ineligible because they were due this follow-up 
beyond the study period.  Therefore, medium- to long-term follow-up was available 
in 80% of patients who had undergone initial follow-up and in 66% of the patients 
who were eligible for late follow-up and had survived the acute episode.  Reasons 
for halting anatomic follow-up after initial follow-up were advanced age in 17 
patients, out-of-region follow-up in 5 patients, patient choice in 12 patients, death 
from unrelated cause in 3 patients, and unknown reasons in 2 patients. Initial 
angiographic follow-up is summarised in table 2.5.  
Complete occlusion was seen in 148 aneurysms (67.6%), a neck remnant was 
seen in 53 (23.3%), and an aneurysmal remnant was seen in 18 aneurysms (8.1%).  
Stable or improved appearances were seen in 178 (81.3%) of 219 aneurysms.  
Twenty-three (10.5%) showed minor anatomic deterioration to the neck remnant but 
remained satisfactorily occluded.  Of those aneurysms with complete occlusion at 
post-coiling angiography undergoing initial follow-up (n=164), the probability of 
complete occlusion was 84.1% (138 aneurysms), of a neck remnant was 12.2% (20 
aneurysms), and of aneurysmal remnant was 3.6% (6 aneurysms). Of those 
aneurysms with a neck remnant at post-coiling angiography undergoing initial 
follow-up (n=47), the probability of complete occlusion was 19.2% (9 aneurysms), 
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of a neck remnant was 70.2% (33 aneurysms), and of an aneurysmal remnant was 
10.6% (5 patients).  
 
Table 2.5 Angiographic outcomes at initial follow-up. 
 
A total of 18 aneurysms (8.1%) showed an aneurysmal remnant at initial 
follow-up, 6 had shown a similar aneurysmal remnant on immediate post-coiling 
angiography, and 12 aneurysms demonstrated deterioration from complete occlusion 
or a neck remnant to an aneurysmal remnant.  Aneurysmal remnants were more 
common in patients with large and giant aneurysms compared with small aneurysms 
at follow-up (15.6% vs 6.3%; P=0.04).  Wide-neck aneurysms were also 
significantly more common in patients who showed an aneurysmal remnant at 
follow-up compared with those with complete occlusion (19.6% vs 55.6%; P < 
0.001).  There were 13 (4.3%) of these patients who were retreated (12 with further 
coiling and 1 with microsurgery).  The remaining 5 patients showed a stable 
aneurysmal remnant and were treated conservatively.  
A total of 158 patients underwent long-term follow-up: 110 patients (69.4%) 
showed complete occlusion, 43 (27.4%) showed a neck remnant, and 5 (3.1%) 
showed an aneurysmal remnant.  A total of 150 (95%) patients, including the 
retreated patients, showed stable appearances.  A new neck remnant that did not 
warrant retreatment was seen in 7 patients, and new aneurysmal remnant was seen in 
only 1 patient. 
 
CHARACTERISTIC Complete 
occlusion 
Neck 
Remnant 
Aneurysm 
remnant 
Retreat 
All aneurysms (n=219) 148 
(67.6%) 
53  
(23.3%) 
18  
(8.1) 
13  
(5.9%) 
Ruptured aneurysms 
(n=175) 
 
117 42 16 13 
Unruptured aneurysms 
(n=44) 
31 11 2 0 
-Small  ≤10mm  137 26 11 6 
-Large 11-24mm  9 26 6 6 
-Giant  ≥25mm  2 1 1 1 
-Wide neck >4mm  29 24 10 7 
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2.4.6 Retreatment 
Twelve of 13 recurrent aneurysms were retreated (4.3% of all aneurysms) 
with coil embolization and 1 with microsurgical clipping. One of 12 endovascular 
patients required 4 additional treatments for a recurrent, large, wide-neck aneurysm; 
she refused surgery. Subsequent angiographic follow-up was available in these 
patients, and 5 achieved complete occlusion (including 1 patient who underwent 
microsurgery), 4 showed a neck remnant, and 4 showed a residual aneurysm. Stent 
or balloon-assisted coiling was used in 5 recurrent aneurysms. No morbidity or 
mortality was related to EVC. 
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2.5 Discussion 
Controversy has existed as to the best mode of therapy for MCA aneurysms.  
The anatomy of MCA aneurysms is often considered more favourable for surgical 
treatment because of the frequency of a wide-neck configuration with incorporation 
of MCA branches that are technically more challenging to treat by EVC.  ISAT 
demonstrated that 116 (71.6%) of 162 endovascular patients and 100 (71.9%) of 139 
surgical patients attained independence (mRS, 0–2) (Molyneux et al, 2005); 
however, MCA aneurysms were relatively underrepresented in ISAT, owing to the 
absence of clinical equipoise at the time of recruitment.  This has led to criticism of 
the practice of applying ISAT to MCA aneurysms and the generalised adoption of 
EVC for aneurysms at this location.  We therefore review the clinical and radiologic 
outcomes of this series in the context of the endovascular and surgical literature.  
 
2.5.1 Clinical outcome in patients with ruptured aneurysms 
Favourable clinical outcomes (mRS, 0–2) for ruptured aneurysms at all 
locations in ISAT (Molyneux et al, 2002) and CLARITY (Cognard et al, 2011) 
(Clinical and Anatomical Results in the Treatment of Ruptured Intracranial 
Aneurysms, a multicentre prospective study of consecutively coiled patients) were 
76.3% and 72.3%, respectively, with the proportion of favourable presenting clinical 
grade patients (WFNS, 1–2) being 88% and 65.7%, respectively.  Favourable clinical 
outcomes (mRS, 0–2 and GOS, 5) in other large series of ruptured MCA aneurysms 
comprising at least 50 patients treated with EVC, are within the 67%–85% range 
(Iijima et al, 2005; Quadros et al, 2007; Oishi et al, 2009; Suzuki et al, 2009; 
Bracard et al, 2010). 
In the present study, the largest published single-centre experience to date, 
patients with consecutive ruptured MCA aneurysms achieved good outcome (GOS, 
5) in 70.3% and favourable outcome (GOS, 4 and 5) in nearly 80%, with the 
proportion of favourable presenting clinical grade patients (WFNS, 1-2) being 72%.  
We were able to directly compare the results of our present study to a large audit of 
ruptured aneurysms at all locations treated through EVC at our institution with 
similar distribution of clinical grade (Renowden et al, 2009). In this study, 711 
patients with 717 ruptured aneurysms were reviewed.  In the 605 patients with 
aneurysms at all locations other than the MCA, favourable outcome (GOS, 4 and 5) 
was seen in 490 (80.9%). Mortality occurred in 89 patients (14.7%). Statistical 
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comparison of clinical outcomes for patients with ruptured MCA aneurysms in the 
present study showed no significant difference in the favourable outcome (P=0.58) 
or mortality (P=0.69). 
Other than the ISAT
 
results (Molyneux et al, 2005), prospective data on 
outcomes for clipping of ruptured MCA aneurysms are lacking.  In 1990, The 
International Cooperative Study on the Timing of Aneurysm Surgery (Kassell et al, 
1990),
 
a multicentre prospective observational study, included 786 patients with 
ruptured MCA aneurysms.  A total of 480 patients (61%) achieved good outcome 
(GOS, 5) at 6 months.  Following this, Rinne et al (1996)
 
published one of the largest 
series of 561 patients with 690 MCA aneurysms, 91% presenting with SAH and 80% 
with Hunt and Hess grades I-III. Overall favourable outcome (GOS, 5) was 60%.  
Poor outcomes (GOS, 1-3) were seen in 32%, and this rate was higher in large or 
giant aneurysms.  It is surprising to note that there were significantly more poor 
outcomes among patients with ruptured MCAs than among those with any other 
anterior circulation aneurysms (32% and 25%, respectively).    
After ISAT, several single-centre studies have been published.  Guresir et al
 
(2011)
 
treated 168 patients with ruptured MCA aneurysms.  Favourable outcome 
(mRS, 0–2) was 55% at 6 months. At the other end of the scale, among 80 patients 
treated by Van Dijk et al (2011)
 
including 67% with WFNS grades I–II, 80% 
achieved an mRS of 0–2 at longer-term clinical follow-up (mean, 4.7 years).  In one 
of the largest and most complete recent series, Rodrıguez-Hernandez et al (2013) 
treated 282 ruptured MCA aneurysms with 78% of patients presenting with Hunt and 
Hess grades I–III; favourable outcomes (mRS, 0–2) were achieved in 70.2%.  
These results are similar to those achieved in the present study by using EVC.  
Therefore, although the conservative view is that surgery should remain the 
treatment of choice of ruptured MCA aneurysms, except when there are extenuating 
comorbidities or overriding patient preferences, we believe that for the range of 
ruptured MCA aneurysms, at least equivalent clinical outcomes to the best surgical 
series can be obtained by use of conventional endovascular techniques.  
 
2.5.2 Coiling in the presence of intracerebral haematoma  
One of the traditional advantages of a clipping strategy is that it allows 
haematoma evacuation.  An alternative approach is to protect the aneurysm before 
evacuation through coiling.  It is possible that this approach is more advantageous 
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because haematoma evacuation in the presence of an unprotected aneurysm may 
initiate intra-procedural rupture (Houkin et al, 1999).
  
Furthermore, clipping may 
require a more extensive surgical exposure to access the aneurysm, perhaps 
involving retraction of contused parenchyma, which can result in oedema or 
ischemia (Yundt et al, 1997); this would no longer be required.  By use of this 
approach in the present series, of 20 patients with WFNS grades III or higher (14/20 
were grades IV and V), 40% of patients achieved an outcome of GOS 4.  Other small 
series have also achieved more impressive outcomes in poor-grade patients by using 
this approach (Tawk et al, 2010).  
 
2.5.3 Technical success  
The coiling procedure was successfully performed in 94.4% of aneurysms 
with post-treatment imaging, demonstrating that 71.7% were completely occluded 
and 19.7% exhibited a neck remnant, equating to a satisfactory occlusion rate of 
91.4%.  The technical failure rate was 4.3%.  These results are very similar to the 
results of a systematic review of 12 series comprising a total of 1030 patients with 
1076 MCA aneurysms (500 patients had ruptured aneurysms, and 541 had 
unruptured aneurysms) (Brinjikji et al, 2011a). 
 
In that study, the EVC failure rate 
was 4.8% (95% CI, 3.7%–6.3%).  Overall, 82.4% (95% CI, 80.0%–84.6%) of MCA 
aneurysms were completely or nearly completely occluded at immediate 
postoperative angiographic follow-up, and 12.7% (95% CI, 10.9%– 14.9%) were 
incompletely occluded.  Prospective data specifically for MCA aneurysms are 
available from the results of the ATENA (Analysis of Treatment by Endovascular 
Approach of Nonruptured Aneurysms) study, which included 86 unruptured MCA 
aneurysms (Pierot et al, 2010a).
  
Complete occlusion was achieved in 69.4%, neck 
remnant in 19.4% (adequate occlusion in 88.8%), and aneurysmal remnant in 11.3%. 
In the CLARITY study, 105 MCA aneurysms were included. Complete occlusion 
was achieved in 45.7%, neck remnant in 39% (adequate occlusion in 84.7%), and 
aneurysmal remnant in 15.2% (Pierot et al, 2010b). 
 
It is important to note that 
though occlusion rates were lower in this study, the results did not differ significantly 
from other anterior circulation locations.  
We hope that this case series dispels the contradictory conclusions of 
previous publications (Ausman et al, 1997; Regli et al, 1999), suggesting that EVC is 
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appropriate only in a minority of MCA aneurysms.  Our experience, and the 
experience of others, concludes that EVC is feasible in most aneurysms.  
 
2.5.4 Short-term follow-up  
Initial angiographic follow-up demonstrated satisfactory occlusion in 92% of 
aneurysms, with 8.1% showing residual aneurysm.  A total of 81% of MCA 
aneurysms, most treated as part of a coil first policy, were stable or showed improved 
appearances at initial angiographic follow-up.  A systematic review of 748 MCA 
aneurysms treated by endovascular means also showed angiographic stability or 
progression to better obliteration in 81% of patients undergoing follow-up 
angiography (Brinjikji et al, 2011a). 
 
In the CLARITY study (Pierot et al, 2012a),
 
of 
53 patients undergoing midterm follow-up, 57.4% (95% CI, 44.8–69.3) showed 
stability or improved appearances and 42.6% (95% CI, 30.7–55.2) had shown some 
degree of anatomic worsening, but presumably, this was not significant in most 
because 77.9% (95% CI, 66.2–87.1) were classified as having adequate occlusion.  
Although the rate of anatomic worsening was higher in other studies, the rate was 
very similar to that at other anatomic locations and was not specific for MCA 
aneurysms. 
  
2.5.5 Adjunctive therapies  
In this series, bare platinum coils were the mainstay of treatment during a 
long enrolment period, with many aneurysms treated by use of old-generation 
technology.  The use of adjunctive devices such as stent placement or balloon 
remodelling was very infrequent, and intra-aneurysmal flow diverters were not used.  
This trend may explain the relatively low thromboembolic complication rate, but also 
lower rates of complete occlusion compared with some recently published series on 
use of adjunctive devices (Vendrell et al, 2011; Johnson et al 2013a). 
 
Adjunctive 
devices have been used in 20.4% of other published MCA series (Brinjikji et al, 
2011a),
 
with the aim of obtaining complete occlusion to minimize the risk for 
subsequent haemorrhage (Johnston et al, 2008).  
A critical appraisal of the available literature has suggested that balloon 
assistance has a very similar safety profile to coiling without remodelling (Pierot et 
al, 2012b). 
 
In the CLARITY (Pierot
 
et al, 2011)
 
and ATENA (Pierot et al, 2009)
 
studies, the use of a balloon was not associated with significantly increased rates of 
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thromboembolic events or aneurysmal perforation but was associated with an 
increased rate of adequate postoperative occlusion.  Vendrell et al (2009) treated 63 
MCA aneurysms with a balloon remodelling technique.  It is interesting to note that 
they found that though this technique allowed treatment of aneurysms with more 
complex morphologic features, it was associated with more recurrences in the long 
term than were treatments without balloon remodelling.  
Stent assistance may lower recurrence and allow more complete treatment of 
more complex lesions.  However, there are reservations regarding procedural safety.  
Procedural morbidity and mortality risks have been shown to be significantly greater 
in those patients who have undergone stent-assisted coiling compared with those 
who have not under gone stent-assisted coiling (Piotin et al, 2010).
  
Procedural 
morbidity and mortality risks are significantly increased when treating ruptured 
aneurysms as opposed to unruptured aneurysms with a stent (Chalouhi et al, 2013b).
  
Several series have recently been published that focus specifically on complex MCA 
aneurysms (Vendrell et al, 2011; Johnson et al, 2013a; Fields et al, 2013).
  
In the 
largest series, Johnson et al
 
(2013a)
 
treated 100 MCA aneurysms with stent 
assistance.  Follow-up imaging showed complete occlusion in 90.6% of aneurysms, 
residual neck in 3.5%, and residual filling in 5.9%.  Four aneurysms (4.7%) required 
retreatment.  Long-term MRA follow-up revealed stability or progressive thrombosis 
in 97.9%.  Permanent morbidity was seen in 1% and mortality in 1%.  These authors 
suggested that this treatment method represented a safe and acceptable alternative to 
craniotomy.  
Intra-aneurysmal flow diverters now represent an additional treatment option 
for wide-neck bifurcation aneurysms.  Pierot et al (2013)
 
treated 34 ruptured and 
unruptured MCA aneurysms with the WEB device.  Adequate occlusion (total 
occlusion or neck remnant) was observed in 83.3% of aneurysms with an acceptable 
safety profile; mortality rate of the treatment was 0.0% and morbidity rate was 3.1% 
(intraoperative rupture with an mRS of 3 at 1-month follow-up).  
 
2.5.6 Long-term follow-up, retreatment, and surgical occlusion rates: do they 
confer a long-term advantage?  
In the present series, 4.3% were retreated. In other endovascular series of at 
least 50 patients, retreatment rates varied from 2.4%-13.9% (Iijima et al, 2005; 
Quadros et al, 2007; Oishi et al, 2009; Suzuki et al, 2009; Vendrell et al, 2009; 
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Bracard et al, 2010).  It is well recognised that the decision to retreat is highly 
variable (McDonald et al, 2013). 
 
Our cohort had no additional morbidity or 
mortality relating to the additional procedures, and in line with previous findings 
(Campi et al, 2007; Renowden et al, 2008),
 
the risk for further coil embolization did 
not negate the advantage of the initial embolization.  At late follow-up, including 
retreated aneurysms, 157 of 158 aneurysms showed complete occlusion, neck 
remnant, or stable aneurysmal remnant.  One case showed significant delayed 
anatomic deterioration.  
Surgical series have shown high rates of complete occlusion.  Each of the 
series published since ISAT have claimed excellent rates of initial complete 
aneurysm obliteration ranging from 89%–98.3% (van Dijk et al, 2011; Guresir et al, 
2011; Rodrıguez-Hernandez et al, 2013).  Long-term angiographic follow-up was 
available in only 22% (Rodrıguez-Hernandez et al 2013) and 29% (Guresir et al, 
2011)
 
in 2 of these series but reported excellent rates of complete occlusion ranging 
from 96%–98%.  This is perhaps one of the principal arguments for clipping 
aneurysms at any location; many of the reservations in the neurosurgical literature 
regarding the use of coiling stem from the lower rate of complete occlusion.  A major 
limitation of this study was the lack of long-term morbidity data, and therefore, 
based on our data, long-term efficacy was unclear.  However, the risk for rerupture 
occurs mostly within the first year (Johnston et al, 2008; Molyneux et al, 2009).
  
Beyond this, the risk lies between 0.11% (Johnston et al 2008)
 
and 0.21% (Molyneux 
et al, 2009)
 
per year.  Both ISAT (Molyneux et al, 2009),
 
CARAT (Cerebral 
Aneurysm Rerupture After Treatment) (Johnston et al, 2008),
 
and BRAT (Barrow 
Ruptured Aneurysm Trial) (McDougall et al, 2012)
 
studies have suggested that the 
benefits of coiling are unlikely to be superseded by the risk of delayed haemorrhage.  
The predicted risk has been calculated from the CARAT study, in which 57% 
showed a neck remnant, and ISAT, in which 27% showed a neck remnant.  
Prospectively acquired, independently assessed anatomic data have suggested that 
the neck remnant rate is not significantly different for MCA aneurysms vs other 
locations (Pierot et al, 2012),
 
and retreatment rates, both in our own series and on 
systematic review of the literature (Brinjikji et al, 2011a),
 
are not in excess of 
retreatment rates at all anatomic locations (Ferns et al, 2009).
  
Therefore, the argument that endovascular MCA occlusion rates are low and 
result in a greater risk of rebleeding is unlikely to be true.  The data from both 
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CARAT and ISAT also raise the question of how aggressively to manage stable neck 
remnants.  Most of these remnants are likely to be benign.  We have noted a trend to 
manage neck remnants conservatively.  This trend may be reflected in the proportion 
of retreated patients in the more recent Cerecyte (Molyneux
 
et al, 2012)
 
and HELPS 
(HydroCoil Endovascular Aneurysm Occlusion and Packing Study) (White et al, 
2011)
 
trials compared with ISAT (5.5% and 3%, respectively, vs 17%).   
 
2.5.7 Morbidity and mortality outcomes  
Aneurysmal perforation was seen in 5% of patients, with permanent 
morbidity and mortality relating to this at 3%.  The perforation rate lies within the 
range of previously published studies that have demonstrated procedural perforation 
complicating 1%– 8.5% of MCA aneurysm treatments (Iijima et al, 2005; Quadros et 
al, 2007; Oishi et al, 2009; Vendrell et al, 2009; Suzuki et al, 2009; Bracard et al, 
2010).
  
In 2 large prospective series of unruptured aneurysms (ATENA) (Pierot et al, 
2008)
 
and ruptured aneurysms (CLARITY) (Pierot et al 2010c) treated by 
endovascular means, the perforation rate for MCA aneurysms was 4.1% and 8.5%, 
respectively.  We have previously suggested that the rate of aneurysmal perforation 
may be higher at the MCA location (Renowden et al, 2009); we demonstrated that 
MCA aneurysms accounted for 13% of cases but 24% of all intra-procedural 
ruptures. In the CLARITY study, the frequency of procedural perforation was 
significantly higher in the MCA group compared with aneurysms at other locations, 
though the cumulative morbidity and mortality rates of procedural perforation were 
not significantly increased (Pierot et al, 2010c).  
The thromboembolic rate was 6%, with permanent morbidity and mortality 
rate relating to this at 3%.  This rate is lower than in many large endovascular series 
(Iijima et al, 2005; Quadros et al, 2007; Oishi et al, 2009; Suzuki et al, 2009; 
Bracard et al, 2010)
 
and in prospective series (Pierot et al, 2008 and 2010c)
 
that 
demonstrate thromboembolism complicating 7%–19.6%.  We attributed this finding, 
at least in part, to the routine use of intravenous aspirin and low use of adjunctive 
devices, particularly stents.  In other series, aspirin administration was not routine 
with ruptured aneurysms that comprised most aneurysms in this series. In the 
CLARITY study (Pierot et al 2010c),
 
although the rate of thromboembolic 
complications was not significantly higher in MCA aneurysms compared with those 
at other locations, the cumulative morbidity and mortality rate related to 
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thromboembolic events was significantly higher in the MCA group than in the non-
MCA group (7.5% vs 3.3%, respectively; P=0.038). Therefore, it was suggested that 
the clinical consequences of thromboembolism are important because of the size and 
function of the MCA territory.  
In this study, 3 patients (1.2%) experienced rebleeds and all died. All 
aneurysms appeared completely occluded on post-procedure angiography, and all 
occurred within the first 24 hours of the procedure.  The CARAT study (Johnston et 
al, 2008)
 
demonstrated a risk of rebleeding at all anatomic locations after complete 
occlusion by use of coiling to be 1.8% and clipping to be 0.9%.  It appears, therefore, 
that the results for MCA aneurysm coiling are not dissimilar to those for all 
locations.  
 
2.5.8 Surgical morbidity and mortality  
Published single-centre surgical series specifically focusing on ruptured 
MCA aneurysms have variably reported procedural complication rates.  Two recent 
series have described complication rates.  Guresir et al (2011)
 
described infarction 
complicating 5.5% of cases and peri-procedural haemorrhage complicating 5.5% of 
cases in their series of 168 cases.  Rodrıguez-Hernandez et al (2013) reported the 
procedural-related combined morbidity and mortality to be 1.1% in a series of 282 
ruptured MCA aneurysms.  Intra-procedural rupture occurred in 7.5%, but there was 
no permanent morbidity or mortality relating to this.  These results are very 
impressive and reflect a highly specialised service, but we do question whether they 
can be generalised to the neurosurgical community as a whole, particularly to centres 
with modest volume.  Indeed, database analysis of a large US population (2454 
patients) with ruptured aneurysms from 2006–2011 at multiple centres demonstrated 
that patients treated with clipping demonstrated an increased likelihood of morbidity, 
as defined by hospital discharge to long-term care facilities, ischemic complications, 
and other postoperative complications, compared with patients treated with coiling 
(McDonald et al, 2013).
  
Prospective data on procedural morbidity and mortality relating to ruptured 
MCA aneurysm clipping are lacking, but data from the PRESAT (Prospective 
Registry of Subarachnoid Aneurysms Treatment) trial (Taki et al, 2011)
 
(40.5% of 
surgical cases were MCA aneurysms) show an overall clipping-related complication 
rate of 17.2%.  This rate included intraoperative rupture in 6.7%, ischemic 
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complications in 6%, and haemorrhagic complications in 5.4% (the latter included 
parenchymal contusions, extradural and subdural haematomas, and primary 
haematoma extension).  
An additional potential drawback of the use of open neurosurgery is the risk 
for epilepsy. This finding was not assessed in the present series, but in late follow-up 
of ISAT (Hart et al, 2011),
 
it has been demonstrated that MCA location is associated 
with an increased epilepsy risk for both coiling and clipping but that this risk is 
significantly greater in patients who had undergone clipping.  In the coiling group, 
the risk for epilepsy at 1 year was 2.6% for non-MCA locations compared with 6.5% 
for MCA aneurysms. At 5 years, the cumulative risk was 10.3% for the MCA 
location.  For clipping, the risk at 1 year for non MCA locations was 4.3%, but for 
MCA aneurysms, this risk was 11.5% and at 5 years, the cumulative risk was 21.7%. 
  
2.5.9 Surgical and endovascular treatment of unruptured MCA aneurysms  
A safety profile is key to an effective treatment in the elective setting.  In the 
endovascular cohort of ISUIA (International Study of Unruptured Intracranial 
Aneurysms) (Wiebers et al, 2003),
 
mortality rate was 1.7% and morbidity rate (mRS, 
3–5) was 2.2% in 451 patients. In our cohort of patients with unruptured aneurysms, 
the mortality rate was 1.8%.  There was no permanent morbidity. The prospective 
ATENA
 
study (Pierot et al, 2008) was not powered to compare outcomes by 
anatomic location, but the rate of thromboembolism and aneurysm perforation was 
9.6% and 4.1%, respectively, for the MCA location and overall morbidity and 
mortality rate was 1.7% and 1.4%, respectively.  A systematic review (Brinjikji et al, 
2011a)
 
of 500 patients with 541 unruptured MCA aneurysms treated at 12 centres by 
EVC demonstrated a permanent procedural morbidity rate of 5.1% and a mortality 
rate of 0.3%.  ATENA also demonstrated no difference in anatomic occlusion 
between the MCA and other anterior circulation aneurysms.  
For unruptured aneurysms, several large surgical series from high-volume 
centres have demonstrated an excellent procedural safety profile, with morbidity 
rates ranging from 2%–6% and mortality rates from 0%–2% (Moroi et al, 2005; 
Morgan et al, 2010; Choi et al, 2012; Rodrıguez-Hernandez et al, 2013).  In 2 
studies, (Moroi et al, 2005; Choi et al, 2012)
 
approximately half of all aneurysms 
treated were <5 mm and most were <10 mm in size. This characteristic may well 
have contributed to the good outcomes, as it is evident that increasing age and 
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aneurysm size are associated with increasing surgical morbidity rates.  In the largest 
series of 263 patients with 339 aneurysms who underwent surgical clipping in 280 
operations, Morgan et al (2010)
 
assessed risk based on age and aneurysm size.  
Patients <60 years old with an aneurysm <12mm constituted a low-risk group with a 
procedural-related combined mortality and morbidity rate of 0.6% (95% CI, 0–3.8). 
Patients >60 years old with an aneurysm >12 mm had a procedural-related combined 
mortality and morbidity rate of 7.4% (95% CI, 1–24.5).  Patients 60 years old with 
an aneurysm size of 12 mm had a procedural-related combined mortality and 
morbidity rate of 9.3% (95% CI, 4.3–18.3).  Patients >60 years old with an aneurysm 
size of >12 mm had a procedural-related combined mortality and morbidity rate of 
22.2% (95% CI, 8.5–45.8).  
These data suggest a good safety profile for small aneurysms but do raise the 
specific question of whether EVC would be more appropriate for older patients with 
larger aneurysms.  Furthermore, whether the results of these surgical series can be 
extrapolated to general neurosurgical practice is questionable.  Multicentre data are 
limited, but one source is the ISUIA study. MCA aneurysms comprised 29% of the 
prospective ISUIA cohort, and surgical-related morbidity and mortality was seen in 
13.7% of patients (Wiebers et al, 2003).  International Classification of Diseases 
code data base analysis of 2535 patients with unruptured aneurysms treated between 
1998 and 2000 demonstrated that EVC was associated with fewer adverse outcomes 
(6.6% vs 13.2%), decreased mortality rates (0.9% vs 2.5%), and shorter lengths of 
hospital stay (4.5 vs 7.4 days) (Higashida et al, 2007).  Using a similar, but larger 
data base analysis of patients treated between 2001 and 2008, Brinjikji et al (2011b)
 
showed that the percentage of patients discharged from the hospital to long term 
facilities was 14.0% (4184/29,918) for patients who underwent clipping compared 
with 4.9% (1655/34,125) of patients who were treated with coiling (P=0.0001).  
Patients who received clipping also had a higher mortality rate because 344 (1.2%) 
of these patients died compared with 215 (0.6%) of patients who received coiling (P 
=0.0001).  
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2.6 Conclusion 
Most MCA aneurysms can be effectively treated with EVC, achieving 
satisfactory rates of occlusion with acceptable safety profiles and rates of favourable 
outcome.  For ruptured aneurysms, clinical results are similar to those for aneurysms 
at other locations and also to those achieved in many surgical series.  The clinical 
and anatomic results of this series are also similar to those of a recently published 
systematic review, suggesting that they are repeatable.  Recurrence is, not 
unexpectedly, more common in giant, large, and wide-neck aneurysms, but results of 
prospective trials suggest that anatomic results are not dissimilar to other anatomic 
locations.  Therefore, the endovascular approach to MCA aneurysms is justifiable.  
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3.1 Abstract  
3.1.1 Background 
Surgical clipping and endovascular coiling yield similar functional outcomes 
for the treatment of saccular aneurysms of the anterior communicating (ACOM) 
artery.  However, surgical treatment may be associated with greater rates of 
cognitive impairment due to injury of adjacent structures. We aimed to quantify the 
rates of injury (infarction/haemorrhage) for both clipping and coiling of ACOM 
aneurysms.  
 
3.1.2 Methods 
This was a retrospective dual-centre radiological investigation of a 
consecutive series of patients with ruptured and unruptured ACOM aneurysms 
treated between January 2011 and October 2014.  Post-treatment CT or MRI was 
assessed for new ischemic or haemorrhagic injury.  Injury relating to the primary 
haemorrhage or vasospasm was differentiated.  Univariate analysis using χ2 tests and 
multivariate analysis using binary logistic regression was used.  
 
3.1.3 Results 
66 patients treated with clipping were compared with 93 patients treated with 
coiling. 32/66 (48.5%) patients in the clipping group suffered treatment-related 
injury (31 ischemic, 1 haemorrhagic) compared with 4/93 (4.4%) patients in the 
coiling group (3 ischemic, 1 haemorrhagic) (p<0.0001).  For patients with 
subarachnoid haemorrhage, the multivariate OR for infarction for clipping over 
coiling was 24.42 (95% CI 5.84 to 102.14), p<0.0001.  The most common site of 
infarction was the basal forebrain (28/66 patients, 42.4%), with bilateral infarction in 
4.  There was injury of the septal/subcallosal region in 12/66 patients (18%).  
 
3.1.4 Conclusion 
Clipping of ACOM aneurysms is associated with significantly higher rates of 
structural injury than coiling, and this may be a reason for superior cognitive 
outcomes in patients treated with coiling in previously published studies.  
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3.2 Introduction 
 The anterior communicating (ACOM) artery represents the most common 
site for cerebral aneurysm formation and the most common site for ruptured 
aneurysms (Kassell et al, 1990).
  
The International Subarachnoid Aneurysm Trial 
demonstrated minimal differences in the rate of poor functional outcome or death 
between surgical clipping (SC) and endovascular coiling (EVC) for treatment of 
ruptured aneurysms at this location (Molyneux et al, 2002).
  
However, patients may 
suffer significant cognitive impairment despite favourable functional outcome scores 
(Hutter & Gilsbach, 1993; Mavaddat et al, 1999; Hadjivassiliou et al, 2001)
 
and it 
has been recognised for some time that SC may be associated with greater rates of 
cognitive impairment than EVC for aneurysms treated at this location (Chan et al, 
2002; Fontanella et al, 2003; Proust et al, 2009). 
 
A post-surgical syndrome of 
amnesia and confabulation is also recognised (DeLuca & Diamond, 1995),
 
although 
this may well be an oversimplification since various patterns of neuropsychological 
impairment can occur (Böttger et al, 1998). 
 
A number of structures within the basal 
forebrain, basal ganglia, and limbic system are vulnerable to injury, probably 
through occlusion of anterior cerebral artery (ACA) or ACOM artery complex 
perforating branch vessels, notably the recurrent artery of Heubner (RAH) or 
subcallosal artery (Mugikura et al, 2014; Meila et al, 2015). 
 
Injuries to the basal 
forebrain and the fornix specifically have been implicated in resulting in memory 
impairment (Damasio et al, 1985; Phillips et al, 1987; Abe et al, 1998; Goldberg et 
al, 1999; Wright et al, 1999; Hashimoto et al, 2000; Mugikura et al, 2014; Meila et 
al, 2015).  
We aimed to quantify the incidence of treatment related injury for patients 
treated with SC and EVC in a consecutive series.  We hypothesize that rates of local 
infarction are greater for patients who undergo SC than for those undergoing EVC 
procedures.  We undertook a radiological review of consecutive patients undergoing 
treatment for both ruptured and unruptured ACOM aneurysms at two neurovascular 
centres to assess the rates of local injury for each treatment modality.  
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3.3 Methods  
Consecutive patients with ACOM aneurysms treated between January 2011 
and October 2014 at two neurovascular centres were included in the analysis.  The 
treatment of both ruptured and unruptured aneurysms was assessed.  Patients were 
treated by six neurovascular surgeons and three interventional neuroradiologists.  
The decision to clip or coil was not necessarily based on aneurysm morphology but 
was dependent on the philosophy of the admitting neurosurgeon, some advocating 
aggressive surgical management with others regularly referring for EVC.  However, 
those lesions that were not favourable for EVC based on neck anatomy were referred 
for clip occlusion on a case-by-case basis.  
CT imaging consisted of triplanar reconstructions acquired using 16–128 
section machines.  MRI consisted of FLAIR and/or T2 axial and coronal images 
acquired on 1.5 or 3 Tesla machines. Acute MRI included diffusion-weighted 
imaging. The presenting CT scan, post-treatment imaging (CT) performed 24–72 h 
after the aneurysm securing procedure, subsequent CT or MRI scan performed 
during the course of the patient’s treatment, and eventual follow-up imaging at 4 
weeks to 6 months was reviewed.  Angiography at day 5–10 was also reviewed to 
record the presence of at least moderate ACA vasospasm (defined as >33% arterial 
narrowing).  The presenting CT scan was interpreted for distribution of haemorrhage 
(Fisher grade, maximal clot thickness, intraventricular haemorrhage, and intra-
parenchymal haemorrhage) and presence of hydrocephalus.  The surgical approach 
was assessed from analysis of the post-procedure CT scan.  The endovascular 
technique was recorded from the intra-procedural imaging.  
The location and rate of treatment-related infarction or haemorrhage was 
assessed on CT imaging performed 24–72 h after treatment (this was supplemented 
by MRI in two patients).  Localization of injury was based on a standardised visual 
proforma (figure 3.1) to assess specific structures, but also included each ACA 
territory.  Basal forebrain lesions were also specifically assessed for involvement of 
the more medial subcallosal or septal structures (figure 3.2).  Treatment-related 
injury was defined as new hypodensity (ischemic injury) or hyperdensity 
(haemorrhage) on the post-treatment CT images.  Where available, post-treatment 
MRI was also included in the assessment. If follow-up CT or MRI was available 
(MRI most commonly performed for post-coiling follow-up), this was cross-
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referenced with the post-treatment imaging for eventual gliosis to improve diagnostic 
certainty.  CT hypodensities relating to ventricular drain insertion or hydrocephalus 
and those lying adjacent to haematomas were differentiated from new focal low 
density appearing on the post-treatment imaging.  Low density in the perisylvian 
regions secondary to surgical access/retraction was not included in the analysis of 
treatment-related injury.  Gyrus rectus hypodensity was categorised as having 
parenchymal injury whether secondary to infarction or resection, but was classified 
as ischemic injury rather than resection when the full length of the gyrus and 
adjacent gyri were involved whereas focal low density within the gyrus was 
categorised as resection, especially if a cavity containing gas was demonstrated.  
Infarcts secondary to the acute injury or vasospasm were also differentiated through 
co-analysis of the presenting CT scan and subsequent angiographic and CT imaging, 
respectively.  
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Figure 3.1 Proforma for identification of infarct location (multiplanar CT reconstructions, 
left and FLAIR axial and coronal images, right): (1) basal forebrain; (2) body of corpus 
callosum; (3) cingulate gyrus; (4) gyrus rectus; (5) medial olfactory gyrus; (6) genu of 
corpus callosum; (7) fornix; (8) caudate nucleus; (9) globus pallidus; (10) putamen; (11) 
anterior limb of internal capsule. 
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Figure 3.2 Structures within the basal forebrain: (1) septum; (2) diagonal band of Brocca; 
(3) subcallosal area; (4) nucleus accumbens. 
  
 
The data were compared using univariate and multivariate analysis. 
Univariate analysis was undertaken using analysis of variance for continuous 
variables and χ2 tests for non-parametric data.  Multivariate analysis was also 
undertaken for variables impacting on treatment-related injury in the group with 
subarachnoid haemorrhage (SAH) using binary logistic regression.  Statistical 
significance was defined as a p value <0.05.  
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3.4 Results 
Sixty-six patients who underwent SC were compared with 93 patients treated 
with EVC. Of the SC patients, 45 (71.2%) presented with SAH compared with 75 
(80.6%) of the EVC patients.  Descriptive statistics for each treatment modality are 
shown in table 3.1.  There was no significant difference in the baseline parameters or 
in the rate of moderate to severe vasospasm.  Nine of the 66 SC patients and 39 of 
the 93 EVC patients had follow-up MRI available in addition to CT.  
The balloon-assisted coiling technique was used in 63 patients (67.7%), 
simple coiling in 23 (24.7%), and stent-assisted coiling in 7 (7.5%).  In the surgical 
group, a modified orbito-zygomatic approach was used in 41 (62.1%) patients and a 
frontotemporal approach in 25 patients (37.9%).  
Thirty-two of the 66 (48.5%) patients in the SC group demonstrated local 
post-treatment injury.  Eight of 21 (38.1%) patients with unruptured aneurysms and 
24 of 45 (53.3%) patients with ruptured aneurysms developed injury following a 
clipping procedure (p=0.2485).  Four of the 93 patients in the EVC group developed 
treatment-related injury (4.4%).  All patients had suffered SAH. The distribution of 
lesions is shown in table 3.2.  In one patient in each of the SC and EVC groups, this 
was due to a peri-procedural haemorrhage rather than infarction.  
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Variable Clip (n=66) Coil (n=93) P 
Age 54.76+/-3.16 54.36+/-2.71 0.7624 
≥65 12 (18.2) 24 (25.8) 0.2576 
Female 37 (56.0) 57 (61.3) 0.5086 
Ruptured 45 (68.2) 75 (80.6) 0.0718 
Unruptured 
Retreatment after clip 
Retreatment after coil 
De novo treatment 
21 (31.8) 
1 
4 
16 
19 (20.4) 
3 
4 
11 
Aneurysm size 
 
5.78+/-0.69 
(2.91) 
 
6.45+/-0.56 (2.58) 
 
0.1437 
Size 
≥10mm 
7 (10.6) 14 (15.1) 0.4143 
Wide Neck (≥4mm or 
dome/neck ratio of ≤1.5) 
23 (34.8) 31 (33.3) 0.4147 
Cistern of the lamina 
terminalis haematoma 
width (mm) 
<5 
5-9 
10-14 
≥15 
 
 
16 (35.6) 
13 (28.9) 
11 (24.4) 
5 (11.1) 
 
 
22 (29.3) 
26 (34.7) 
16 (21.3) 
11 (14.7) 
 
 
 
0.7963 
Fisher grade 
1 
2 
3 
4 
 
1 (2.2) 
6 (13.3) 
37 (82.2) 
1 (2.2) 
 
2 (2.7) 
13 (17.3) 
54 (72.0) 
6 (8.0) 
 
 
0.5118 
Intraventricular 
haemorrhage 
18 (40.0) 40 (53.3) 0.1055 
Intra-parenchymal 
haemorrhage 
16 (35.6) 24 (32.0) 0.6891 
Hydrocephalus 27 (60.0) 44 (58.7) 0.8942 
Vasospasm 12 (26.7) 16 (21.3) 0.5914 
 
Table 3.1 Baseline characteristics of the study groups. 
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Region of injury Clip (n=66) 
N (%) 
Coil (n=93) 
N (%) 
Caudate nucleus 9 (14.9) 2 (2.2) 
ALIC 8 (11.9) 0 
Putamen 7 (10.6) 0 
Globus pallidus 3 (4.5) 0 
Basal forebrain 28 (42.4) 
(bilateral in 4 
cases (6.1%)) 
1 (1.1) 
Septal/subcallosal 12 (18.1) 1 (1.1) 
Hypothalamus 1 (1.5) 0 
Gyrus rectus 9 (13.6) 1 (1.1) 
Medial orbital gyrus 6 (9.1) 0 
Genu of corpus callosum 7 (10.6) 3 (3.3) 
Body of corpus callosum 4 (6.0) 0 
Cingulate Gyrus 1 (3.0) 0 
Fornix 5 (7.6) 1 (1.1) 
Superior frontal gyrus 0 1 (1.1) 
Other 1 (1.5) 0 
 
Table 3.2 The distribution of treatment related injury for clipped and coiled patients.  ALIC, 
anterior limb of internal capsule. 
 
The median number of regions involved per patient in the SC group was 
three.  Nineteen of 41 patients (46.3%) with a modified orbito-zygomatic approach 
and 13/25 (52%) with a frontotemporal approach suffered injury (p=0.6554). For 
ruptured aneurysms, SC was a stronger predictor of treatment-related infarction than 
EVC on multivariate analysis (OR 24.42, 95% CI 5.84 to 102.14, p<0.0001), along 
with large aneurysm size (≥10 mm) (OR 6.73, 95% CI 1.08 to 41.98, p<0.05) when 
taking into account aneurysm neck width, local haematoma width (≥10 mm), intra-
parenchymal extension of haemorrhage, intraventricular extension of haemorrhage, 
and older patient age (≥65 years) (see table 3.3).  
The site of the most common lesion was the basal forebrain (28 patients with 
33 lesions, bilateral in four patients). The basal forebrain lesion was present on the 
side of the approach in 25/28 (88.9%) patients. Basal forebrain lesions were 
78 
accompanied by caudate head lesions in 9/28 cases (figure 3.3). This was the next 
most common site for treatment-related injury. Injury to the basal forebrain occupied 
or extended into the more medial subcallosal or septal region in 12 patients in the SC 
group. The fornix and genu of corpus callosum lesions were seen in five (7.5%) and 
seven (10.6%) of the 66 SC patients and in three (3.3%) of the 93 EVC patients 
(figure 3.4). Gyrus rectus lesions were classified as ischemic in six of nine patients 
and after resection in three.  
 
Variable Infarct % OR 95% CI P 
Clipping 24/45 53.3 24.42 5.84-102.14 <0.0001 
Aneurysm size ≥10 
mm 
5/16 31.3 6.73 1.08-41.98 0.0411 
Wide neck > 4mm 
or dome/neck ratio 
of ≤1.5 
8/35 22.9 0.70 0.18-2.79 0.6139 
 
Intra-
parenchymal 
extension of 
haemorrhage 
10/40 25 2.76 0.72-10.60 0.1398 
Intraventricular 
haemorrhage 
11/58 18.9 0.66 0.18-2.35 0.5211 
 
Local haematoma 
width ≥10 mm 
10/40 25 1.41 0.43-4.60 0.5729 
 
Age ≥65 5/28 17.9 1.24 0.31-4.95 0.7591 
 
 
Table 3.3 Multivariate odds ratios for treatment related infarction for patients with treated 
ruptured anterior communicating artery aneurysms 
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Figure 3.3 Coronal (A) and axial (B) CT demonstrating right caudate nucleus, anterior limb 
or internal capsule, and putaminal infarct extending into the region of the nucleus 
accumbens. T2-weighted MR coronal (C) and axial (D) images in a different patient 
demonstrate a similar pattern. 
 
 
Figure 3.4 Axial (A) and coronal (B) CT demonstrating low density in the genu of the 
corpus callosum, fornix and subcallosal region indicative of an ischemic injury. Axial 
FLAIR (C), diffusion-weighted imaging (D), and apparent diffusion coefficient maps (E) 
demonstrating forniceal and genu of corpus callosum infarction. 
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Several patterns of infarction were recognised. These included:  
1. basal forebrain injury associated with caudate, internal capsule, and lentiform 
nucleus injury akin to the territory of the RAH (figure 3.3);  
2. septal/subcallosal infarction in association with forniceal andgenu of corpus 
callosum infarction akin to the territory of the subcallosal artery (figure 3.4);  
3. unilateral subcallosal infarction (figure 3.5);  
4. unilateral basal forebrain injury involving the nucleus accumbens but sparing 
the subcallosal/septal region (figure 3.6);  
5. a combination of any of the above patterns (figure 3.7);  
6. body of corpus callosum infarction (figure 3.8).  
 
 
 
Figure 3.5 Axial FLAIR (A) and T2 coronal (B and C) images demonstrating ischemic 
injury to the right septal and subcallosal region. Note also the high signal in the contralateral 
left subcallosal region, although this is less marked. Coronal CT reconstructions (D–F) in 
three additional patients with a similar pattern of infarction. 
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Figure 3.6 Coronal CT reconstructions in three different patients (A–C) demonstrating low 
density in the basal forebrain involving the region of the nucleus accumbens. 
 
 
 
Figure 3.7 Baseline axial CT (A) and immediate post-clipping axial CT scans (B and C) 
demonstrating right caudate/basal forebrain infarction (white arrowhead) with forniceal 
(hollow arrowhead) and genu of corpus callosum infarction (white arrowhead). Follow-up 
coronal (D) and axial CT scans (E) demonstrating right basal forebrain infarct extending into 
the right septal region (white arrowhead), right caudate and internal capsule infarct (white 
arrowhead) and forniceal infarct (hollow arrowhead). 
 
Figure 3.8 Sagittal CT reconstructions in three different patients (A–C) demonstrating body 
of corpus callosum infarction (white arrowheads). 
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3.6 Discussion  
It has been demonstrated in several studies that SC may result in inferior 
cognitive outcomes following treatment of ACOM aneurysms (Chan et al, 2002; 
Fontanella et al, 2003; Proust et al, 2009).
 
Domains of memory, attentional, and 
executive functions may be affected. A number of case reports and series have 
suggested that lesions of the basal forebrain and/or fornix are predominantly 
responsible for memory deficits (Damasio et al, 1985; Phillips et al, 1987; Böttger et 
al, 1998; Abe et al, 1998; Goldberg et al, 1999; Wright et al, 1999; Hashimoto et al, 
2000; Mugikura et al, 2014; Meila et al, 2015).  Prefrontal lesions may be associated 
with attentional, executive, and psychopathological dysfunctions (Böttger et al, 
1998).  We aimed to quantify the difference in the rate of treatment-related structural 
injury for SC and EVC of both ruptured and unruptured aneurysms.  In a consecutive 
population of patients with treated ACOM aneurysms, the rate of local treatment-
related injury was significantly greater in the SC group than in the EVC group.  
Forty-nine per cent of the SC group versus 4.4% of the EVC group had treatment-
related injury.  Clipping was a strong predictor of treatment-related injury on 
multivariate analysis.  The infarct rate for coiling was in line with a recent systematic 
review of the literature (Fang et al, 2014).  The majority of the surgical lesions were 
probably ischemic in aetiology; most were on the side of the surgical approach.  One 
possibility is that the clip(s) may result in compromise of adjacent minute 
perforators, that perforators need to be sacrificed to access the aneurysm, or that the 
direct exposure and handling of the artery may result in subsequent ischemic 
lesions.  
The most common site of infarction was the basal forebrain with 
approximately 42% of patients in the SC group suffering injury to this location; 14% 
of patients in the SC group also suffered infarction of the caudate nucleus.  Other 
authors have demonstrated that clipping represents an independent risk factor on 
multivariate analysis for postoperative ACA territory infarction (Moussouttas et al, 
2013).
  
The finding of such a high rate of treatment-related ischemic injury in this 
series is surprising.  A review of all-cause infarction at all locations in clipped 
patients treated in the tirilizad trials demonstrated that 707 (27%) out of 2741 
patients developed cerebral infarction (Furgusson & Macdonald, 2007),
 
but other 
authors have recognised high rates of postoperative infarction in patients with 
ACOM artery aneurysms
 
(Proust et al, 2009; Umredkar et al, 2010).  Using CT 
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imaging, Umredkar et al (2010)
 
demonstrated a postoperative infarct rate of 42.5% in 
patients with SAH who underwent SC.  The current study could be criticised for 
relying on CT hypodensity for diagnosis in the majority of patients.  There is a 
possibility that postoperative oedema could limit specificity.  However, where 
subsequent follow-up imaging was available, these regions demonstrated residual 
low density and/or atrophy implying regions of permanent structural injury.  Use of 
triplanar imaging could have resulted in a greater rate of lesion pick-up compared 
with studies using axial imaging only.  Additionally, there were recurring patterns of 
hypodensity in regions not normally subject to retraction or resection in the majority.  
Furthermore, our findings are in keeping with those of a cohort of 50 patients (14 
EVC, 36 SC) in whom a significantly greater number of SC patients suffered foci of 
encephalomalacia on follow-up MRI (Proust et al, 2009).
  
In that series, 33% of SC 
patients had basal forebrain lesions, 28% corpus callosum lesions, 11% caudate 
lesions, and 64% had frontobasal lesions.  
An additional finding in this study was that infarction of structures presumed 
to be supplied by ACOM perforators including the subcallosal artery was greater in 
the SC group; lesions of the septal or subcallosal area that may harbour structures 
more vital with regard to memory (Böttger et al, 1998
; 
Fujii, 2008)
 
were seen in 12 
SC patients (18%) and one EVC patient (1.1%). Infarcts of the fornix (7.5% 
vs 1.1%) and genu of the corpus callosum (10.5% vs 3.3%) were also more common 
in the SC patients.  We suspect that this may well be an underestimation of the true 
incidence of subcallosal artery or ACOM perforator disruption since MRI was not 
used universally or acutely. Interestingly, it also illustrates that these vessels can 
rarely be vulnerable during EVC procedures, although perhaps less often than in SC 
procedures.  
We noted a number of patterns of infarction (figures 3.4–3.8): (1) more 
lateral basal forebrain injury sparing the septal and subcallosal structures but 
involving the nucleus accumbens; (2) basal forebrain injury in addition to caudate, 
internal capsule and lentiform nucleus injury; (3) isolated basal forebrain injury 
involving the septal and subcallosal structures unilaterally; (4) fornix, subcallosal 
region and genu of corpus callosum; and (5) body of corpus callosum infarction. We 
suggest that the first two patterns are secondary to either A1 or A2 perforators or 
RAH disruption and the latter three patterns are due to disruption of subcallosal 
artery, median callosal artery, or other ACOM artery perforators.  
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Perforators may arise from the A1 and A2 ACA; 2–15 perforating arteries 
travel superiorly and posteriorly from the A1 into the anterior perforated substance 
(Harrigan & Deveikis, 2009).  Additionally, perforating branches of the A2 segment 
are located along the first 5 mm of the vessel and penetrate the brain at the gyrus 
rectus and olfactory sulcus (Harrigan & Deveikis, 2009). 
 
The most important 
perforator is the RAH.  This vessel doubles back on its parent ACA and passes 
above the carotid bifurcation and middle cerebral artery into the medial part of the 
sylvian fissure before entering the anterior perforated substance. In a more recent 
autopsy study (Loukas
 
et al, 2006)
 
the RAH was found as a single vessel in 77%, as 
double arteries in 17%, and was absent in 6%.  The origin of the RAH was from the 
junction of the ACA and ACOM artery in 62.3%, from the proximal A2 segment in 
23.3%, and from the A1 segment in 14.3%.  Both the length and diameter of the 
vessel can vary widely.  During surgery the vessel is liable to injury during elevation 
of the frontal lobe from the optic nerve and chiasm or during exposure of the A2 
segments (Loukas et al, 2006).  Occlusion of the RAH may result in infarction of the 
caudate head, anterior limb of the internal capsule, putamen, globus pallidus and 
basal forebrain.  
The ACOM artery perforators are highly variable in number and territory 
supplied (Sekhar et al, 2007).
  
Broadly, they can be categorised as hypothalamic, 
subcallosal, and median callosal and may vary in number from 0 to 11 (Sekhar et al, 
2007; Hernesniemi et al, 2008). 
 
The subcallosal artery and the implications of 
occlusion have been described in two recent case series (Mugikura et al, 2014; Meila 
et al, 2015).
  
This is usually a single vessel and typically the largest of the arteries 
arising from the ACOM artery.  The subcallosal artery supplies the bilateral 
subcallosal areas, but also the bilateral columns of the fornix and the genu of the 
corpus callosum. It may extend to the body of the corpus callosum and is therefore 
recognised as the medial callosal artery (Serizawa et al, 1997).
  
The unilateral 
subcallosal infarction recognised in this study is not consistent with previous 
descriptions of the subcallosal perforators since a bilateral supply is often stressed in 
descriptions of these vessels (Serizawa et al, 1997; Hernesniemi et al, 2008). 
 
However, we were using CT to assess many of these patients, and limitations in 
sensitivity for ischemic changes in relatively small structures (whereby less marked 
contralateral ischemia was present but not recognised) could account for this finding 
(see figure 3.5).  
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The basal forebrain contains a number of structures that are believed to play a 
role in cognition.  These include the nucleus accumbens, substantia innominata, 
nucleus basalis of Meynert, and medial septal-diagonal band of the Brocca complex 
(Fujii, 2008).
  
Basal forebrain lesions have been linked to the occurrence of amnesia 
and/or confabulation in a number of case reports and series (Damasio et al, 1985; 
Phillips et al, 1987; Böttger et al, 1998; Abe et al, 1998; Goldberg et al, 1999; 
Wright et al, 1999; Hashimoto et al, 2000)
 
and a functional imaging study has also 
suggested that the basal forebrain is likely to play a role in episodic memory recall 
(Fujii et al, 2002).  The medial septal-diagonal band of the Brocca complex region is 
likely to be an important interface within the so-called septohippocampal system 
(Böttger et al, 1998).
  
Bilateral basal forebrain lesions do produce more severe 
memory deficits (Böttger et al, 1998).  
The fornix is a compact fiber bundle connecting the hippocampus with the 
hypothalamus and a number of other structures including the septal area of the basal 
forebrain.  It is an important constituent of the Papez circuit and is involved in the 
formation and consolidation of declarative memories (Meila et al, 2015).
  
Diffusion-
weighted MRI-proven infarction limited to the fornices has been reported in 
conjunction with acute onset of amnesia, suggesting that an isolated injury to this 
structure may be critical (Mugikura et al, 2014).
  
Injuries to other vulnerable 
structures including the corpus callosum and caudate nucleus have also been 
implicated in resulting in neuro-behavioural sequelae (Mendez et al, 1989; Kasow et 
al, 2000). 
 
Caudate nucleus lesions may result in depression, agitation, abulia, 
neglect (right-sided lesions), memory disturbance (particularly if bilateral), 
dysarthria, aphasia (left-sided lesions), movement disorders (ballistic, choreatiform), 
or motor weakness (Kumral et al, 1999).
  
There is controversy as to the role of the 
gyrus rectus in cognition, particularly as the gyrus rectus is deliberately resected to 
gain access to the aneurysm on occasions (Sekhar et al, 2007). 
 
An association 
between memory quotient and gyrus rectus resection was demonstrated in a 
neuropsychological analysis of 32 patients with clipped ACOM artery aneurysms 
(Teissier du Cros & Lhermitte, 1984).
  
Other studies have failed to demonstrate an 
association (Horikoshi et al, 1992; Böttger et al, 1998). 
A number of studies have found significantly increased rates of cognitive 
impairment in patients with ACOM artery aneurysms treated with SC as opposed to 
EVC.  Chan et al (2002)
 
studied 18 patients who had undergone treatment for 
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ruptured ACOM aneurysms, half with SC and half with EVC; 33% of the SC 
patients showed severe impairment of memory and executive function whereas no 
EVC patient demonstrated this impairment.  Fontanella et al
 
(2003)
 
assessed 37 
consecutive WFNS grade I or II patients who underwent treatment of ACOM 
aneurysms within 48 h of rupture; 20 of 37 were treated with SC and 17 were treated 
with EVC.  Both groups were compared with 16 angiogram-negative patients with 
SAH and 18 normal controls.  All patients were neurologically intact at discharge 
and were Glasgow Outcome Scale 1 at 6-month follow-up after SAH.  Surgically 
treated patients showed a significant worse performance on the logical memory and 
on the frontal lobe executive functions compared with controls, while the 
endovascular group and the angiogram-negative group showed a significant decrease 
only in the literal fluency score.  Furthermore, the surgical group showed a 
significant impairment in using grammatical and syntactical rules to produce 
sentences.  Proust et al (2009)
 
studied 36 SC and 14 EVC patients at 14-month 
follow-up.  They found no difference in executive dysfunction although there was a 
significant impairment of verbal memory in the SC group.  
These results raise the question of how to optimize patient treatment in 
future.  However, while cognition is a factor that may impact on a patient’s life, it 
needs to be weighed against other factors such as safely securing the aneurysm and 
durability of treatment.  Balloon assistance has increased the number of patients who 
can be treated using the endovascular techniques without a significant increase in 
complication rate (Pierot et al, 2011).
  
For elective cases, a number of case series 
have described success in stent coiling at the ACOM location (Huang et al, 2009; 
Johnson et al, 2013b). 
 
In the largest series comprising 64 patients
 
(Johnson et al, 
2013b)
 
the morbidity was 1.6% and mortality was 1.6%; 5.5% required retreatment.  
A systematic review of stent coiling at all locations in patients with SAH who were 
managed with dual antiplatelet therapy demonstrated clinically significant 
intracranial haemorrhagic complications in 27 (8%) of 339 patients, including 9 
(10%) of 90 patients known to have had ventricular drain-related haemorrhages.  
Clinically significant thromboembolic events occurred in 16 (6%) of 288 patients 
(Bodily et al, 2011). 
 
Perhaps a trial comparing more aggressive endovascular 
approaches (e.g. using stents or even flow diversion) with SC for less favourable 
aneurysms, particularly for locations such as this, would be worthwhile. Such a study 
should include neuropsychological testing as part of the outcome measures.  
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3.7 Limitations of the study  
This was a retrospective study of a relatively small patient sample reflecting 
practice at two centres only.  There was inherent bias as to which patients were 
selected for EVC or SC. Some aneurysms were referred for SC on the basis of being 
morphologically challenging for endovascular treatment whereas others were 
selected for SC on the philosophy of the managing neurosurgeon, some favouring 
surgical management.  It is conceivable that the rate of infarction for EVC patients 
would have been greater if less favourable aneurysms were treated using an 
endovascular approach.  The imaging assessment was predominantly with CT, which 
has an inherent lack of sensitivity for identification of lesions in this anatomical 
region, especially in the presence of clip or coil artefact.  Another potential source of 
error was the limited specificity of CT hypodensity for infarction. In the absence of 
diffusion-weighted MRI, it could be claimed that a proportion of the focal 
hypodensities noted could represent postoperative oedema.  We were also unable to 
assess the rate of microinfarction with diffusion imaging that is known to complicate 
endovascular procedures. However, follow-up MRI was available for many EVC 
patients and we believe that, if MRI was available for all SC patients, then the 
differences in the rate of structural injury may have been more marked. At this stage 
we do not have cognitive test scores available for this cohort with which to assess the 
neurophyschological significance of the radiological findings, and we can only 
hypothesize based on other reports in the literature as discussed. It is possible that 
many patients did not suffer overtly clinically detectable neurocognitive deficits 
despite the high rate of injury as few SC patients were imaged with MRI during their 
postoperative course.  
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3.8 Conclusion 
This retrospective analysis suggests that the degree of structural damage in 
regions known to impact on the cognitive outcome of the patient incurred through 
treating ACOM aneurysms using SC is significantly greater than that for EVC.  
Further work is necessary to assess the direct effect on cognitive outcomes.  
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CHAPTER 4 
 
 
 
 
SHORT TERM OUTCOMES FOLLOWING CLIPPING AND COILING OF 
RUPTURED INTRACRANIAL ANEURYSMS: DOES SOME OF THE 
BENEFIT OF COILING STEM FROM LESS PROCEDURAL IMPACT ON 
DERANGED PHYSIOLOGY AT PRESENTATION? 
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4.1 Abstract 
4.1.1 Background 
Endovascular coiling (EVC) has been shown to yield superior clinical 
outcomes to surgical clipping (SC) in the treatment of ruptured cerebral aneurysms.  
The reasons for these differences remain obscure.  We aimed to assess outcomes of 
EVC and SC relative to baseline physiological derangement.  
 
4.1.2 Methods 
This was an exploratory analysis of prospectively collected trial data. 
Physiological derangement was assessed using the Acute Physiology and Chronic 
Health Evaluation II (APACHE II) scoring system.  Other contributory variables 
such as age, World Federation of Neurosurgical Societies (WFNS) grade, and 
development of complications, including hydrocephalus and vasospasm, were 
included in the analysis.  Clinical outcome was independently assessed at 90 days 
using the modified Rankin Scale (mRS).  Hospital stay, ventilated days, and total 
norepinephrine dose were also used as secondary outcomes.  Multivariate analysis 
was performed using binary logistic regression.  
 
4.1.3 Results  
EVC was performed in 69 patients and SC in 66 patients. More profound 
physiological derangement (APACHE II score >15) was the strongest predictor of 
poor outcome in the overall cohort (OR 17.80, 95% CI 4.78 to 66.21, p<0.0001).  
For those with more deranged physiology (APACHE II score>15; 59 
patients), WFNS grade ≥4 (OR 6.74, 1.43 to 31.75) and SC (OR 6.33, 1.27 to 31.38) 
were significant predictors of poor outcome (p<0.05).  Favourable outcome (mRS 0–
2) was seen in 11% of SC patients compared with 38% of EVC patients in this 
subgroup. SC patients had significantly increased total norepinephrine dose, 
ventilated days, and hospital stay (p<0.05). 
 
4.1.4 Conclusion 
  More profound physiological derangement at baseline is a strong predictor of 
eventual poor outcome, and outcomes for patients with more profound baseline 
physiological derangement may be improved if undergoing a coiling procedure. 
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4.2 Introduction  
The International Subarachnoid Aneurysm Trial (ISAT) demonstrated an 
absolute 6.9% reduction in the rate of death or dependency at 1 year for patients 
treated with endovascular coiling (EVC) following aneurysmal subarachnoid 
haemorrhage (SAH) (Molyneux et al, 2002).
  
Subsequent systematic reviews
 
of this 
and other prospective controlled studies have also concluded that EVC yields better 
clinical outcomes compared with surgical clipping (SC) (Lanzino et al, 2013; Li et 
al, 2013).  The reasons for this difference have been debated in the literature and 
include rates and severity of cerebral vasospasm and delayed ischemia, (Dumont et 
al, 2010; Dorhout Mees et al, 2012), degree of procedural brain tissue damage (Shim 
et al, 2012)
 
and the rate of medical complications (Vergouwen et al, 2011c).
  
Physiological derangement and medical comorbidities are also recognised as risk 
factors for poor outcome following aneurysmal SAH (Claasen et al, 2004; Schuiling 
et al, 2005; Mocco et al, 2006; Rosengart et al, 2007).  However, assigning patients 
to either SC or EVC has traditionally been based on anatomical rather than 
physiological criteria, and there is little evidence regarding the interaction of 
treatment modality and presenting physiological derangement.  
The Acute Physiology and Chronic Health Evaluation II (APACHE II) 
scoring system is widely used in many intensive care units and allows approximate 
prognostication based on a score from 0 to 71 for clinical and biochemical markers 
of cardiopulmonary, renal, haematological, and neurological function (Knaus et al, 
1985). 
 
Using this system, we aimed to investigate the difference in outcomes for 
EVC and SC patients relative to the degree of physiological derangement at 
baseline.  
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4.3 Methods  
4.3.1 Study design and inclusion/exclusion criteria  
This was an exploratory analysis of prospectively acquired clinical trial data 
obtained primarily for the assessment of clinical outcomes, and vasospasm severity 
and incidence, in patients treated with magnesium following aneurysmal SAH 
(Bradford et al, 2013). 
  
The study was approved by the Northern Sydney and Central 
Coast Ethics Committee and written informed consent was obtained from each 
patient or legal surrogate.  
Patients admitted between April 1, 2005 and February 1, 2010, presenting 
within 72 h of SAH confirmed by CT were included. Exclusion criteria included age 
<18 years, serum creatinine >200 mmol/L, if death was thought imminent within 72 
h, if the patient had myasthenia gravis or was pregnant, or if vasospasm was present 
prior to inclusion in the study.  The original study included 166 patients.  This 
explorative analysis included only patients treated in the acute period with EVC or 
SC. Those patients who were angiographically negative were not included. 
 
4.3.2 Patient management  
All patients were managed on the neurointensive care unit with routine 
insertion of arterial and central lines. After admission, digital subtraction 
angiography or CT angiography was performed, and the aneurysm responsible for 
the bleeding was occluded by operative or endovascular means using conventional 
techniques within 48 h.  Decision to clip or coil was not necessarily based on 
aneurysm morphology but was dependent on the philosophy of the admitting 
neurosurgeon, some advocating aggressive surgical management with others 
regularly referring for EVC. At one of the centres participating in the study, there 
was limited endovascular availability.  During the study period, young patients, those 
with multiple aneurysms accessible via a single surgical approach, or those with a 
haematoma requiring evacuation were primarily clipped.  
Following clipping or coiling of the aneurysm, systolic blood pressure was 
maintained between 120 and 150 mm Hg. A nimodipine infusion of 20 mg/kg/h was 
commenced on arrival in the intensive care unit.  All patients received nimodipine 
for 21 days, with at least 10 days of intravenous administration.  Body temperature 
was aimed to be maintained below 37.5°C.  Oxygen saturation was monitored 
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continuously by pulse oximetry and maintained at >95%.  Serum electrolytes were 
maintained within normal limits, and glucose levels were maintained at 6–10 
mmol/L.  Angiographic screening for vasospasm was performed routinely at days 5–
7 or at an earlier time point if vasospasm was suspected.  Patients were managed 
with adequate hydration, systolic blood pressure maintained between 140 and 160 
mm Hg, and continued nimodipine infusion.  The majority of patients with 
moderate–severe vasospasm (>25% arterial narrowing) were managed with a pre-
emptive endovascular approach previously documented (Mortimer et al, 2015b). 
 
4.3.3 Data collected and analysis  
Baseline variables were collected, including demographic data, history of 
smoking, hypertension, use of statins, use of trial magnesium, previous SAH or 
stroke Glasgow Coma Scale (GCS) score, World Federation of Neurosurgical 
Societies (WFNS) grade, and APACHE II score.  Aneurysm site, size, and presence 
of hydrocephalus were recorded through assessment of angiographic and CT 
imaging, respectively.  Modified Rankin Scale (mRS) scores were obtained at 90 
days by independent assessors.  Favourable outcome was defined as mRS 0–2. 
Secondary outcome measures, including norepinephrine dose (mg), length of stay in 
the intensive care unit, ventilator time, and length of hospital stay were also 
assessed.  
Statistical analysis was performed using Openstat statistical software. Non-
parametric data (sex, WFNS grade, history of smoking, hypertension, SAH, stroke, 
magnesium or statin use, hydrocephalus, aneurysm location, and aneurysm securing 
modality) were compared using Fisher’s exact test, and parametric data (age, length 
of stay in the intensive care unit (days), ventilation duration (days), hospital stay 
(days), norepinephrine dose) were compared using analysis of variance.  Ordinal data 
(APACHE II score and GCS) were compared using the Mann– Whitney U test. 
Binary logistic regression was used for analysis of multiple variables, including age, 
gender, smoking history, vasospasm, hydrocephalus, aneurysm securing technique, 
APACHE II score, and WFNS grade with respect to patient outcome. Statistical 
significance was defined as p<0.05.  
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4.4 Results  
A total of 135 patients (69 EVC and 66 SC) were included in the analysis.  
Two patients who underwent SC were lost to follow-up and were therefore not 
included.  Descriptive statistics are shown in table 4.1.  
There tended to be more patients with a prior history of previous stroke, statin 
use, and smoking among patients in the EVC group but this was not statistically 
significant.  The magnitude and distribution of APACHE II and GCS scores was 
very similar between the EVC and SC groups (see figure 4.1).  The incidence of 
moderate–severe and severe vasospasm was similar although there tended to be more 
endovascular interventions per treated patient in the SC group.  Patients in the SC 
group as a whole received a significantly increased total norepinephrine dose and had 
a significantly longer hospital stay (p<0.05) (see table 4.2).  
 
95 
 
Variable Clipped (n=66) Coiled (n=69) P 
Age (Mean +/- 95% CI (SD)) 54.56+/-3.41 
(12.34) 
56.65+/-3.33 
(15.43)  
0.3873 
Age ≥75 2 (3.03) 13 (18.84) 0.0048 
Female Sex 49 (72.24) 44 (63.77) 0.4678 
Previous SAH 1 (1.51) 2 (2.90) 1.0000 
Hypertension 24 (36.36) 29 (42.03) 0.5973 
Smoker 23 (34.85) 30 (43.48) 0.2867 
Previous CVA 0 4 (5.80) 0.1198 
Statin 9 (13.36) 16 (23.19) 0.1863 
Magnesium 36 (54.54) 35 (50.72) 0.7311 
WFNS grade 1-3 47 (71.21) 49 (71.01) 
1.0000 
WFNS grade 4-5 19 (28.78) 20 (28.99) 
APACHE II score, Median (IQR) 13 (10) 14 (10.5) 0.3681 
APACHE>15 27 (40.91) 32 (46.37) 0.6033 
GCS, Median, (IQR) 14 (3) 14 (6) 0.5962 
Aneurysm location 
Anterior 
Posterior 
 
61 (92.42) 
5 (7.58) 
 
52 (75.36) 
17 (24.64) 
0.0096 
Aneurysm size 
≤10 mm 
>10 mm 
 
52 (78.79) 
8 (12.12) 
 
57 (82.60) 
8 (11.59) 
 
0.7546 
Hydrocephalus 35 (53.03) 37 (53.62) 1.0000 
Moderate-severe vasospasm 35 (53.85) 30 (46.88) 0.4831 
Severe vasospasm  19 (29.23) 15 (23.44) 0.5498 
Endovascular treatment of 
vasospasm 
TBA 
Vasodilators 
19 (29.23) 
8 
18 
23 (35.94) 
5 
22 
0.4561 
Vasospasm interventions 
(mean±95% CI) 
4.89+/-1.38 3.23+/-1.28 0.0806 
 
 
Table 4.1  Descriptive analysis of the overall cohort. Values are (n (%)) unless otherwise 
stated. APACHE II, Acute Physiology and Chronic Health Evaluation II; CVA, 
cerebrovascular accident; EVC, endovascular coiling; GCS, Glasgow Coma Scale; SAH, 
subarachnoid haemorrhage; SC, surgical clipping; TBA, transluminal balloon angioplasty; 
WFNS, World Federation of Neurosurgical Societies. 
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Figure 4.1. Distribution of Acute Physiology and Chronic Health Evaluation II (APACHE 
II, left) scores and Glasgow Coma Scale (GCS, right) scores in patients undergoing   
endovascular coiling or surgical clipping. 
 
 
When APACHE II score was plotted against outcome for all patients (figure 
4.2), a threshold of 15 was evident for the majority of outcomes clearly moving from 
favourable to unfavourable. Fifty-nine of 135 patients (43.7%) had an APACHE II 
score of >15. This value was close to the median score (13 for SC and 14 for EVC). 
Multivariate analysis (table 4.3) of the overall study cohort demonstrated that age 
≥75 years (OR 9.9, 95% CI 1.62 to 60.60, p<0.05), WFNS grade ≥4 (OR 10.81, 95% 
CI 3.51 to 33.31, p<0.0001), and SC (OR 5.27, 95% CI 1.63 to 16.95, p<0.01) were 
significant predictors of poor outcome; 35/66 (53.03%) SC patients versus 44/69 
(63.76%) of EVC patients achieved a favourable outcome. However, the greatest 
predictor of poor outcome was an APACHE II score of >15 (OR 17.80, 95% CI 4.78 
to 66.21, p<0.0001). When WFNS grade 1–2 patients were individually investigated 
so as to minimize the neurological influence within the APACHE II score on 
outcome, on multivariate analysis, an APACHE II score of >15 was the strongest 
predictor of poor outcome (OR 11.89, 95% CI 3.08 to 45.07, p<0.001).  
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Outcome 
Mean and 
95% CI (SD) 
All patients APACHE II ≤15 APACHE II >15 
SC 
(n=66) 
EVC 
(n=69) 
P SC 
(n=39) 
EVC 
(n=37) 
P SC 
(n=27) 
EVC 
(n=32) 
P 
Noradrenaline 
dose (mg) 
 
175.5+/-
39.00 
(188.23) 
101.44 
+/-37.43 
(116.58) 
0.0069 136.03+/-
38.98 
(145.46) 
80.35+/-
40.02 
(91.32) 
0.0507 232.52+/-
71.50 
(227.90) 
126.61+/-
66.7 
(138.36) 
0.0343 
Ventilated 
days 
 
8.36 +/-
2.76 
(14.55) 
5.13 +/-
2.75 
(6.94) 
0.1040 2.87+/-
1.76 
(5.79) 
2.67+/-
1.80 
(5.21) 
0.8773 16.29+/- 
5.5 
(19.23) 
8.17+/-
5.25 
(7.66) 
0.0371 
Hospital days 
 
37.07+/- 
4.91 
(23.08) 
25.64 
+/-4.86 
(16.07) 
0.0014 29.87+/-
4.46 
(17.15) 
21.89+/- 
4.6 
(9.5) 
0.0150 48.56+/-
9.12 
(26.22) 
27.87 +/-
8.51 
(21.16) 
0.0016 
ITU days 
 
15.53+/-
2.70 
(14.36) 
14.67+/-
2.68 
(6.43) 
0.6562 13.73+/-
2.28 
(4.40) 
 
12.10+/-
2.22 
(8.71) 
0.3111 20.48+/-
5.54 
(19.01) 
15.83+/-
5.26 
(8.23) 
0.2280 
 
Table 4.2 Total noradrenaline dose (mg), ventilated days, ITU and hospital length of stay 
(days) by treatment modality (Values are mean±95% CI (SD)). APACHE II, Acute 
Physiology and Chronic Health Evaluation II; EVC, endovascular coiling; ITU, intensive 
therapy unit; SC, surgical clipping. 
 
 
 
 
 
Figure 4.2 Acute Physiology and Chronic Health Evaluation II (APACHE II) score plotted 
against favourable outcome (modified Rankin Scale (mRS) score of 0–2) and unfavourable 
outcome (mRS score 3–6) for the population as a whole. 
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Variable OR (95% CI) P 
Age ≥75 9.9 (1.62-60.60) 0.0131 
Female sex 0.56 (0.17-1.81) 0.3353 
Smoker 3.07 (0.97-9.67) 0.0556 
WFNS grade ≥4 10.81 (3.51-33.31) <0.0001 
Vasospasm 1.23 (0.43-3.89) 0.6400 
Clipping 5.27 (1.63-16.95) 0.0053 
Hydrocephalus 0.71 (0.23-2.16) 0.5482 
APACHE II score >15 17.80 (4.78-66.21) <0.0001 
 
Table 4.3 Multivariate analysis of variables potentially impacting on outcome in the study 
population as a whole. APACHE II, Acute Physiology and Chronic Health Evaluation II; 
WFNS, World Federation of Neurosurgical Societies. 
 
The study population was then dichotomised by APACHE II score of ≤15 or 
>15 to explore outcomes by modality relative to the degree of physiological 
derangement.  Descriptive statistics for two groups are shown in table 4.4.  In the 
APACHE II ≤15 group, there was a significant increase in length of hospital stay in 
the SC group (p<0.05).  On multivariate analysis, poor WFNS grade was the only 
significant predictor of poor outcome (OR 13.76, 95% CI 2.25 to 83.93, p<0.05).  
For patients with an APACHE II score of ≤15, there was no significant difference in 
outcomes between SC and EVC patients across all grades or within the good grade 
(WFNS 1–2) subgroup.  There tended to be more severe vasospasm in the SC group 
but this was not significant.  The distribution of favourable and unfavourable 
outcomes by baseline APACHE II score subgroupings (≤15 or >15) for each 
aneurysm securing modality is shown in table 4.4. 
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 APACHE II Score ≤15 APACHE II Score >15 
Variable SC 
(n=39) 
EVC 
(n=37) 
P SC  
(n=27) 
EVC  
(n=32) 
P 
APACHE II 
Median (IQR) 
9 (6) 10 (4.5) 0.5619 19 (5) 20 (6) 0.9362 
Age 
Mean, 95% CI 
(SD) 
50.64+/-
4.26 
(13.10) 
51.97+/-
4.38 
(13.63) 
0.6653 60.22+/-
5.02 
(8.58) 
62.06+/-
4.61 
(15.81) 
0.5907 
Age ≥75 1 (2.56) 2 (5.4) 0.6100 1 (3.7) 11 (34.38) 0.0037 
Female Sex 28 
(71.79) 
19 
(51.35) 
0.0980 22 (81.48) 26 (81.25) 1.0000 
Previous SAH 1(2.56) 1(2.70) 1.0000 0 1 (3.13) 1.0000 
Hypertension 10 
(25.64) 
10 
(27.03) 
1.0000 14 (51.85) 19 (59.38) 0.6068 
Smoker 13 
(33.33) 
15 
(40.54) 
0.4833 10 (37.04) 15 (46.89) 0.5976 
Previous stroke 0 0 1.0000 0  4 (12.5) 0.1176 
GCS  
Median (IQR) 
15 (1) 15 (2) 0.7279 11 (8) 13 (7) 0.6312 
WFNS grade 1-
3 
36 
(92.31) 
30 
(81.08) 
0.1858 
11 (40.74) 19 (59.38) 
0.1954 
WFNS grade 4-
5 
3 (7.69) 7 (18.92) 16 (59.26) 13 (40.63) 
Hydrocephalus 21 
(53.85) 
15 
(40.54) 
0.2616 16 (59.23) 20 (62.5) 1.0000 
Vasospasm 16 
(41.03) 
19 
(51.35) 
0.4902 19 (70.37) 11 (34.38) 0.0089 
Severe 
Vasospasm 
12 
(30.77) 
7 (18.92) 0.2935 7 (25.93) 8 (25.0) 1.0000 
 
Table 4.4 Descriptive analysis for dichotomised populations with APACHE II scores of ≤15 
or >15 Values are (n (%)) unless otherwise stated. APACHE II, Acute Physiology and 
Chronic Health Evaluation II; EVC, endovascular coiling; GCS, Glasgow Coma Scale; 
SAH, subarachnoid haemorrhage; SC, surgical clipping; WFNS, World Federation of 
Neurosurgical Societies. 
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APACHE 
II 
WFNS Favourable outcome  
(mRS 0-2) (%) 
OR (95% 
CI) 
P 
SC EVC 
>15 1-5 3/27 (11.1) 12/32 (37.5) 6.33 (1.27-
31.38) 
0.0238 
1-2 3/10 (30) 9/16 (56.3) 5.30 (0.74-
37.92) 
0.0970 
≤15 1-5 32/39 (82.05) 32/37 (86.49) 3.02 (0.63- 
14.39) 
 
0.1658 
 
1-2 32/35 (91.42) 27/30 (90.00) 0.96 (0.16-     
5.66) 
 
0.9654 
 
Table 4.5 Favourable outcomes (mRS 0-2) for clipped and coiled patients by dichotomised 
APACHE II subgroups (≤15 or >15) and multivariate odd ratios (OR) with 95% confidence 
intervals (CI) for poor outcome in each subgroup for clipped versus coiled patients. 
APACHE II, Acute Physiology and Chronic Health Evaluation II; EVC, endovascular 
coiling; mRS, modified Rankin Scale; SC, surgical clipping; WFNS, World Federation of 
Neurosurgical Societies. 
 
 
For those patients with an APACHE II score of >15, there tended to be more 
vasospasm and poorer grade patients in the SC group but this did not reach 
significance.  There were a significantly greater number of older patients (≥75 years 
of age) in the EVC group (p<0.05).  On multivariate analysis, WFNS grade ≥4 (OR 
6.74, 1.43 to 31.75) and SC (OR 6.33, 1.27 to 31.38) were the only significant 
predictors of poor outcome (p<0.05).  In this population, 11% (3/27) of SC patients 
achieved a favourable outcome compared with 37.5% (12/32) of patients in EVC 
group.  For good grade patients (WFNS 1–2) with an APACHE II score of >15, 
favourable outcome for SC was 3/10 (30%) and for EVC 9/16 (56.3%).  SC patients 
also demonstrated significantly increased total norepinephrine dose, ventilated days, 
and hospital stay (p<0.05) relative to EVC patients.  As grouped APACHE II scores 
increased, these outcome measures and the percentage favourable outcome (mRS 0-
2) diverged for SC relative to EVC patients (figure 4.3, table 4.6). 
 
101 
 
 
Figure 4.3 Outcome variables by grouped Acute Physiology and Chronic Health Evaluation 
II (APACHE II) scores for patients undergoing endovascular coiling or surgical clipping. 
 
APACHE 
II score 
Favourable 
outcome 
(mRS 0-2) 
(%) 
Hospital days Ventilator days Noradrenaline dose 
(mg) 
SC EVC SC EVC SC EVC SC EVC 
0-10 19/21 
(90.5) 
20/22 
(90.9) 
28.9+/-
9.18 
22.45+/-
6.84 
1.45+/-
5.53 
2.27+/-
2.28 
113.8+/-
82.6 
 
84.5+/-
47.58 
 
11-15 13/18 
(72.2) 
12/15 
(80) 
31+/-
9.92 
21.07+/-
8.29 
4.37+/-
5.67 
3.26+/-
3.35 
159.42+/-
84.76 
 
74.27+/-
64.18 
 
16-20 3/16 
(18.8) 
9/20 
(45.0) 
42.31+/-
10.52 
26.16+/-
7.37 
10.0+/-
6.38 
7.35+/-
3.60 
211.63+/-
92.36 
 
120.21+/-
57.03 
 
≥21 0/11 
(0) 
3/12 
(25.0) 
57.63+/-
12.69 
 
30.58+/-
9.27 
24.17+/-
7.13 
8.65+/-
3.15 
262.91+/-
111.4 
 
136.75+/-
61.9 
 
 
Table 4.6 Favourable outcome, hospital days, ventilator days, and total norepinephrine dose 
by increasing grouped APACHE II scores for patients undergoing endovascular coiling or 
surgical clipping. Values are mean±95% CIs unless otherwise stated. APACHE II, Acute 
Physiology and Chronic Health Evaluation II; EVC, endovascular coiling; mRS, modified 
Rankin Scale; SC, surgical clipping. 
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4.5 Discussion 
The APACHE II scoring system is well established in intensive care practice. 
The system allows approximate prognostication based on a score from 0 to 71 for 
clinical and biochemical markers of cardiopulmonary, renal, haematological, and 
neurological function (Knaus et al, 1985).  A breakdown of the scoring system is 
displayed in table 4.7.  A number of observational studies have related other 
physiological scores to outcomes in SAH patients (Schuiling et al, 2005; Mocco et 
al, 2006).  We aimed to identify whether the physiological derangement expressed 
by the APACHE II score had implications for differences in clinical outcome 
following either EVC or SC. 
To our knowledge, this is the first study that has investigated the impact of a 
dichotomised APACHE II score in SAH.  We have demonstrated that more 
significant physiological derangement, defined as a dichotomised APACHE II score 
of >15 at presentation, is a strong independent predictor of poor outcome in the SAH 
population as a whole.  We did not investigate the impact of specific physiological 
variables within the score but it has previously been shown that hypoxemia, 
metabolic acidosis, hyperglycaemia, and cardiovascular instability are the dominant 
factors that influence eventual outcome (Claasen et al, 2004). 
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Physiological Variable Points range 
Age 0-6 
Temperature 0-4 
Mean Arterial Pressure 0-4 
Heart rate  0-4 
Respiratory rate 0-4 
PaO2 0-4 
Arterial pH 0-4 
Serum Sodium 0-4 
Serum Potassium 0-4 
Serum Creatinine 0-8 
Haematocrit 0-4 
White Blood Cell Count 0-4 
Glasgow Coma Scale 0-12 
Chronic Health Problems:  
1) Cirrhosis of the liver confirmed by 
biopsy 2) New York Heart Association 
Class IV  
3) Severe COPD: hypercapnia, home O2 
use, or pulmonary hypertension  
4) Regular dialysis  
5) Immunocompromised 
None 0 
Emergency procedure 5 
 
Table 4.7 Breakdown of the physiological variables with contribution to the APACHE II 
score.  APACHE II, Acute Physiology and Chronic Health Evaluation II; COPD, chronic 
obstructive pulmonary disease. 
 
While clinical outcomes did not differ by treatment modality in the less 
physiologically deranged population (APACHE II ≤15), for those with more 
profound physiological derangement (APACHE II >15) there was a significant 
difference in clinical outcome by treatment modality.  Within this population there 
tended to be more poor grade (WFNS ≥4) patients in the SC group, but on 
multivariate analysis both poor grade and SC were predictors of poor outcome.  
Furthermore, functional outcome differences by treatment modality for the good 
grade subgroup (WFNS grades 1–2) tended to significance (perhaps not reaching 
significance as the study was underpowered), suggesting an effect independent of 
presenting grade. In keeping with this, outcomes in the EVC group were improved 
despite having a significantly greater number of older patients. SC was associated 
with a marked increase in inotropic support (total norepinephrine dose), and hospital 
and ventilated days, suggesting a more profound physiological impact.  This may 
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have been confounded by a higher incidence of vasospasm in the SC group but the 
incidence of severe vasospasm was similar, and on multivariate analysis, clipping 
and poor WFNS grade were significant predictors of poor outcome of similar 
magnitude in these patients, whereas vasospasm was not. 
Functional outcomes for SC and EVC patients appeared to diverge with 
increasing APACHE II grouped scores along with degree of inotropic support, time 
ventilated, and hospital stay.  The findings do suggest that the impact of the clipping 
procedure relative to a coiling procedure on deranged physiology may result in 
worse clinical outcomes. 
These findings may give a clue as to why EVC is associated with better 
outcomes following treatment of aneurysmal SAH. Nevertheless, a clear underlying 
reason for these differences is uncertain.  In one study, surgical and endovascular 
aneurysm therapies were associated with similar risks of cardiac injury and 
dysfunction after SAH (Miss et al, 2004).  Rates of postoperative pulmonary oedema 
were also similar when the treatment modalities were compared (Horie et al, 2014).  
Craniotomy and SC is associated with longer procedural times but whether it results 
in a greater systemic inflammatory response (which is known to complicate SAH) 
(Yoshimoto et al, 2001)
 
remains to be demonstrated.  Immunodepression is also 
known to complicate SAH (Sarrafzadeh et al, 2011)
 
and predisposes to pneumonia 
but the impact of aneurysm securing procedure has not been studied.  Could a more 
minimally invasive aneurysm securing procedure limit these processes in some 
patients?  
Common non-neurological complications of SAH include anaemia, 
hypertension, cardiac arrhythmia, fever, electrolyte changes, pulmonary oedema, 
pneumonia, hepatic dysfunction, renal dysfunction, and thrombocytopenia (Solenski 
et al, 1995).
  
Pneumonia, sepsis, fever, anaemia, and hyperglycaemia independently 
predict poor outcome and death (Wartenberg et al, 2006).  Medical complications are 
linked to severity of presenting grade (Solenski et al, 1995). 
 
Additionally, a large 
Canadian multicentre study demonstrated that SC patients more commonly suffered 
medical complications, such as urinary tract infection, pneumonia, cardiorespiratory 
arrest, and seizures, and that these complications were linked to poor outcome 
(Vergouwen et al, 2011c).  Our finding that SC patients with more profound 
physiological derangement (APACHE II >15) were noted to have significantly 
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increased total norepinephrine dose, days ventilated, and hospital stay is consistent 
with this finding. 
Many authors have attempted to explain the differences in outcome between 
patients undergoing EVC and SC through assessing the rates of cerebral vasospasm 
or delayed ischemia.  Although there is some controversy regarding this, the general 
consensus is that that clipping results in more vasospasm and delayed ischemia 
(Dumont et al, 2010; Dorhout Mees et al, 2012). 
 
Naidech et al, (2006) have also 
demonstrated an association between baseline physiological derangement and rates 
of infarction on CT.
  
We demonstrated a significantly increased incidence of 
moderate–severe vasospasm in the SC population with more deranged physiology 
(APACHE II >15) but not in the SC population with an APACHE II score of ≤15, 
which suggests that a possible synergistic effect may exist, with both physiological 
derangement and craniotomy/clipping combining to result in a greater risk of 
vasospasm.  However, the rate of vasospasm in the coiled population with an 
APACHE II score ≤15 was higher than in the population with an APACHE II score 
>15, suggesting that physiological derangement did not necessarily contribute to the 
development of vasospasm.  Furthermore, we did not demonstrate a difference in the 
rate of severe vasospasm between treatment modalities.  Interestingly, vasospasm 
failed to represent an independent predictor of poor outcome but the majority of 
patients in this study were managed using a paradigm employing angiographic 
screening and pre-emptive hypertensive and endovascular management on 
identification of significant angiographic vasospasm (Mortimer et al, 2015b),
 
which 
may limit its clinical impact.  
The results of this study have implications for daily practice: the choice of 
whether to clip or coil an aneurysm has traditionally been made on the basis of 
morphological criteria, such as aneurysm location, size, and neck anatomy.  We 
suggest, on the basis of these findings, that as well as anatomical criteria it is worth 
considering the physiological condition of the patient as one of the primary factors in 
assigning treatment modality.  For example, is it preferable to clip a complex 
aneurysm in a medically unwell patient or would it be preferable to treat with partial 
coiling of the dome (Waldau et al, 2012)
 
in order that the patient can be brought back 
for retreatment (using stents, flow diversion, or surgery) following recovery rather 
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than undergo an acute clipping procedure?  This approach has not been answered by 
this study but certainly warrants future investigation.  
This was a small explorative analysis, and although the data suggest some 
interesting findings, it is necessary to explore these concepts in a larger population. 
The data were not collected specifically to answer the impact of physiological 
derangement relative to aneurysm securing procedure on outcome.  Dichotomising 
APACHE II score based on the available data introduces bias, and the assignment of 
treatment modality was not randomised so there is an inherent selection bias with 
respect to this also.  The procedural complication rate was not specifically recorded. 
There were more posterior circulation aneurysms in the coiling group, and Fisher 
grade was not taken into account; it is plausible that the results were therefore biased 
by patients needing surgical haematoma evacuation being selected into the clipping 
group. However, in a recent prospective study of 381 consecutive SAH patients, 
haematoma evacuation was a reason for SC in only 3% of patients (Cognard et al, 
2014).  Furthermore, in this study, SC was a significant predictor of poor outcome of 
similar magnitude to poor WFNS grade (indicative of acute neurological injury) on 
multivariate analysis, and there also tended to be more favourable outcomes in the 
good grade (WFNS 1-2) subgroup with more deranged physiology (APACHE II 
>15) when coiled rather than clipped, suggesting an interaction between treatment 
modality and physiological derangement independent of the acute neurological 
injury.  
An additional criticism of this study is that the short follow-up period of 90 
days is likely to show a poorer outcome when assessing a more invasive 
intervention, such as a craniotomy.  Ideally, if a future study were to be constructed 
to explore the interaction between deranged physiology, treatment modality, and 
outcome, a longer follow-up period would be needed.  On the other hand, it could be 
argued that this is precisely the point; patients undergoing a more invasive procedure 
may require more inotropic support, more time ventilated, and more time in hospital.  
They could therefore take much longer to recover and are therefore more at risk of 
nosocomial infection and other medical complications.  The results do therefore give 
an interesting insight into the role that physiological assessment could have in 
shaping the design of future prospective investigations.  
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4.6 Conclusion  
In summary, we have demonstrated that in this population, more marked 
physiological derangement at baseline is a strong predictor of eventual poor 
outcome.  These preliminary results also suggest that clinical outcomes for patients 
with more severe baseline physiological derangement could possibly be improved if 
undergoing a coiling rather than a clipping procedure but this should be investigated 
using a prospective approach in the future.  
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5.1 Abstract 
5.1.1 Background  
Perimesencephalic subarachnoid haemorrhage (PMSAH) is only rarely 
associated with a ruptured cerebral aneurysm and CT angiography (CTA) has very 
good sensitivity and specificity for aneurysm detection.  The necessity for invasive 
imaging with digital subtraction angiography (DSA) is therefore debatable.  We 
chose to assess the negative predictive value (NPV) of CTA in a series of patients 
with PMSAH treated at our institution over a 9-year period.  
 
5.1.2 Methods 
We retrospectively assessed the diagnostic yield of DSA after initial negative 
CTA in patients with a PMSAH pattern defined as blood centred anterior to the 
midbrain and/or pons within the pre-pontine or interpeduncular cistern with possible 
quadrigeminal or ambient cistern extension; possible extension into the basal parts of 
the Sylvain fissures but not the lateral sylvian fissures; possible extension to the 
cisterna magna but not centred on the cisterna magna; and possible extension into the 
fourth ventricle and occipital horns of the lateral ventricles.  
 
5.1.3 Results 
Using this definition of PMSAH, of 72 patients, one patient showed a 
potentially significant finding on DSA that was not demonstrated on initial CTA 
(NPV 98.61% (95% CI 92.47% to 99.77%)).  However, when cisterna magna 
extension was excluded from the definition of PMSAH, no false negative CTAs in 
56 patients were encountered (NPV 100% (95% CI 93.56% to 100.00%)).  
 
5.1.4 Conclusion 
  The NPV of normal CTA for an arterial abnormality in patients with PMSAH 
is high and our results therefore question the role of invasive imaging.  The findings 
also suggest that a prospective study designed to clarify the necessity of performing 
DSA in this population would be feasible.  
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5.2 Introduction 
Perimesencephalic subarachnoid haemorrhage (PMSAH) represents a distinct 
clinic-radiological entity characterised by haemorrhage centred on the 
perimesencephalic cisterns, aneurysm negative angiographic investigation and a 
more benign clinical course (van Gijn et al, 1985; Rinkel et al, 1991a; Rinkel et al, 
1991b; Brilstra et al, 1997; Greebe et al, 2007). 
 
The PMSAH pattern is 
demonstrated in approximately 5% of patients with subarachnoid haemorrhage 
(SAH) and has an incidence of 0.5/100 000 patients (Flaherty et al, 2005). 
 
The 
incidence of an underlying aneurysm presenting with a PMSAH pattern has been 
reported in as many as 12% (Kallmes et al, 1996),
 
but a recent meta-analysis of 1031 
patients with strict criteria for PMSAH concluded a rate of 0.78% (Kalra et al, 
2015). 
 
Angiographic imaging is mandatory, but the question of how far to 
investigate these patients has been debated for some time, largely owing to reports of 
low diagnostic yield for digital subtraction angiography (DSA) in the face of 
negative CT angiography (CTA) (Velthuis et al, 1999; Kalra et al, 2015; 
Kershenovich et al, 2006; Westerlaan et al, 2007; Agid et al, 2010; Cruz et al, 2011; 
Moscovici  et al, 2013; Delgado Almandoz  et al, 2013; Zhong  et al, 2014) and the 
risk to the patient incurred by the former investigation (Willinsky et al, 2003). 
Critical to defining which patients could forgo DSA is the definition of 
PMSAH itself, and various definitions have been used (van Gijn et al, 1985; 
Schievink et al, 1994; Delgado Almandoz et al, 2012; Wallace et al, 2016).
  
The 
pattern of haemorrhage first described by van Gijn et al in 1985
 
was that of blood 
centred anterior to the midbrain or pons but not extending to the lateral Sylvain 
fissures or anterior interhemispheric fissure and only a small volume of 
intraventricular haemorrhage.  More recently, Wallace et al (2016) have described a 
pattern whereby haemorrhage could extend to the cisterna magna but not into the 
Sylvain fissures, with intraventricular blood confined to the fourth ventricle or 
occipital horns of the lateral ventricles only.  Using their algorithm, no patients had 
an underlying aneurysm in their series.  
We aimed to investigate the diagnostic yield of DSA in the face of a negative 
CTA in patients with PMSAH to elucidate the negative predictive value of CTA in 
this population.  We based our investigation on 9 years of practice in a regional 
neuroscience centre where the established protocol was to investigate all patients 
with CTA and DSA.  
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5.3 Methods 
This retrospective investigation was approved by the institutional audit 
committee.  All CTAs performed between January 2006 and December 2014 in 
patients aged 18 years an over were screened and those performed in the context of 
non- traumatic SAH were reviewed by two consultant neuroradiologists (SR and 
AA) for the presence or absence of an underlying aneurysm.  Patients with CT-
confirmed SAH but a negative CTA were initially identified. Each non-contrast CT 
(NCCT) scan was then reviewed for the pattern of SAH; those with a PMSAH 
pattern agreed by two consultant neuroradiologists (SR and AM) by consensus were 
then included in the final study cohort.  The presence of hydrocephalus, 
intraventricular extension, and extension of haemorrhage to the cisterna magna was 
also recorded.  Subsequent DSAs were assessed for the presence of underlying 
arterial pathology that could account for the SAH, principally aneurysmal disease or 
arterial dissection.  CTA studies from outside institutions were excluded from the 
study.  For patients with defined PMSAH, the medical notes were reviewed to 
confirm the presentation and performance of initial NCCT imaging within 72 h of 
ictus.  Patients who did not undergo DSA were excluded from the final analysis.  
Descriptive statistics and negative predictive value for CTA were calculated using 
Medcalc statistical software.  
 
5.3.1 Definition of perimesencephalic subarachnoid haemorrhage   
Patients were categorised radiologically as having PMSAH on the basis of 
features modified from van Gijn et al (1985) and Wallace et al (2016). See figure 
A1, appendix 1. 
1. Haemorrhage centred anterior to the midbrain and/or pons within the pre-
pontine and interpeduncular cisterns with possible extension to the 
quadrigeminal or ambient cisterns.  
2. No deep extension into the anterior interhemispheric fissure.  
3. Possible extension into the basal parts of the Sylvain fissures with no 
extension into the lateral Sylvain fissures.  
4. Possible extension to the cisterna magna but not centred on the cisterna 
magna.  
5. Possible extension into the fourth ventricle and occipital horns of the lateral 
ventricles.  
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5.3.2 Imaging protocol  
All patients underwent CTA using a 64-slice scanner (Siemens Medical 
Systems, Erlangen, Germany).  CTA was acquired using a contrast bolus of 75 mL 
Iomeron 400 (400 mg iodine/mL; Bracco, UK) followed by a 40 mL saline chaser 
injected via an 18–20-gauge cannula in the upper limb with a flow rate of 5 mL/s.  A 
bolus tracking technique was used with a marker placed at the ascending aorta, 
triggering at 120 Hounsfield Units above baseline with a 10 s delay prior to image 
acquisition.  Images were acquired from C2 to vertex. CTA parameters were as 
follows: 120 kVp; 110 mA; 0.37 s/rotation; 0.6 mm thick sections; and table speed 
1.2 mm/rotation.  Images were reconstructed and reviewed in three planes using 
Synapse picture archiving and communications system (Fujifilm, New York, USA). 
DSA was performed using a dedicated biplane neuroangiography suite (Siemens 
Medical Systems, Erlangen, Germany and Philips, Massachusetts, USA).  Using a 5 
F system, injections of both internal carotid arteries and the dominant vertebral 
artery were performed with standard anteroposterior, lateral, and oblique views.  
Three-dimensional rotational angiography was used for problem solving.  
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5.4 Results 
  CTA-negative SAH was identified in 243 patients.  Of these patients, 74 
were classified as having PMSAH and presenting within 72 h of ictus.  Two did not 
undergo DSA and were therefore excluded from the final analysis, leaving 72 
patients in the primary study cohort.  Patient age ranged from 33 to 79 years (mean 
52.7 years, SD 10.8 years).  The cohort comprised 24 women (33.3%) and 48 men 
(66.6%) (M:F 2:1).  Of the patients defined as having PMSAH, 9 (12.5%) had 
radiological evidence of hydrocephalus, 3 (4.2%) had intraventricular extension, and 
16 (22.2%) had extension of haemorrhage to the cisterna magna.  
Two patients demonstrated findings on DSA that were not identified on 
CTA, but the abnormality in each case was of debatable significance.  This included 
a small A1 anterior cerebral artery bleb in one patient that was felt not to be 
responsible for the haemorrhage and was successfully managed conservatively.  A 
second patient who had a poor quality CTA owing to movement and non-dominant 
vertebral artery irregularity was identified on DSA; this was equivocal for 
underlying atheroma or dissection but was managed with parent vessel occlusion on 
a risk/benefit basis (see figure A2, appendix 1). CTA therefore had a negative 
predictive value of 98.61% (95% CI 92.47% to 99.77%) for significant arterial 
pathology using a definition of PMSAH that allowed extension of haemorrhage to 
the cisterna magna.  However, none of the 56 patients with haemorrhage that did not 
extend to the cisterna magna had a significant finding on DSA, equating to a 
negative predictive value of 100% (95% CI 93.56% to 100.00%) in this subgroup.  
Importantly, one patient (1.4%) suffered a complication of DSA, developing 
presumed neurotoxicity to the contrast agent resulting in widespread MR detectable 
cerebral oedema, hemiparesis and coma, but this subsequently resolved (see figure 
A3, appendix 1).  
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5.5 Discussion 
Approximately 5% of patients with SAH present with a perimesencephalic 
pattern of bleeding (Flaherty et al, 2005),
 
and these patients usually have a more 
benign clinical course; quality of life and life expectancy are normal in this 
population (Rinkel et al, 1991b; Brilstra et al, 1997; Greebe et al, 2007). 
 
However, 
aneurysmal rupture may rarely present with a PMSAH pattern of haemorrhage 
(Kalra
 
et al, 2015)
 
and accurate angiographic imaging is therefore necessary.  The 
role of invasive versus non-invasive imaging in this population has been debated for 
over a decade.  
We have demonstrated that the diagnostic yield for DSA in the face of a 
negative CTA is low and that the negative predictive value of CTA is 98–100%, 
depending on the definition of PMSAH.  Excluding patients with haemorrhage 
extending to the foramen magnum resulted in a negative predictive value of 100%.  
These findings are in line with those of other published series in which the rate of 
abnormality detection on DSA following an initial negative CTA is low (table 5.1) 
(Velthuis et al, 1999; Kershenovich et al, 2006; Westerlaan et al, 2007; Agid et al, 
2010; Cruz et al, 2011; Moscovici et al, 2013; Delgado Almandoz et al, 2013; 
Zhong et al, 2014; Kalra et al, 2015).  
The sensitivity and specificity of CTA for aneurysm detection with modern 
16- and 64-section machines have been systematically reviewed and have 
demonstrated values in the order of 98% and 100%, respectively (Westerlaan et al, 
2011). 
 
Techniques that allow bone subtraction may improve sensitivity, particularly 
for aneurysms lying adjacent to bone (Chen et al, 2013; Cheng et al, 2015).
  
It 
therefore appears that, for the subgroup with PMSAH (particularly if the 
haemorrhage is not seen to extend to the cisterna magna), who are likely to exhibit a 
low yield for any angiographic imaging, investigation with CTA only maybe 
sufficient.  Technological improvements may also see aneurysm detection improve 
further.  For example, 320-slice bone subtraction CTA in 282 consecutive patients 
yielded sensitivity, specificity, and accuracy for depicting aneurysms of 99.2%, 
100%, and 99.4%, respectively, on a per aneurysm basis (Chen et al, 2013). 
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Study Number of patients False negative CTA 
Velthuis et al,  
(1999) 
15 0 
Kershenovich et al, 
(2006) 
30 0 
Westerlaan et al, 
(2007) 
30 0 
Agid et al, 
 (2010) 
93 0 
Cruz et al,  
(2011) 
49 1 (2.4%) 
Moscovici et al,  
(2013) 
25 0 
Delgado Almandoz et 
al, (2013) 
11 0 
Zhong et al,  
(2014) 
49 0 
Kalra et al,  
(2015) 
18 0 
Present study 72 
56 (no cisterna magna 
haemorrhage) 
1 (1.4%) 
0 
 
Table 5.1 Summary of studies assessing the use of CT angiography (CTA) in the 
investigation of perimesencephalic subarachnoid haemorrhage. 
 
 
CTA offers a swift, non-invasive investigation, whereas DSA necessitates 
arterial puncture and a recognised permanent neurological complication rate in the 
order of 0.5% (Willinsky et al, 2003).
  
Ruigrok et al (2000) calculated from the 
literature combined with their own series that the average risk of permanent 
neurological complications from DSA in patients with PMSAH was 0.74% (95% CI 
0.09% to 2.7%).  We noted one transient but potentially serious complication of 
DSA in our series.  However, the risk of forgoing DSA does have to be weighed 
against the risk to the patient if an aneurysm is missed.  Rehaemorrhage is associated 
with poor outcome; Hijdra et al (1987b)
 
studied patients surviving the first 24 h after 
initial rupture and only 7/39 patients (18%) who suffered rehaemorrhage had 
survived at 3 months.  The International Cooperative Study on the Timing of 
Aneurysm Surgery
 
(Kassel et al, 1990) reported that aneurysm rerupture was the 
second most common cause of morbidity and mortality.  
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Current European Stroke Organisation guidelines suggest that, although it is 
uncertain as to whether DSA may be avoided in this population, repeat DSA is not 
necessary (Steiner et al, 2103). 
 
The American Heart Association/American Stroke 
Association guidelines suggest that DSA may not be necessary if a classic 
perimesencephalic pattern of haemorrhage is present and CTA may suffice 
(Connolly et al, 2012). 
 
We are currently debating our own institutional guidelines 
and one protocol that could conceivably be introduced is that of forgoing DSA in the 
presence of a perimesencephalic pattern of haemorrhage and normal CTA as agreed 
by two experienced neuroradiologists on separate reads.  
Critical to applying a protocol using CTA to investigate PMSAH exclusively 
are that strict definitions of what constitutes a perimesencephalic haemorrhage are 
understood and applied and that there is good inter-observer agreement.  This is of 
importance as the likelihood of an underlying vascular abnormality is probably 
greater with a non-perimesencephalic pattern (Westerlaan et al, 2007; Delgado 
Almandoz et al, 2013; Dalyai et al, 2013).  Dalyai et al (2013)
 
demonstrated that the 
diagnostic yield of repeat angiography was 0% in patients with a PMSAH pattern 
and 12.5% in those with a non-PMSAH pattern when they systematically performed 
follow-up angiographic imaging in patients with a negative initial angiogram.  
However, the diagnosis of a PMSAH pattern is not straightforward.  Inter-observer 
disagreement rates vary considerably among studies from 2.8% to 22% (Cruz et al, 
2011; Wallace et al, 2016),
 
highlighting a potential problem with institution of such 
a protocol.  Most definitions of PMSAH stress that the focus of haemorrhage is 
centred on the perimesencephalic cisterns, but definitions vary as to whether it is 
acceptable to allow basal Sylvain fissure, ventricular, or cisterna magna extension 
(van Gijn et al, 1985; Schievink et al, 1994; Delgado Almandoz et al, 2012; Wallace 
et al, 2016).
  
We chose to unify the initial description of PMSAH (van Gijn et al, 
1985),
 
which allows extension into the basal Sylvain fissures, with a more recent 
definition allowing extension to the cisterna magna also (Wallace et al, 2016).
  
However, when cisterna magna extension was included in the definition, one patient 
was identified as having a possible vertebral artery dissection on follow-up DSA, 
raising doubt as to whether this should be used as a criterion.  
This was a retrospective study of a relatively small sample of patients, 
although it should be said that the majority of studies investigating this clinico-
radiological dilemma are of similar design but of smaller cohort size.  Application of 
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the results of this type of investigation could be criticised but the results do pave the 
way for a larger prospective study that could be used to comprehensively answer the 
question of whether invasive imaging is necessary or justified in this subgroup with 
SAH.  
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5.6 Conclusion 
The results of this retrospective study suggest that perimesencephalic 
haemorrhage without extension to the cisterna magna may be investigated with CTA 
with a high negative predictive value for an arterial abnormality in the order of 
100%.  If a prospective study is required to conclusively answer whether invasive 
imaging is necessary in patients with PMSAH, the results of this investigation and 
others suggest that this would be a safe and potentially beneficial study.  
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6.1 Abstract  
6.1.1 Background 
Severe angiographic vasospasm (aVSP) is a risk factor for infarction 
following subarachnoid haemorrhage and infarction is strongly associated with poor 
outcome.  We present the clinico-radiological results of cohort with severe aVSP 
who underwent a program of angiographic surveillance and sustained endovascular 
treatment using multiple verapamil infusions and/or transluminal balloon angioplasty 
(TBA).  
 
6.1.2 Methods 
This was a dual-centre retrospective observational study.  Angiographic 
screening for vasospasm was undertaken at days 5-7 post-ictus.  Treatment was 
instituted principally on the basis of radiographic findings. The rate of infarction was 
evaluated on follow-up CT.  Clinical outcome was assessed using the modified 
Rankin Scale (mRS).  
 
6.1.3 Results 
Fifty-seven WFNS grades 1-5 patients were studied.  The mean number of 
procedures/patient was 6, range 2-13.  Mean verapamil dose administered to the 
ICA was 14 mg and VA was 12 mg.  Thirty-one patients underwent TBA (52.6%).  
The rate of proximal vessel infarction was 3/45 (6.7%) for patients presenting < 72 
hours.  Rates of favourable outcome (mRS 0-2) were 16/19 (84.2%) for WFNS 
grades 1-2, 12/19 (63.2%) for grades 3-4 and 5/19 (26.3%) for grade 5 patients.  
Delayed presentation > 72 hours was the only factor on multivariate analysis to 
significantly predict aVSP-infarction [OR 19.3 (3.2-116.6) P = 0.0012].  Large 
aVSP infarction [OR 19.0 (1.7-216.4) 0.0179] and poor WFNS grade [OR 6.6 (1.3-
33.9) P = 0.0233] were significant predictors of poor outcome on multivariate 
analysis.  
 
6.1.4 Conclusion 
This approach may result in low rates of aVSP-infarction and encouraging 
rates of favourable outcome when compared to literature benchmarks.  Delayed 
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presentation, however, predicts infarction and large infarct and poor initial grade 
significantly influence functional outcome.  
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6.3 Introduction  
Cerebral infarction is strongly associated with poor outcome following SAH 
(Furgusson & Macdonald, 2007, Vergowen et al, 2011b).  Aetiologies include the 
acute injury (Wartenberg et al, 2011), aneurysm treatment, or delayed ischaemia 
(Rowland et al, 2012).  Proposed mechanisms for delayed ischaemia, either alone or 
in combination (Pluta et al, 2009; Rowland et al, 2012), include microthrombosis, 
spreading depolarisation with cortical ischaemia and angiographic vasospasm 
(aVSP).  The contribution of the latter is controversial (Pluta et al, 2009; Macdonald, 
2013; Hou & Zhang, 2013), largely stemming from the finding that endothelin-
receptor antagonists reduce the rate of moderate-severe aVSP but not the rate of poor 
outcome (Macdonald et al, 2008; Macdonald et al, 2011).  However, there is a strong 
correlation between the severity of aVSP and infarct incidence (Crowley et al, 2011).  
The majority of delayed infarcts occur in association with aVSP (Crowley et al, 
2011; Wagner et al, 2013; Brown et al, 2013), mostly with severe aVSP (Weidauer 
et al, 2007; Crowley et al, 2011, Inagawa et al 2014), which results in the most 
significant perfusion deficits (Weidauer et al, 2007; Dankbaar et al, 2009; Vatter et 
al, 2011; Dhar et al, 2012).  Severe aVSP is associated with poor cognition, worse 
patient-relevant outcomes, and greater inpatient healthcare resource use (Macdonald 
et al, 2012).  
Two endovascular approaches have been employed to treat vasospasm; 
prophylactic TBA before vasospasm onset (Zwienenberg-Lee et al, 2009) or, use of 
TBA and/or IA vasodilators as a rescue procedure in patients who deteriorate despite 
medical therapy.  The former approach may result in unnecessary treatments. The 
latter relies on early detection of clinical deterioration.  However, these patients are 
often poor grade, comatose or sedated and difficult to assess.  They may suffer silent 
infarction that itself has a negative impact on outcome (Shimoda et al, 2001; 
Schmidt et al, 2008; Macdonald et al, 2013).  An alternative approach is to screen 
for vasospasm with the intention of treating it while it is minimally symptomatic.  
We routinely undertake a program of angiographic surveillance at days 5-7 post-
ictus, at or just before the time that most patients become symptomatic (Suarez et al, 
2002; Ionita et al, 2010) with subsequent endovascular treatment (multiple 
procedures where necessary) based on symptomology and radiographic features.  We 
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hypothesised that using this approach and comparing to benchmarks in the literature, 
rates of infarction and clinical outcomes were favourable.  
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6.4 Methods  
This was a dual-centre retrospective observational study of patients with 
severe aVSP following aneurysmal SAH treated between November 2009 and 
December 2013.  The study was approved by the regional ethics committee.  
Patients included were defined as having severe aVSP on the basis of > 66% 
arterial narrowing (Crowley et al, 2011) on initial screening or subsequent DSAs.  
Statistical analysis was performed using Openstat software, 2013.  Univariate 
analysis of nonparametric variables and their relationship to infarction and 
unfavourable outcome (mRS 3-6) was calculated using χ2.  For variables that 
demonstrated P <0 0.1 on univariate analysis, multivariate binary logistic regression 
was undertaken with statistical significance defined as P < 0.05.  Patients were 
managed in line with published protocols (Mortimer et al, 2015c).  Significant aVSP 
was treated using IA verapamil or TBA, with a repeat angiogram the following day. 
Papaverine was used as a second-line IA vasodilator.  Decision to use vasodilators or 
TBA was undertaken on a case-by-case risk/benefit basis.  Vasodilators were used 
for distal (M2/3MCA, A2/3-ACA and PCA) disease.  Severe proximal (VA, BA, 
ICA, M1-MCA or A1-ACA) vasospasm was treated with TBA where possible.  For 
refractory vasospasm, daily treatments were undertaken until either vasospasm was 
no longer significant or vasospasm proved to be unsatisfactorily treated with this 
regime.  For multiple treatments the groin sheath was sutured in situ, replaced daily 
and side alternated after 3-4 days.  
A neuroradiologist assessed presenting CT and CTs performed during the 
treatment period and at 2 to 6 weeks’ follow-up.  The initial CT was interpreted for 
extent and distribution of haemorrhage and hydrocephalus.  The initial DSA was 
interpreted for the site and size of the aneurysm.  Vasospasm distribution and 
severity was then recorded from subsequent angiography. Severe vasospasm was 
defined as arterial narrowing of >66% relative to the angiogram performed within 72 
hours of ictus.  For late presenters, severe vasospasm was defined as ICA, BA, M1-
MCA and A1-ACA vessel diameters of ≤ 2 mm, ≤ 1.5 mm, ≤ 1.5 mm and ≤ 1 mm 
respectively.  
Delayed CT scans were interpreted in conjunction with DSA to record the 
rate and characteristics of aVSP-related infarction.  This was defined as hypodensity 
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in a vascular territory or watershed distribution correlating with the distribution of 
aVSP.  Infarcts were classified as proximal (M1 or M2-MCA, A1-ACA, or P1-
PCA), watershed, perforator or distal branch.  Hypodensities present prior to the 
development of vasospasm, relating to EVD insertion or hydrocephalus, lying 
adjacent to haematomas or relating to aneurysm treatment were excluded.  Clinical 
outcome was graded through means of a modified Rankin Scale score (mRS) at 
mean 16 ± 4 months’ follow-up.  
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6.5 Results  
Fifty-seven patients were included: 18 males (31.6%) and 39 females 
(68.4%) of mean age 50.4 ± 3.0 years.  Clinico-radiological features at presentation 
are shown in table 6.1.  Twenty-two patients (38.6%) were clipped and 35 patients 
(61.4%) were coiled.  The aneurysm responsible for the haemorrhage was anterior 
circulation in 47 (82.5%) [ACA 24, ICA 14 and MCA 9] and posterior circulation in 
10 (17.5%).  Seven aneurysms (12.3%) were large (≥ 10 mm) and one was giant. 
Eleven patients (19.3%) presented >72 hours and had vasospasm on initial 
angiography.  Clinical state when commencing treatment for vasospasm was GCS 3-
6 in 16 patients (28.1%), GCS 7-12 in 16 (28.1%), GCS 13-14 in 17 (29.8%) and 
GCS 15 in 4 (7%).  Four patients (7%) were sedated for raised intracranial pressure 
and could not be assessed.  Thirteen patients (22.8%) underwent decompressive 
craniectomy. 
  
6.5.1 Distribution of aVSP  
The distribution of severe aVSP is shown in figure 6.1.  Severe aVSP was 
seen in 1 vessel (ICA, MCA, ACA, VA or BA), in 11 patients (19.3%), 2 vessels in 
17 patients (29.8%), 3 vessels in 10 (17.5%), 4 vessels in 11 (19.3%) and 5-7 vessels 
in 8 patients (14.1%).  All patients had at least one proximal segment treated during 
the course of their surveillance.  Only one patient was treated prior to the screening 
window of 5-7 days.  
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WFNS grade  1 2 3 4 5 
11 (19.3) 8 (14) 6 (10.5) 13 (22.8) 19 (33.3) 
Fisher grade 1 2 3 4  
0 (0) 1 (1.8) 50 (87.7) 6 (10.5)  
Maximal clot thickness ≤5mm 5-10mm 11-15mm >15mm  
6 (10.5) 13 (22.8) 20 (35.1) 18 (31.6)  
Intraventricular 
haemorrhage 
46 (80.7) 
Intraparenchymal 
extension of 
haemorrhage 
28 (49.1) 
Hydrocephalus 48 (84.2) 
Hypertension 18 (31.5) 
Diabetes mellitus 2 (3.5) 
History of smoking 22 (38.5) 
 
Table 6.1 Clinico-radiological features at presentation (%). 
 
 
 
Figure 6.1 Distribution of severe aVSP in the treated cohort. 
6.5.2 Endovascular treatment  
The mean number of procedures/patient was 5.87 ± 0.77 (2-13 per patient).  
All patients had at least one verapamil infusion.  Doses administered are displayed in 
table 6.2.  Mean day of first treatment was 6.  Papaverine was used as a second-line 
treatment in 21 patients with 64 infusions; 30 were selective microcatheter 
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injections.  The mean dose was 133.68 ± 19.67 mg and mean number of infusions 
2.17 (1-6 per patient).  Thirty-one patients (52.6%) underwent TBA. Vessels 
angioplastied are shown in figure 6.2. Of the 89 vessels angioplastied, one required 
retreatment with TBA (1.1%).  
 
 
Vessel Mean dose 
(mg) 
Range (mg) Mean 
number of 
treatments 
Range 
RICA 14.39+/-0.78 8.33-22 5 1-12 
LICA 14.21+/-0.83 8.5-20.7 4.7 1-13 
RVA 11.87+/-1.83 5.0-17.0 3.36 1-15 
LVA 12.59+/-1.33 10.0-15.0 2.58 1-6 
 
Table 6.2 Dose and number of Verapamil infusions by vessel. 
 
 
Figure 6.2 Vessels treated with TBA. 
 
6.5.3 Complications 
 Fifty-seven patients underwent 335 procedures.  Complications included two 
asymptomatic external iliac dissections, one symptomatic external iliac dissection 
requiring stenting, two asymptomatic grade 1 ICA dissections and one 
thromboembolism treated with thrombectomy.  No complication had permanent 
sequaele but the serious complication rate was 3.5% (patient-specific) and 0.6% 
(procedure-specific).  
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6.5.4 Vasospasm-related infarction  
Follow-up imaging was not available in 1 patient.  The rate of proximal 
territory infarction in patients presenting <72 hours from ictus was 3/45 (6.7%). If 
smaller infarcts were included, infarction was demonstrated in 8/45 patients (17.8%). 
Eight of 11 patients (72.7%) who presented with aVSP on initial angiography at >72 
hours suffered aVSP infarction.  Delayed presentation was a significant risk factor 
for infarction on univariate analysis (8/16; 50% versus 3/40; 7.5%, P = 0.0002) and 
on multivariate analysis (OR 19.3, 3.2—116.6, P = 0.0012).  Of those patients who 
developed large infarcts, 4/7 presented at >72 hours.  Of the overall cohort, 9/16 
infarcts were small (4 perforator, 2 watershed and 3 distal branch infarcts).  
Vasospasm involving ≥4 vessels significantly increased the risk of 
developing aVSP-related infarction on univariate analysis (10/16; 68.8% versus 9/40; 
25%, P = 0.0042).  This trended to significance on multivariate analysis (OR 4.2, 
0.9—18.0, P = 0.0634).  Although fewer good grade patients suffered aVSP-related 
infarction, (21% versus 32%) this was not significant.  No significant difference in 
the rate of aVSP-related infarction was noted for clipped versus coiled patients, age ≤ 
50, gender, intraventricular haemorrhage, hydrocephalus, intraparenchymal 
extension of haemorrhage, use of TBA plus vasodilators versus vasodilators alone, or 
maximal clot thickness ≥ 10 mm.  
 
6.5.5 Clinical outcomes  
Outcomes for the overall cohort are displayed in table 6.3 and outcomes by 
grade are displayed in table 6.4 and figure 6.3.  For WFNS grades 1-4, favourable 
outcome (mRS 0-2) was seen in 28/38 (73.7%). WFNS grade and proximal vessel 
aVSP-related infarction significantly impacted on outcome on both univariate and 
multivariate analysis (table 6.5).  No significant difference in the rate of 
unfavourable outcome was seen for age, sex, clip/coiling, presentation beyond 72 
hours, hydrocephalus, intraventricular or intraparenchymal haemorrhage or 
vasospasm treatment modality (TBA and vasodilators versus vasodilators alone). 
 
 
 
 
130 
mRS 0 1 2 3 4 5 6 
N (%) 15 (26.3) 14 (24.6) 4 (7.0) 6 (10.5) 4 (7.0) 5 (8.8) 9 (15.8) 
 
Table 6.3 Distribution of clinical outcomes in the overall cohort. 
 
Grade WFNS 1-2 WFNS 3-4 WFNS 5 
Clinical Outcome 
Good (mRS 0-2) 16 (84.2) 12 (63.2) 5 (26.3) 
Moderate (mRS 3) 0 1 (5.3) 5 (26.3) 
Poor (mRS 4-6) 3 (15.8) 6 (31.6) 9 (47.4) 
 
Table 6.4 The distribution of clinical outcome by presenting WFNS grades. 
 
 
 
 
Figure 6.3 The distribution of clinical outcomes by WFNS grade. 
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Variable Unfavourable 
outcome (%) 
 
Favourable 
outcome 
(%) 
 
P Multivariate OR 
(95% CI) 
P 
Vasospasm-
infarction 
(large) 
6/23 (26.1) 1/33 (3.0) 0.0102 19.0 (1.7-216.4) 0.0179 
Poor grade 
(WFNS  
3-5) 
21/24 (87.5) 17/33 (51.5) 0.0043 6.6 (1.3-33.9) 0.0233 
 
Table 6.5 Significant predictors of unfavourable outcome (mRS 3-6).  
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6.6 Discussion 
Two established philosophies exist for endovascular vasospasm management: 
prophylactic TBA or rescue therapy.  We use an intermediate paradigm, identifying 
aVSP and commencing treatment prior to neurological deterioration or whilst the 
patient is minimally symptomatic.  Rates of cerebral infarction and clinical outcome 
were assessed. Rates of infarction associated with severe aVSP range from 46-81% 
(see table 6.6) (Crowley et al, 2011; Inagawa et al, 2014; Weidauer et al, 2014).  In 
contrast, when patients presented within 72 hours and were treated using our 
algorithm, the rate of proximal territory infarction was 6.7%.  However, presenting 
after 72 hours was a significant predictor of infarction.  This suggests that securing 
the aneurysm, nimodipine administration and therapeutic hypertension is effective in 
protecting against infarction.  More diffuse severe aVSP involving ≥4 vessels was 
significantly associated with infarction on univariate analysis and tended to 
significance on multivariate analysis (perhaps not reaching significance as the study 
was underpowered).  Most infarcts were small (watershed, distal branch or 
perforator).  Proximal infarction significantly predicted poor outcome, underlining 
the need for prevention. 
 
 
 
Study/Modality Severity of aVSP 
 
Infarct rate (%) 
Cowley et al (2011)/CT Mild (<34%) 1 
Moderate (34-66%) 9 
Severe (>66%) 46 
Inagawa et al (2014)/CT Mild-moderate 
(<50%) 
5 
Severe (>50%) 63 
Weidauer et al 
(2007)/MR 
Mild (10-33%) 3 
Moderate (34-66%) 16 
Severe (>66%) 81 
Present study/CT Severe (>66%) 18 
 
Table 6.6 Rates of vasospasm related infarction relative to degree of vasospasm. 
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TBA and IA verapamil may be effective since both have been shown to 
significantly increase vessel diameters in the setting of aVSP (Higashida et al, 1989; 
Firlik et al, 1997; Rosenwasser et al, 1999; Sehy et al, 2010).  Improvements in CBF 
have demonstrated using perfusion imaging following TBA and IA vasodilators 
(Firlik et al, 1997; Elliott  et al, 1998; Beck et al, 2006; Hanggi et al, 2008).  Jestaedt 
et al (2008) also demonstrated a reduction in the infarction rate in angioplastied 
MCA versus non-angioplastied ACA territories (7% versus 38% respectively).  The 
use of IA vasodilators and TBA has previously been reviewed by Pierot et al 
(2010d). 
There is limited data available defining the natural history for those with 
severe aVSP.  The CONSCIOUS-1 trial results suggested that of WFNS grades 1-4 
patients with moderate-severe aVSP (> 33% narrowing), the rate of favourable 
outcome was 40% in symptomatic patients and 65% in asymptomatic patients, 
equating to 54.1% overall (Vergouwen et al, 2011a).  More specifically, 43% of 
those with severe aVSP had a favourable outcome (mRS 0-2) [R.L. Macdonald 
2014, unpublished data].  Functional status scores remained significantly worse after 
adjustment for age and grade (Macdonald et al, 2012).  Our results suggest that the 
majority of patients (73% of WFNS grades 1-4) with treated severe aVSP can 
achieve favourable outcome (mRS 0-2).  Outcomes by grade compared favourably 
with those of a large SAH population, despite the detriment of severe aVSP (see 
table 6.7) (Rosen et al, 2004).  In an analysis of prospective trial data, we have 
demonstrated that there is no significant difference in outcome for patients with 
treated severe vasospasm versus those without significant vasospasm (Mortimer et 
al, 2015c).  We noted two severe angiographic complications equating to a patient-
specific rate of 3.5% and a procedure-related rate of 0.6%.  Although it is recognised 
that elevated intracranial pressure, systemic hypotension and seizures may 
complicate infusion of either agent (Abruzzo et al, 2012), this was not encountered 
in this series.  Recognised complications of TBA include vessel dissection, 
perforation, occlusion and rupture, reperfusion haemorrhage, infarction and clip 
displacement (Rahme et al, 2013).  Older series had documented rupture rates as 
high as 4-5% but with modern compliant balloons the rupture rate is probably in the 
order of 1% (Pierot et al, 2010d, Abruzzo et al, 2012). 
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Retrospective analyses at hospital and nationwide levels have suggested that 
institutions that offer endovascular treatment for vasospasm may have lower rates of 
unfavourable outcome (Khatri et al, 2011a; Khatri et al, 2011b).  However, the 
decision to treat, timing and number of treatments is crucial and this study differs 
from others (Jun et al, 2010; Chalouhi et al, 2014; Hayashi et al, 2014) in the 
approach. DSA was used to screen.  It is often stated that DSA is the gold standard 
tool for vasospasm evaluation and can be used to institute treatment but is invasive 
with recognised complication rate; repeated procedures carry the risk of significant 
radiation exposure.  Others have developed local expertise with TCD and CT 
perfusion and each may be valid to guide a similar algorithm.  Both are non-invasive 
tools; CT perfusion may play a more prominent role in the future (Lefournier et al, 
2010).  TCD is operator dependant and limited in its ability to assess the ACA, 
posterior circulation and distal vasospasm.   
 
 
WFNS grade Favourable outcome 
Rosen et al (2004): all 
patients with SAH 
(GOS 4-5) 
Present study: patients with 
treated severe aVSP 
(mRS 0-2) 
1-2 82.1% 84.2% 
3-4 48.1% 63.1% 
5 33.0% 26.3% 
.   
Table 6.7 Comparison of outcomes by grade to those seen in the Tirilizad trials (Rosen et al, 
2004) 
 
It is our current policy to base the decision to treat principally on 
radiographic features of severe aVSP prior to significant deterioration.  We employ 
daily treatments (mean 5 per patient for the anterior circulation).  We suspect that, 
although the duration of action of vasodilators is temporary, in concert with induced 
hypertension, this combats the sustained ischaemia of persisting vasospasm.  
Although controversial, the approach of treating the radio-graphic appearances is 
used by others (Bulsara et al, 2015).  Whilst it is commonly quoted that 
approximately half of patients with aVSP become symptomatic, severe aVSP is 
associated with a higher incidence of symptoms (Dankbaar  et al, 2009; Inagawa et 
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al, 2014), and patients without acute deterioration but severe aVSP may still develop 
infarction (Shimoda  et al, 2001; Schmidt et al, 2008), which is our justification for 
managing severe aVSP, an independent predictor of poor outcome (Vergouwen et al, 
2011a).  This approach differs from prophylactic TBA or rescue treatment. 
Prophylactic TBA was investigated in a multicentre randomised trial 
(Zwienenberg-Lee  et al, 2009).  Fisher grade 3 patients were randomised to 
receiving prophylactic TBA before the typical vasospasm window, or maximal 
medical therapy.  Clinical outcomes were no different between the TBA-treated 
patients and controls.  There was no difference in the rate of TCD defined 
vasospasm, length of ICU or hospital stay.  However, the incidence of delayed 
ischaemic deficit, trended towards significant reduction (24% of TBA patients versus 
32% of controls).  A significant reduction in rescue angioplasty was demonstrated, 
(12% of TBA patients versus 26% of controls), perhaps reflecting a lower incidence 
of severe, medically refractory vasospasm.  Furthermore, for good grade patients 
(Hunt and Hess 1 and 2), there was a 9.5% reduction in unfavourable outcome.  We 
suggest that the treatment algorithm was suboptimal as it did not select patients with 
documented vasospasm for treatment thereby diluting the effect of interventional 
therapy.  Identifying patients with significant aVSP prior to deterioration may be 
more suitable.  It is possible that TBA has a more sustainable result when used in 
vessels that are vasospastic.  Histological analysis of post-angioplasty vessels 
suggests that the mechanism for the long-lasting effects is stretching and disruption 
of degenerative muscle and proliferative non-muscle components of the vasospastic 
vessels (Honma et al, 1995). 
Following the more traditional rescue approach, reported rates of clinical 
improvement vary widely between studies for both TBA and IA vasodilators: 30% to 
80% for TBA and 0 to 66% for IA verapamil (Higashida et al, 1989; Coyne et al, 
1994; Firlik et al, 1997; Bejjani et al, 1998; Feng et al, 2002; Keuskamp  et al, 2008; 
Stuart et al, 2011).  In the largest study comprising 645 patients undergoing TBA 
and/or IA vasodilators, 64.7% exhibited neurological improvement (Hayashi et al, 
2014).  The differences in rates of improvement likely stem from the contribution of 
the acute injury to the patient’s status and the timing of treatment relative to 
infarction: a number of series have failed to demonstrate improvements in poor grade 
patients (Higashida et al, 1989; Coyne et al, 1994; Stuart et al, 2011), suggesting 
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that the acute injury may mask overt clinical benefit in some.  However, since infarct 
size is inversely proportional to outcome (Attyé et al, 2012), minimising infarct 
development/growth may be a reasonable end-point, potentially allowing favourable 
outcome after rehabilitation.  
The impact of timing is highlighted by a study showing that TBA within 2 
hours of symptom onset was associated with 70% clinical improvement compared to 
only 40% when performed later (Rosenwasser et al, 1999).  In the JR-NET2 audit 
(Hayashi et al, 2014), early treatment was associated with neurological improvement 
on multivariate analysis.  Polin et al (2000) showed no improvement for TBA-
treated patients but more than half underwent procedures after 6 hours.  Interestingly, 
22/29 patients who had follow-up imaging available had large hemispheric infarcts, 
suggesting that delayed treatment in symptomatic patients is futile.  Detection of 
neurological worsening, particularly in the presence of sedation or for non-eloquent 
areas of ischaemia is a challenge and these patients may be at risk of silent infarction 
if a rescue approach is employed.  This was a single-arm retrospective analysis of a 
small sample with heterogeneity in the distribution of vasospasm and the treatment 
employed.  There was no control group and only surrogate comparisons with the 
literature could be made.  Assessment of infarction was made via analysis of CT, 
which is less sensitive than MRI.  Our outcome observations may have benefited 
from late clinical evaluation (mean 16 months) and after a period of rehabilitation; 
this needs to be acknowledged when performing inter-study comparisons.  We were 
unable to extract the relative benefit of endovascular therapy over medical therapy 
including hypertension; the benefit of this approach remains unknown but it was 
associated with relatively low morbidity and is clinically feasible, so further 
evaluation with comparison to a control population in a prospective study is 
warranted. 
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6.7 Conclusion  
This study suggests that an intensive endovascular approach of TBA and 
multiple IA verapamil infusions can result in low rates of vasospasm-associated 
infarction and encouraging rates of favourable outcome when compared to literature 
benchmarks if treatment is instituted early when the patient is minimally 
symptomatic.  Delayed presentation, however, predicts infarction and large infarct 
and poor initial grade significantly influence functional outcome.  Further 
investigation is needed to fully evaluate the efficacy of this approach. 
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7.1 Abstract 
7.1.1 Background 
Severe angiographic vasospasm (aVSP) is a risk factor for poor functional 
outcome following subarachnoid haemorrhage.  We investigated the impact of 
angiographic surveillance and intensive endovascular treatment using transluminal 
balloon angioplasty (TBA) and/or verapamil infusion for severe aVSP through 
comparison of clinical outcomes in patients of similar presenting grade but with 
no/mild vasospasm.  
 
7.1.2 Methods 
This was an analysis of prospectively acquired clinical trial data. World 
Federation of Neurosurgical Societies (WFNS) grade 1–2 patients presenting within 
72 hours were included.  Angiographic screening for vasospasm was undertaken at 
days 5–7 or in response to clinical deterioration.  Severe aVSP was defined as >50% 
luminal narrowing on digital subtraction angiography.  Treatment was instituted on 
the basis of radiographic findings and/or clinical deterioration.  Discharge 
destination and favourable clinical outcomes (discharge Glasgow Outcome Score 
(GOS) 4–5, 90 day modified Rankin Scale (mRS) score 0–2, and GOS 4–5) for 
patients with severe aVSP were compared with those without significant vasospasm. 
Statistical analysis was undertaken using Fisher’s exact test.  
 
7.1.3 Results 
Sixty-three WFNS grade 1–2 patients with minimal vasospasm were 
compared with 17 WFNS grade 1–2 patients with severe aVSP treated with induced 
hypertension and endovascular therapy.  Results were available in 62 and 16 
patients, respectively.  Rates of favourable outcome did not differ significantly 
between the two groups.  For patients with treated severe vasospasm, 90 day mRS 0–
2 was seen in 15/17 (88.2%) and GOS 4–5 was achieved in 16/17 (94.1%).   
 
7.1.4 Conclusion 
An intensive endovascular approach of TBA and/or intra-arterial verapamil 
in combination with induced hypertension for severe aVSP may result in comparable 
clinical outcomes to those without vasospasm.  
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7.2 Introduction 
Angiographic vasospasm (aVSP) is an independent predictor of poor 
outcome following subarachnoid haemorrhage (SAH) (Vergouwen et al, 2011a).
  
There is a strong correlation between the severity of aVSP and the incidence of 
cerebral infarction (Crowley et al, 2011),
 
which itself is strongly associated with 
poor outcome following SAH (Furgusson & Macdonald, 2007; Vergouwen et al, 
2011b).
  
The majority of delayed infarcts are related to severe aVSP (Weidauer et al, 
2007; Crowley et al, 2011; Brown et al, 2013; Inagawa et al, 2014)
 
which results in 
the most severe perfusion deficits (Weidauer et al, 2007; Vatter et al, 2011; Dakbaar 
et al, 2009; Dhar et al; 2012).
  
The goal of endovascular therapy, using either 
transluminal balloon angioplasty (TBA) or intra-arterial vasodilators, is to improve 
cerebral blood flow and therefore to reduce the risk of infarction.  Endovascular 
methods are most commonly employed as ‘rescue’ procedures.  This has been shown 
to be effective in case series but neurological improvement is maximal if treatment is 
performed early in this setting (Rosenwasser et al, 1999; Hayashi et al, 2014).
  
Delayed endovascular treatment following development of symptoms is probably of 
limited clinical benefit (Polin et al, 2000).
  
The use of prophylactic TBA undertaken 
prior to development of vasospasm has also been investigated in a multicenter 
randomised trial (Zwienenberg-Lee et al, 2009).
  
Although there were significant 
reductions in the rate of patients requiring rescue therapy in the treatment arm and 
possible outcome benefits in the good grade patients, overall clinical outcome was 
not significantly different in those treated with prophylactic TBA.  
An alternative approach is to screen for vasospasm at or just before the time 
when the majority of patients develop symptoms (Suarez et al, 2002; Ionita et al, 
2010). 
 
The goal of this practice is to identify those patients with significant 
angiographic vasospasm who may benefit from treatment prior to development of 
symptoms or who are at risk of silent infarction as they are clinically too difficult to 
accurately assess (Schmidt et al, 2008).
  
We routinely undertake a program of 
angiographic surveillance at days 5-7 post ictus, at or just before the time point that 
most patients become symptomatic (Suarez et al, 2002; Ionita et al, 2010),
 
with 
subsequent endovascular treatment and multiple procedures where necessary based 
not only on symptomology but also on radiographic features.  
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We analysed prospectively collected trial data obtained at our institution to 
assess the clinical efficacy of this approach through comparison of outcomes of 
patients with treated severe aVSP with those of similar presenting grade who did not 
develop significant aVSP.  
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7. 3 Methods 
7.3.1 Study design and inclusion/exclusion criteria  
This was an analysis of prospectively acquired clinical trial data obtained 
primarily for the assessment of clinical outcomes and aVSP severity and incidence in 
patients treated with magnesium following aneurysmal SAH (Bradford et al, 2013).
  
The primary aim of this study was to compare clinical outcomes for patients 
with either no aVSP or mild aVSP (<25% arterial narrowing) treated with medical 
therapy only, with those patients with severe aVSP (>50% arterial narrowing) treated 
using an intensive combined medical and endovascular approach involving induced 
hypertension, TBA, and/or intra-arterial infusion of verapamil.  
Patients admitted to a tertiary hospital (Royal North Shore Hospital) between 
April 1, 2005 and February 1, 2010, presenting within 72 hours of SAH confirmed 
by CT, were included.  The study was confined to those presenting with World 
Federation of Neurosurgical Societies (WFNS) grades 1–2 to minimize the 
confounding impact of poor grade/acute injury on outcomes.  Exclusion criteria 
included age <18 years, serum creatinine >200 mmol/L, if death was thought 
imminent within 72 h, if the patient had myasthenia gravis or was pregnant, or if 
aVSP was present prior to inclusion in the study.  The study was approved by the 
Northern Sydney Ethics Committee and written informed consent was obtained from 
each patient or legal surrogate.  
 
7.3.2 Patient management  
All patients were managed on the neurointensive care unit with routine 
insertion of arterial and central lines.  After admission, digital subtraction 
angiography or CT angiography was performed, and the aneurysm responsible for 
the bleeding was occluded by operative or endovascular means within 48 h.  
Following clipping or coiling of the aneurysm, systolic blood pressure was 
maintained between 120 and 150 mm Hg.  A nimodipine infusion of 20 mg/kg/h was 
commenced on arrival in the ICU.  All patients received nimodipine for 21 days, 
with at least 10 days of intravenous administration.  For body temperature, the aim 
was to maintain the temperature below 37.5°C.  Oxygen saturation was monitored 
continuously by pulse oximetry and maintained at >95%.  Angiographic screening 
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for vasospasm was performed routinely at days 5-7.  In the event that vasospasm was 
suspected at an earlier time point, hydrocephalus was excluded with CT and 
angiographic investigation was brought forward.  If felt to be clinically deteriorating 
secondary to aVSP, patients were managed with adequate hydration, systolic blood 
pressure maintained between 140–160 mm Hg, and continued nimodipine infusion.  
 
7.3.3 Endovascular technique  
Digital subtraction angiography was performed via a femoral approach using 
a 5 F system.  Vasospasm was defined as none, mild (<25%), moderate (25–50%), 
and severe (>50%) by two neuroradiologists by consensus.  If significant aVSP was 
identified, this was treated using either chemical or balloon angioplasty, and a repeat 
angiogram was undertaken the following day.  In cases of severe refractory 
vasospasm, multiple treatments were undertaken.  Angiography was repeated daily 
until either aVSP was no longer significant or aVSP proved to be unsatisfactorily 
treated with this regimen.  In the event that multiple treatments were required, the 
groin sheath was sutured in situ, replaced at each sitting, and femoral angiography 
was performed at daily intervals to screen for external iliac artery dissection.  The 
side of the sheath was routinely changed after 4 days if further treatments were 
required.  
The decision to treat and mode of treatment were based on the degree and site 
of arterial narrowing in conjunction with the clinical state of the patient, with 
treatment generally reserved for moderate–severe aVSP.  Severe proximal aVSP 
involving the vertebral artery (VA), basilar artery, internal carotid artery (ICA), M1 
middle cerebral artery, or A1 anterior cerebral artery was treated with TBA where 
possible.  M2 middle cerebral artery and distal vasospasm was treated with intra-
arterial vasodilators.  Verapamil was delivered via a 5 F catheter positioned in the 
proximal ICA or VA at a rate of 1 mg/min, typically 10–15 mg total to a maximum 
dose of 25 mg per territory.  Papaverine (used as a second line agent) was delivered 
via a microcatheter positioned proximally within the target vessel.  Arterial 
monitoring was used during the procedure to augment blood pressure control through 
slowing of the vasodilator administration and/or titration of inotropic support.  
Patients undergoing TBA were systemically anticoagulated using intravenous 
heparin (typically 5000 U total) with a goal of doubling baseline activated clotting 
time.  A guiding catheter was placed on heparinised saline drip in either the cervical 
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ICA or cervical VA.  Next, a compliant balloon microcatheter (HyperGlide, ev3, 
Irvine, California) was navigated over a compatible 0.010 inch microwire to the most 
distal aspect of the spastic vessel segment to be treated (i.e. the smallest spastic 
arterial branch farthest from the femoral access site).  A single, gentle, brief (<30 s) 
inflation with iodinated contrast material were performed to achieve at least 70% of 
the expected baseline vascular luminal diameter.  If the response was inadequate, 
further balloon inflations were performed.  
 
7.3.4 Data collected and analysis  
Baseline variables were collected, including demographic data, history of 
smoking, hypertension, use of statins, use of trial magnesium, previous SAH or 
stroke, and Acute Physiology and Chronic Health Evaluation (APACHE II) score.  
WFNS grade was assessed at admission.  Aneurysm site and presence of 
hydrocephalus were recorded through assessment of angiographic and CT imaging, 
respectively.  Clinical outcomes, including discharge Glasgow Outcome Score 
(GOS), discharge destination, and 90 day GOS and modified Rankin Scale (mRS) 
score were obtained, acquired by independent assessors.  Secondary outcome 
measures, including length of ITU stay and length of hospital stay, were also 
assessed.  
Statistical analysis was performed using Medcalc statistical software.  Non-
parametric data (sex, WFNS grade, history of smoking, hypertension, SAH, 
cardiovascular event, magnesium or statin use, hydrocephalus, aneurysm location, 
and aneurysm securing modality) were compared using Fisher’s exact test, and 
parametric data (age, APACHE II score, ITU days, ventilated days, hospital days, 
and noradrenaline dose) were compared using analysis of variance.  Statistical 
significance was defined as p<0.05.  
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7.4 Results 
Analysis of the trial database identified 80 patients; 63 patients with either no 
aVSP or mild aVSP who were treated with medical therapy only and 17 patients with 
severe aVSP who were treated with medical therapy and endovascular treatment.  
Fifteen patients with moderate aVSP were also identified but these patients were 
variably treated with endovascular therapy and were therefore not included in the 
analysis.  Two patients with severe vasospasm who were not treated using 
endovascular therapy were not included in the analysis. Baseline variables are 
displayed in table 7.1.  There was no significant difference in baseline characteristics 
between the two groups, including sex, age, history of smoking, hypertension, 
previous stroke or SAH, magnesium or statin use, APACHE II score, or incidence of 
hydrocephalus (table 7.1).  Patients in the severe aVSP group tended to be younger, 
although this did not reach statistical significance.  There were significantly more 
WFNS grade 2 patients in the severe aVSP group.  No significant difference in the 
distribution of responsible aneurysm or aneurysm securing treatment method 
(endovascular vs surgical clipping) was demonstrated.  
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 None/Mild aVSP 
(n=63) 
Treated severe 
aVSP (n=17) 
P 
Females  40 (63.5) 14 (77.7) 0.2422 
Age (years) (mean +/-
95% CI) 
56.5 +/-3.5  48.9 +/-6.2  0.0818 
WFNS grade 2 17 (30.0) 11 (64.7) 0.0083 
Smoking history 18 (28.6) 5 (29.4) 1.0000 
Hypertension 20 (31.7) 5 (29.4) 1.0000 
Previous CVE 3 (4.8) 0 1.0000 
Previous SAH 2 (3.2) 0  1.0000 
Prior Statin use 15 (23.8) 4 (23.5) 1.0000 
APACHE II score 
(mean and 95% CI) 
11.4 +/-1.4 11.1 +/- 2.7  0.8239 
Ruptured aneurysm 
location 
Posterior 
Anterior 
Unknown 
 
 
9 (14.3) 
42 (66.7) 
12 (19.0) 
 
 
2 (11.8) 
14 (82.4) 
1 (5.9) 
 
 
1.0000 
1.0000 
0.2781 
Hydrocephalus at 24 
hours 
3 (4.8) 3 (17.6) 0.1067 
Coiled  30 (47.6) 7 (41.2) 0.7855 
Treated with 
magnesium 
33 (52.4) 7 (41.2) 0.5856 
 
Table 7.1 Baseline characteristics. APACHE, Acute Physiology and Chronic Health 
Evaluation; aVSP, angiographic vasospasm; CVE, cardiovascular event; SAH, subarachnoid 
haemorrhage; WFNS, World Federation of Neurosurgical Societies. 
 
 
Patients with severe aVSP had a significantly greater ITU and hospital stay 
and spent significantly more days ventilated.  They had a significantly increased total 
noradrenaline dose (table 7.2).  The mean first day of vasospasm treatment following 
haemorrhage was 6.6±1.5.  For those with severe aVSP, mean duration of aVSP was 
6.5±2.5 days. Of those with severe aVSP, 8/17 patients (47%) underwent TBA with 
a total of 15 procedures.  Seventeen patients underwent verapamil chemical 
angioplasty with a total of 67 procedures.  The mean total dose of verapamil that any 
one patient received at each procedure was 20.3 ±2.3 mg (range 5–40 mg).  Four 
patients were additionally treated with intra-arterial papaverine (mean dose 90 mg; 
range 60–120 mg) with a total of eight infusions.  The distribution of severe 
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vasospasm and treatment employed for each patient in the study population are 
shown in table 7.3.  
 
 
 
 None/Mild aVSP 
(Mean +/- 95% CI) 
Treated severe aVSP 
(Mean +/-95% CI) 
P 
Noradrenaline dose 
(mg) 
61.9+/-29.7 118.1+/-98.4 0.0002 
Ventilated days 1.8+/-2.9 5.4+/-4.0 0.0122 
ITU days 12.3 +/-2.4 20.2 +/-2.7 <0.0001 
Hospital days 21.5+/-3.4 27.1+/-3.6 0.0392 
 
Table 7.2 Differences in care between the two populations studied. aVSP, angiographic 
vasospasm. 
 
Clinical outcome data are shown in tables 7.4 and 7.5 and figures 7.1 and 7.2.  
Clinical outcomes were available for 62 patients with none or mild aVSP and for 16 
patients with treated severe vasospasm.  No significant difference in discharge GOS, 
proportion of patients discharged home, mortality, 90 day GOS, or 90 day mRS was 
demonstrated between the two groups if favourable outcome was dichotomised as 
GOS 4–5 or mRS 0–2.  Patients with no/mild aVSP achieved a 90 day GOS 4–5 and 
mRS 0–2 of 83.9% and 82.2%, respectively.  Of those with aggressively treated 
severe vasospasm, 90 day GOS and mRS were 94.1% and 88.2%, respectively.  If 
favourable outcome was dichotomised as mRS 0-1, there tended to be more 
favourable outcomes in the no/mild vasospasm group but this did not reach 
significance (p=0.2693).  However, there were significantly more WFNS grade 2 
patients in the severe aVSP group (10/17, 64.7% v 17/63, 30%) confounding this.  
When outcomes were assessed by grade, this difference was less apparent (see table 
7.4.6).  For example, for WFNS grade 2 patients without significant spasm, 
favourable outcome was 7/17 (41.2%) mRS 0-1 and 13/17 (76.5%) mRS 0-2.  
Outcomes for WFNS grade 2 patients with treated severe aVSP were 4/11 (36.4%) 
mRS 0–1 and 10/11 (90.9%) mRS 0-2.  Furthermore, if favourable outcome was 
dichotomised by GOS 5, no significant difference was demonstrated.  
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Patient Location of severe 
vasospasm 
Treatment Number of 
Treatments 
1 Bilateral ICA and 
MCA 
TBA 2 
2 Left MCA Verapamil 
Papaverine 
2 
3 Left MCA Verapamil 1 
4 Left ICA and MCA 
Right ACA 
TBA 
Verapamil 
Papaverine 
8 
5 Left ICA and MCA TBA 
Verapamil 
Papaverine 
8 
6 Left ICA, MCA and 
ACA, Right MCA 
TBA 
Verapamil 
 
6 
7 Bilateral ICA and 
MCA 
Verapamil 2 
8 Left ICA and MCA 
and right ACA 
TBA 
Verapamil 
3 
9 BA Verapamil 1 
10 Right MCA and 
ACA 
TBA 
Verapamil 
3 
11 Bilateral ICA, MCA 
and ACA 
TBA 
Verapamil 
Papaverine 
7 
12 Bilateral ACA Verapamil 4 
13 Bilateral MCA and 
left ACA 
TBA 
Verapamil 
7 
14 Right MCA and 
bilateral ACA 
Verapamil 1 
15 Bilateral MCA, PCA, 
SCA 
Verapamil 5 
16 Right ICA and MCA Verapamil 5 
17 Bilateral ACA Verapamil 2 
 
Table 7.3 Distribution of vasospasm and treatments used.  ACA, anterior cerebral artery; 
BA, basilar artery; ICA, internal carotid artery; MCA, middle cerebral artery; PCA, posterior 
cerebral artery; SCA, superior cerebellar artery; TBA, transluminal balloon angioplasty. 
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Outcome 
measure 
None/Mild aVSP 
(n=63 (%)) 
Treated severe 
aVSP 
(n=17 (%)) 
P 
Discharge GOS 
4-5 
35 (55.5) 8 (47.1) 0.5910 
Discharge to 
home 
41 (65.1) 12 (70.5) 0.7777 
90 day GOS 4-5 52 (82.5) 16 (94.1) 0.4444 
90 day GOS 5 30 (47.6) 7 (41.2) 0.7855 
90 day mRS 0-2 51 (81.0) 15 (88.2) 0.7224 
90 day mRS 0-1 40 (63.5) 8 (47.1) 0.2693 
Mortality 2 (3.2) 0 1.0000 
Missing data 1 1 - 
 
Table 7.4 Outcomes for each of the two populations studied. aVSP, angiographic 
vasospasm; GOS, Glasgow Outcome Score. 
 
90 day mRS 
n (%) 
90 day GOS 
n (%) 
 No/Mild aVSP Severe aVSP  No/Mild aVSP Severe aVSP 
0 13 (20.6) 2 (11.8) 5 30 (47.6) 7 (41.2) 
1 27 (42.8) 6 (35.3) 4 22 (34.9) 9 (52.9) 
2 11 (17.5) 7 (41.7) 3 8 (12.7) 0 
3 6 (9.5) 0 2 0 0 
4 3 (4.8) 1 (5.9) 1 2 (3.2) 0 
5 0 0    
6 2 (3.2) 0    
Missing 
data 
1 (1.6) 1 (5.9) Missing 
data 
1 (1.6) 1 (5.9) 
 
Table 7.5 Clinical outcomes at 90 days by modified Rankin Scale and Glasgow Outcome 
Scale. aVSP, angiographic vasospasm; GOS, Glasgow Outcome Score; mRS, modified 
Rankin Scale. 
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Figure 7.1 Ninety day Glasgow Outcome Score for patients with minimal or severe 
vasospasm. 
 
 
Figure 7.2 Ninety day modified Rankin Scale scores for patients with minimal or severe 
vasospasm. 
 
 
 
 
WFNS grade No/mild aVSP 
n, (%) 
Severe aVSP 
n, (%) 
mRS 0-1 mRS 0-2 mRS 0-1 mRS 0-2 
1 33/46 (71.7) 41/46 (89.1) 4/6 (66.7) 5/6 (83.3) 
2 7/17 (41.2) 13/17 (76.5) 4/11 (36.4) 10/11 (90/9) 
 
Table 7.6 Favourable outcomes by World Federation of Neurosurgical Societies grade. 
aVSP, angiographic vasospasm; mRS, modified Rankin Scale; WFNS, World Federation of 
Neurosurgical Societies. 
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Complications included one thromboembolic event treated using intravenous 
abciximab with prompt angiographic resolution.  This equated to a procedural risk of 
1.5% and a patient specific risk of 5.9% but there was no permanent morbidity or 
mortality related to the treatment.  
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7.5 Discussion 
We have demonstrated that for good grade SAH patients (WFNS 1–2) who 
subsequently develop the complication of severe cerebral vasospasm and are treated 
aggressively with a combination of induced hypertension and intensive endovascular 
management, comparable clinical outcomes can be obtained with patients who do 
not develop this complication.  No significant difference in discharge GOS, the 
proportion of patients discharged home, 90 day mRS, or 90 day GOS was 
demonstrated for those with severe vasospasm undergoing treatment compared with 
those without vasospasm, whose outcomes were in line with those published in 
previous trials (Rosen et al, 2004).
  
Of patients with severe vasospasm, 88% achieved 
mRS 0–2.  Similarly, in a retrospective analysis of the period spanning 2009 and 
2013 demonstrated that 84% of WFNS grade 1-2 patients with severe vasospasm 
achieved mRS 0-2 (Mortimer et al, 2015b).  In an earlier study spanning 1992–1998 
(Morgan et al, 2000),
 
in which a similar protocol based on papaverine angioplasty 
was used, favourable clinical outcomes for good grade patients who developed 
significant vasospasm were seen in 93%.  There are two possible conclusions that 
can be drawn from these data.  Firstly, it could be argued that angiographic 
vasospasm has no impact on patient outcome and that these favourable outcomes are 
incidental.  Secondly, it could be argued that intensive efforts to improve cerebral 
blood flow have a beneficial impact on clinical outcomes in patients afflicted by 
severe vasospasm.  
Critics of this approach to treating angiographic vasospasm may cite 
uncertainty regarding the role of aVSP in delayed cerebral ischemia (Pluta et al, 
2009; Macdonald, 2013; Hou & Zhang, 2013).
  
A number of clinical trials of 
pharmaceutical agents have demonstrated improvement in the rate of moderate–
severe vasospasm but not in the rate of favourable outcome (Macdonald et al, 2008; 
Macdonald et al, 2011).
  
Likewise, while nimodipine remains the only 
pharmacological treatment to improve outcomes, this benefit is achieved without 
angiographic evidence of cerebral vasodilation (Petruk et al, 1988; Feigin et al, 
1998). 
 
As a result of this, there has recently been much emphasis on the role of 
alternative mechanisms of delayed ischemia, including microthrombosis and 
spreading depolarization with cortical ischemia, that may act separately or in 
combination with aVSP.  However, analysis of the CONSCIOUS-1 trial has 
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demonstrated that moderate–severe angiographic vasospasm is an independent 
predictor of poor functional outcome (OR 2.62 (1.58–4.36), p<0.0001) (Vergouwen 
et al, 2011a).  
 
In that study, 46% of patients with moderate to severe aVSP (>33% 
arterial narrowing) had a poor outcome at 3 months.  The International Co-operative 
Study on the Timing of Aneurysm Surgery found that vasospasm was more often the 
cause of death or disability than any other factor, including the direct effect of the 
initial bleed (Kassell et al, 1990).  
Intuitively, the impact of vasospasm on outcome stems from an increased risk 
of cerebral infarction, which itself is strongly associated with poor outcome 
(Furgusson & Macdonald, 2007; Vergouwen et al, 2011b). 
 
There is a strong 
correlation between the severity of aVSP and the incidence of cerebral infarction 
(Crowley et al, 2011).
  
The more severe the vasospasm, the more severe the 
perfusion deficit (Weidauer et al, 2007; Dankbaar et al, 2009; Vatter et al, 2011; 
Dhar et al, 2012),
 
and we believe strongly that the haemodynamic effects of 
vasospasm are appropriate to target to reduce the risk of associate infarction.  While 
it is commonly quoted that approximately half of patients with vasospasm will be 
‘symptomatic’, the severity of vasospasm correlates with symptomology, and even if 
asymptomatic, angiographic vasospasm can result in infarction (Vergouwen et al, 
2011a; Inagawa et al, 2014).
  
Although we were unable to analyse the rate of aVSP 
associated infarction in this study, we have analysed this in a separate cohort of 
WFNS grade 1-5 patients (Mortimer et al, 2015b), and for those presenting within 72 
h of ictus, 6.7% suffered proximal vessel infarction if treated using the same regimen 
used in this study.  If smaller perforator infarcts and watershed infarcts were 
included, the overall rate of infarction was 17.8%, but if this is compared with other 
reported rates of infarction in the region of 46–81% for severe vasospasm (Weidauer 
et al, 2007; Crowley et al, 2011; Inagawa et al, 2014),
 
the results are promising.  
The Poiseuille equation states that flow is directly proportional to the 
pressure gradient and radius to the fourth power and inversely proportional to the 
fluid viscosity and vessel length.  This formula forms the basis for hypertensive 
treatment in the intensive care unit but also for attempts to improve flow through an 
increase in vessel diameter.  While flow will increase with a change in pressure, it 
will increase markedly with a change in vessel diameter.  Both TBA (Higashida et 
al, 1989; Firlik et al, 1997; Rosenwasser et al, 1999)
 
and (more modestly) verapamil 
(Sehy et al, 2010)
 
have been shown to significantly increase vessel diameter in the 
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setting of aVSP (albeit with a lag of approximately 30 min with the latter).  TBA and 
intra-arterial calcium channel antagonists result in significant improvements in 
cerebral blood flow (Firlik et al, 1997; Elliot et al, 1998; Beck et al, 2006; Hänggi et 
al, 2008).
  
While TBA has a relatively durable effect (Honma et al, 1995; Abruzzo et 
al, 2012),
 
the duration of action of verapamil on the cerebral circulation remains 
unknown and further investigation is required to elucidate this.  We have evolved a 
system of performing daily vasodilator infusions where necessary and in a number of 
patients, multiple procedures, as previously discussed (Rosen et al, 2004).
  
Others 
have experimented with indwelling microcatheters (Albanese et al, 2010)
 
although 
we are reluctant to employ this approach because of the potential risk of 
thromboembolic complication.  
In this study, patients with severe angiographic vasospasm had a significantly 
increased ITU stay and ventilated days.  This can be explained partly by the impact 
of vasospasm on clinical status, partly by local protocols which centre on 
hypertensive therapy in patients with vasospasm, and partly on the need for inotropic 
support in patients treated with high dose verapamil.  Indeed, the total noradrenaline 
dose was significantly higher for those with severe vasospasm.  We were unable to 
elucidate the relative benefit of endovascular therapy over hypertensive therapy but 
these finding suggest that a combined approach of endovascular therapy and induced 
hypertension may have a role in the prevention of delayed cerebral infarction 
following the development of severe aVSP and further lends support for design of a 
trial to test this hypothesis and to elucidate the relative impact of each facet of 
treatment.  
The approach used in the study was different to that often previously 
published which centres on either prophylactic TBA prior to development of 
significant vasospasm or rescue therapy in patients who deteriorate despite maximal 
medical therapy or who cannot tolerate medical therapy.  Our aim has been to 
identify significant vasospasm prior to neurological deterioration.  
This is controversial but is employed by other centres surveyed in a recent 
US national questionnaire (Bulsara et al, 2015).  The use of prophylactic TBA has 
been investigated in a multicentre randomised trial (Zwienenberg-Lee et al, 2009).
  
Fisher grade 3 patients were randomised to receiving either prophylactic TBA at a 
mean 51 hours (range 19–94 hours) post SAH, prior to the typical vasospasm 
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window, or maximal medical therapy.  Balloons were inflated to the vessel diameter 
until apposition of the balloon to the vessel wall was identified fluoroscopically.  
The primary outcome measure (dichotomised GOS score at 3 months after 
haemorrhage) was no different between patients treated with prophylactic TBA and 
controls.  There was no difference in the secondary outcome measures of vasospasm 
(defined by transcranial Doppler (TCD), length of stay in the ICU, or total length of 
hospitalization).  However, the secondary outcome measure, incidence of delayed 
ischemic deficit, trended toward significance, with 24% of prophylactic TBA 
patients developing a deficit versus 32% of controls.  A significant difference was 
identified in the need for rescue angioplasty, with only 12% of prophylactic TBA 
patients requiring this procedure compared with 26% of controls, perhaps reflecting 
a lower incidence of severe medically refractory vasospasm in the prophylactic TBA 
group.  Furthermore, for good grade patients (Hunt and Hess grades 1 and 2), there 
was a 9.5% reduction in unfavourable outcome.  
We suggest that the treatment algorithm of this trial was suboptimal as it did 
not select patients with documented cerebral vasospasm for treatment, thereby 
diluting the treatment effect of prophylactic TBA.  Selection based purely on Fisher 
grade is likely to result in a proportion of patients undergoing unnecessary treatment.  
Furthermore, 56% of the prophylactic TBA group developed vasospasm by TCD 
criteria, which suggests that TBA may not be as effective in non-spastic vessels 
(TBA seems to be effective through stretching and disruption of both the 
degenerative muscle and the proliferative non-muscle components, mainly in the 
media of the vasospastic vessels (Honma
 
et al, 1995)) and there remains the problem 
of more distal vasospasm.  We suggest that identifying patients with significant 
angiographic vasospasm and selecting these patients for treatment prior to significant 
deterioration may be a more suitable approach.  
The approach of reserving endovascular treatment for use as a rescue therapy 
alone following clinical deterioration suffers from two major limitations. Firstly, the 
therapeutic window is narrow (Rosenwasser et al, 1999; Hayashi et al, 2014)
 
(this 
probably accounts for a limited number of patients showing neurological 
improvement with vasodilator therapy or TBA) (Coyne et al, 1994; Bejjani et al, 
1998; Feng et al, 2002; Keuskamp et al; 2008; Stuart et al, 2011; Macdonald, 2013; 
Hou & Zhang, 2013) and secondly, patients may suffer infarction in the absence of 
acute deterioration (especially if poor grade and difficult to assess) which itself is 
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associated with a poor eventual outcome (Ionita et al, 2010). 
 
A process of screening 
for and treating severe aVSP may allow more timely intervention prior to more 
severe ischemia but the risks of this approach need to be justified, and critical to this 
is the safety of the screening method and chemical and balloon angioplasty.  In this 
study, there was one transient thromboembolic complication.  This equates to a 
procedural risk of 1.5% but patient risk of 5.9%, although with no permanent 
morbidity and mortality relating to the procedure.  However, the group sizes in this 
study are probably too small to draw firm conclusions.  The feared complications of 
TBA are vessel rupture and thromboembolic events.  In a recent review of the 
literature, it has been suggested that the procedural risk of rupture for TBA with 
modern compliant balloons is approximately 1%, and thromboembolic complications 
have been reported in 4–5% (Abruzzo et al, 2012).  For chemical angioplasty, the 
risks are related to the angiographic procedure and also to the agent being used.  We 
now rely on verapamil as the first line vasodilator.  In our experience, it is associated 
with a low rate of complications but there are reports in the literature of elevated 
intracranial pressure (Feng et al, 2002; Keuskamp et al, 2008).
  
We manage these 
patients with inotropic support as required and titrate the rate of administration of 
verapamil with blood pressure to limit systemic hypotension.  Papaverine use is now 
second line both at our institution and at other surveyed centres (Bulsara et al, 2015)
 
owing to its side effect profile (Abruzzo et al, 2012).  
The approach of investigating for vasospasm with digital subtraction 
angiography utilizes the gold standard imaging modality for detection of vasospasm 
and allows therapeutic intervention but does carry with it a small but not 
insignificant procedural risk.  Others have developed local expertise in the use of 
TCD and CT angiography/perfusion.  Each may be a valid method of evaluation 
either alone or in combination to guide a treatment algorithm of similar philosophy.  
Both TCD and CT angiography/perfusion are non-invasive tools. TCD is operator 
dependant and is limited in its ability to assess the anterior cerebral artery and 
posterior circulation as well as distal vasospasm.  CT angiography and CT perfusion 
may play a more prominent role in vasospasm diagnosis in the future. CT 
angiography has limits in demonstration of distal vasospasm and vessels adjacent to 
clip or coil artefact, and CT perfusion can be limited by the amount of brain volume 
coverage, radiation exposure, and clip or coil artefact (Greenberg et al, 2010; Mir et 
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al, 2014). 
 
Accurate quantification with CT perfusion is also dependent on an intact 
blood– brain barrier, which may not be the case with ischemic tissue.  
This was a post hoc analysis of trial data that was not specifically collected to 
answer the question of the impact of endovascular treatment or hypertensive therapy 
from available data.  The study group with severe aVSP contained a small sample of 
only 17 patients and there was considerable difference in the size of the study group 
compared with the control population without spasm, comprising 63 patients.  There 
was no control population with severe aVSP who did not undergo endovascular 
therapy with which to compare, and as a result we are unable to report on the 
additional benefit of endovascular treatment over hypertensive therapy.  
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7.6 Conclusion 
The results of this prospectively acquired single institution study suggest that 
clinical outcomes for patients with severe angiographic vasospasm are similar to 
those without vasospasm if treated with induced hypertension and an intensive 
endovascular regimen of TBA and/or chemical angioplasty based on a verapamil 
protocol.  Further trials are necessary to fully elucidate the individual impact of 
medical treatment and endovascular therapy on the natural history of vasospasm with 
patients receiving medical and timely interventional treatment versus matched 
controls receiving medical management alone.  
 
159 
 
 
 
CHAPTER 8 
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8.1 Abstract  
8.1.1 Background 
Aneurysm recurrence following coil occlusion is well recognised. However, 
there is controversy as to how long these patients should be followed up after coiling 
to detect reopening.  We aimed to identify the rate of late reopening and the risk 
factors for reopening in a large single-centre cohort of ruptured aneurysms that 
appeared adequately occluded at 6 months.  We also aimed to assess whether rates of 
recurrence have altered over time with improving coil and angiographic technology.  
 
8.1.2 Methods 
Patients treated between 1996 and 2010 were assessed and those with both 6-
month initial and subsequent long-term follow-up with either digital subtraction 
angiography or magnetic resonance angiography were included.  Aneurysms were 
stratified by features such as size, neck width, anatomical location and time of 
treatment: 1996–2005 (cohort 1) and 2006–2010 (cohort 2).  ORs for risk of 
recurrence were calculated for aneurysm features and rates of recurrence in each 
cohort were compared using a χ2 test.  
 
8.1.3 Results 
437 patients with 458 adequately occluded aneurysms at 6 months had mean 
long-term follow-up of 31 months; 57 (12.4%) were large (≥10 mm) and 104 
(22.7%) were wide-necked (>4 mm).  Nine aneurysms (2%) showed significant late 
anatomical deterioration whereby retreatment was considered or undertaken.  The 
risk was greater for large aneurysms (≥10 mm) (OR 15.61, 95% CI 3.79 to 64.33, 
p=0.0001) or wide-necked aneurysms (>4 mm) (OR 12.70, 95% CI 2.60 to 62.13, 
p=0.0017).  The frequency of significant late anatomical deterioration and 
retreatment was also less common in those treated in cohort 2 (p<0.05).  No 
completely occluded aneurysm at 6 months demonstrated significant late recurrence.  
 
8.1.4 Conclusion 
Most aneurysms adequately occluded at 6 months did not show evidence of 
late recurrence.  Large and wide-neck aneurysms are, however, at greater risk of 
later recurrence.  
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8.2 Introduction  
Endovascular coiling is the preferred treatment for ruptured cerebral 
aneurysms, but systematic review of the literature suggests that approximately 20% 
of aneurysms will show reopening or recurrence following treatment (Ferns et al, 
2009).
  
Intuitively, the principal indication for following aneurysms with imaging 
after coil occlusion is to identify aneurysm recurrence (either through coil 
compaction, migration into thrombus or aneurysm regrowth) and to pre-empt 
rehaemorrhage through retreatment.  A number of studies have demonstrated an 
inverse relationship between the degree of occlusion and the risk of rerupture 
(Johnston et al, 2008; Sherif et al, 2012).  
 
However, there is little consensus in the 
literature as to the most appropriate timing of follow-up or length of follow-up, and 
long-term follow-up is not without detriment; there is evidence that those patients are 
more prone to anxiety and depression (Ferns et al, 2011a).
  
Follow-up also brings 
with it a financial cost either to health systems or patients.  
Although previous series with variable initial follow-up time have suggested 
that long-term follow-up is mandatory to detect late aneurysm reopening (Cognard, 
et al, 1999; Piotin et al, 2007; Campi et al; 2007),
 
recent evidence provided by a 
study using a fixed initial follow-up date of 6-months post-treatment in adequately 
occluded aneurysms suggests differently (Ferns et al, 2011b).
  
In 400 patients with 
440 aneurysms, the rate of aneurysm reopening was very low (2.6%) on long-term 
follow-up (mean 6 years) and consequently the risk of delayed rebleeding in 
adequately treated aneurysms is reported to be extremely low (Gallas et al, 2005; 
Johnston et al, 2008; Molyneux et al, 2009).
  
An additional question is whether some 
aneurysms (e.g. large, wide-necked or those at specific anatomical locations) are 
more prone to recurrence than others, even when adequately occluded at 6 months, 
and it may be that longer follow-up should be focused on these subgroups.  
At our centre we follow aneurysms routinely at 6 months and then at 30 
months, but continue for longer until stability is achieved or a remnant is retreated.  
We aimed to assess the rate of late reopening in adequately occluded aneurysms 
(defined as those either completely occluded or with a small neck remnant at 6-
months’ follow-up) in patients treated between 1996 and 2010 to assess whether late 
follow-up was necessary in all of these patients.  We also aimed to assess whether 
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reopening or retreatment rates for patients with adequately occluded aneurysms at 
initial follow-up have changed with evolving coil and angiographic technology.  
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8.3 Methods  
Patient details were retrieved from two institutional databases containing all 
ruptured aneurysms coiled at our institution between 1996 and 2005 (cohort 1) and 
all those coiled between 2006 and 2010 (cohort 2).  Only patients with both short- 
and long-term imaging follow-up were included in the primary study population.  
These patients were stratified into those with adequately occluded aneurysms 
(complete occlusion or only a small neck remnant) at 6-month angiographic follow-
up and those with an aneurysmal remnant; this was determined by occlusion status as 
recorded on the neuroradiological reports.  Subsequent long-term digital subtraction 
angiography (DSA) or magnetic resonance angiography (MRA) follow-up was then 
assessed for evidence of anatomical deterioration.  Occlusion status was re-
adjudicated by the study personnel through consensus between two neuroradiologists 
(AMM and SAR).  Further retreatment was also recorded.  
 
8.3.1 The endovascular procedure  
All procedures were performed by consultant interventional neuroradiologists 
(SAR and MDB).  The aim was to place coils sequentially into the aneurysmal sac to 
the point of angiographic occlusion.  The vast majority of coils deployed were bare 
platinum (Boston Scientific (now Stryker), Kalamazoo, Michigan, USA; Micrus 
(now Codman Neurovascular), Raynham, Massachusetts, USA; ev3 (now Covidien), 
Dublin, Ireland).  A minority of aneurysms in the study cohort were coiled with 
balloon remodelling and none with stent assistance.  In only a small number of 
aneurysms were bioactive coils used.  The coiling technique did not alter over the 
study period.  The aneurysm responsible for haemorrhage was identified by blood 
distribution on CT, aneurysm appearance, and vasospasm distribution.  If it was not 
possible to clearly identify the ruptured aneurysm, all possible candidates were 
treated and aneurysms were classified as ruptured.  The degree of initial aneurysm 
occlusion was recorded on the basis of post-coiling angiography.  
 
8.3.2 Imaging follow-up protocol  
Prior to 2005 we followed aneurysms with DSA.  After 2005 our institutional 
protocol changed to following with 3D time-of-flight (TOF) MRA, often favoured as 
a non-invasive tool for detection of reopening (Weng et al, 2008; Wee et al, 2007; 
164 
van Amerongen et al, 2013).
  
MRI examinations were performed on 1.5 T or 3 T 
systems (Philips Healthcare).  The MRI protocol included axial T2-weighted fast 
spin echo and multiple overlapping thin slab acquisition 3D TOF MRA sequences.  
Axial images and triplanar maximum intensity projections were assessed. If the 
initial MRA was performed using 1.5 T, the subsequent scan would have been either 
1.5 T or 3 T. If the initial scan was 3 T, subsequent scans were also at 3 T. A 3 T 
scan never preceded a 1.5 T scan.  
Anatomical deterioration was defined as increased flow on DSA or MRA at 
the base or within the aneurysm, either caused by compaction of the coil mesh or by 
aneurysm growth, when compared with the initial MRA.  The aneurysms were 
dichotomised between adequately occluded aneurysms (completely occluded or 
small neck remnant) and incompletely occluded aneurysms.  Mild deterioration (but 
continued adequate occlusion) was classified as deterioration to a small neck 
remnant or mild enlargement of a neck remnant (see figure 8.1).  Significant 
deterioration was classified as deterioration to aneurysm residuum (see figure 8.2).  
 
 
Figure 8.1 Mild anatomical deterioration. Right middle cerebral artery aneurysm completely 
occluded on immediate angiography (A) and at 6-month follow-up magnetic resonance 
angiography (B), but showing a small neck remnant at 30 months (C). 
 
 
 
Figure 8.2 Significant anatomical deterioration. Foetal posterior communicating artery 
aneurysm showing complete occlusion at immediate angiography (A), a neck remnant at 6-
months magnetic resonance angiography (B), but aneurysmal residuum at 30 months (C). 
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8.3.4 Statistical analysis  
The results were compared statistically (Medcalc V.12.4.0, Ostend, 
Belgium).  ORs were used to compare patients with and without aneurysm reopening 
in terms of factors such as aneurysm size and neck width, early recanalization and 
location.  Analysis of variance was used for comparison of age between the two 
cohorts. χ2 test was used for statistical comparison of proportions for patient sex, 
aneurysm size ≥10 mm, neck size >4 mm, aneurysm location and rates of recurrence 
in each of the two cohorts selected on the basis of year of procedure.  
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8.4 Results 
A summary of patient selection is shown in figure 8.3.  Between 1996 and 
2010, 1106 patients with subarachnoid haemorrhage underwent endovascular 
coiling.  The primary study population included 437 patients with 458 adequately 
occluded aneurysms at 6 months with mean long-term follow-up of 31 months.  This 
population was subdivided into those aneurysms treated between 1996 and 2005 
(cohort 1; 197 patients with 198 aneurysms) and those treated between 2006 and 
2010 (cohort 2; 241 patients with 260 aneurysms).  
 
 
 
Figure 8.3 Summary of patient selection for the study population. 
 
8.4.1 Patients not included in the primary study population  
A total of 669 patients were not included in the primary study population for 
the following reasons: (1) no angiographic follow-up; (2) follow-up at 6 months 
only; (3) aneurysms incompletely occluded at 6 months.  
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Two hundred and eighty-five patients had no follow-up; 163 patients died in 
the acute period and 122 had no follow-up for the following reasons: advanced age 
(37), severe clinical outcome (24), out of region follow-up (14), and other reasons 
(19).  Twenty-eight patients refused follow-up.  Three hundred and three patients 
with 306 aneurysms had a single follow-up DSA or MRA available for assessment.  
The occlusion grades at initial follow-up in these aneurysms were complete 
occlusion 80.4% (246/306) and small neck remnant 19.3% (59/306). All but one 
patient was therefore adequately occluded.  There was no subsequent follow-up 
available for reasons such as advanced age, out of region follow-up, severe outcome, 
and patient choice.  
Eighty-one patients with 82 aneurysms were deemed incompletely occluded 
at initial 6-month follow-up.  Of these, 70 had shown anatomical deterioration and 
12 were stable but incompletely occluded.  Wide neck and large size represented 
significant risk factors for incomplete occlusion at 6 months: 31 (37.8%) were large 
compared with 95 of the 764 (12.4%) adequately occluded aneurysms at initial 
follow-up (OR 4.28, 95% CI 2.61 to 7.03, p<0.0001) and 38 (46%) were wide-
necked compared with 190 of the 764 (24.9%) adequately occluded aneurysms at 
initial follow-up (OR 2.61, 95% CI 1.64 to 4.15, p=0.0001).  Fifty-five of these 
aneurysms (67% of incompletely occluded aneurysms as adjudged at 6 months) were 
retreated.  Those that were not retreated were managed conservatively for reasons 
such as patient age, anatomical configuration, and estimated procedural risk.  
Analysis of the primary study population: overall outcomes for adequately 
occluded aneurysms at 6 months A total of 437 patients with 458 adequately 
occluded aneurysms at 6 months had mean long-term follow-up of 31 months.  Two 
hundred and ninety-nine (68.4%) were women.  Mean age was 50.3 years.  Table 8.1 
summarizes the aneurysm characteristics: 57 (12.4%) were large (≥10 mm) and 104 
(22.7%) were wide-necked (>4 mm).  
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Table 8.1 Characteristics of the total primary study population (n=458). 
 
 
Immediate post-coiling angiography demonstrated adequate occlusion in 
97.8%. In cohort 1, adequate occlusion was 97.4% (193/198 aneurysms) and, in 
cohort 2, adequate coiling was 98.1% (255/260 aneurysms).  Therefore, although 
immediate angiography suggested some residual aneurysm in a minority, by 
definition, all went on to adequate occlusion by 6 months.  
Overall, 28 aneurysms (6%) showed any anatomical deterioration between 6 
months and 30 months of follow-up, but most remained adequately occluded at late 
follow-up with only nine (2.0%) showing significant deterioration to aneurysmal 
remnant whereby retreatment was either considered or performed. Six of the nine 
were retreated, one which was stable between 30 and 42 months opted for 
neurosurgical clipping, and the other two continue to be followed.  
In the group that deteriorated to aneurysmal remnant, seven of nine (78%) 
were wide-necked (OR 12.70, 95% CI 2.60 to 62.13, p=0.0017) and six (60%) were 
Characteristic N % 
Anterior circulation 390 85.1 
ACA 180 39.3 
MCA 79 17.2 
ICA 
-PCom 
131 
88 
28.6 
19.2 
Posterior circulation 
-Basilar tip 
68 
38 
14.8 
8.3 
Size ≥10mm 57 12.4 
Neck >4mm 104 22.7 
Immediate complete 
occlusion 
314 68.4 
Immediate small neck 
remnant 
134 29.1 
Immediate aneurysmal 
remnant 
10 02.2 
6-month complete 
occlusion 
290 63.2 
6-month small neck 
remnant 
169 36.8 
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large (OR 15.61, 95% CI 3.79 to 64.33, p=0.0001).  The anatomical locations were 
as follows: two in the anterior communicating artery (22.2%), two in the posterior 
communicating artery (22.2%), two in the basilar tip (22.2%, OR 3.28, 95% CI 0.66 
to 16.37, p=0.1479), and one each in the ophthalmic artery, posterior inferior 
cerebellar artery, and distal anterior cerebral artery.  
Sixty-one of the 430 aneurysms (14.2%) that had long-term stability showed 
minor deterioration between the initial post-coiling angiogram and 6-month follow-
up compared with five of the 28 aneurysms (17.9%) that did show late deterioration 
(OR 1.32, 95% CI 0.48 to 3.59, p=0.5930).  
 
8.4.2 Outcomes for completely occluded aneurysms  
In all, 290 aneurysms were completely occluded at 6 months (see table 8.2), 
50 (17.2%) of which were wide-necked and 27 (9.3%) were large; 16 (5.5%) of these 
aneurysms showed deterioration to small neck remnant on late follow-up, but none 
of these aneurysms required retreatment.  All remain adequately occluded.  Three of 
these aneurysms were large (OR 2.40, 95% CI 0.64 to 9.03, p=0.1940), two were 
wide-necked, and six of the 16 were posterior communicating artery aneurysms (OR 
2.50, 95% CI 0.87 to 7.19, p=0.0886).  There have been no cases of delayed 
rebleeding from aneurysms completely occluded at 6 months initially treated from 
January 1996 to date.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8.2 Characteristics of those aneurysms that were completely occluded (n=290). 
 
 
 
 No recurrence Mild 
recurrence 
Characteristic N % N % 
Neck >4mm 48 16.6 2 12.5 
Size ≥10mm 24 8.3 3 18.8 
Anterior circulation 252 86.9 14 87.5 
     ACA 111 38.3 4 25.0 
     MCA 57 19.7 3 18.8 
     ICA 
     -PCom 
84 
53 
30.0 
18.3 
7 
6 
43.8 
37.5 
Posterior circulation 38 13.1 2 12.5 
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8.4.3 Comparison of anatomical outcomes over time  
A summary of the populations treated between 1996 and 2005 (cohort 1) and 
2006 and 2010 (cohort 2) is shown in table 8.3.  There was no significant difference 
in either patient or aneurysm characteristics.  In cohort 1, 16 aneurysms showed late 
anatomical deterioration (8%).  Seven showed significant deterioration to the 
aneurysm residuum and six (3%) were retreated.  In cohort 2, 12 aneurysms showed 
late anatomical deterioration (4.6%). Only two of these cases (0.8%) showed 
significant deterioration, both stable on later follow-up, but one awaits neurosurgical 
clipping.  The difference in the rate of significant late recurrence reached 
significance (p=0.0345), with a smaller number of significant deteriorations in 
cohort 2.  The rate of retreatment was also significantly lower in cohort 2 
(p=0.0221).  Comparison of aneurysms that exhibited reopening versus those that did 
not within each cohort is displayed in table 8.4.  In cohort 1, aneurysm size ≥10 mm 
significantly predisposed to any recurrence (OR 4.72, 95% CI 1.46 to 15.27, 
p=0.0097) and in cohort 2 aneurysm size ≥10 mm also increased the risk of 
recurrence significantly (OR 3.38, 95% CI 1.02 to 12.51, p=0.0474).  In cohort 2, 
posterior communicating artery aneurysms tended to show more recurrence and 
anterior cerebral artery aneurysms showed less recurrence, but this was not 
reproduced in cohort 1 so the validity of this is questionable.  
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Characteristic 
Cohort 1 Cohort 2  
P  197 patients with 198 aneurysms 
1996-2005 
241 patients with 260 aneurysms 
2006-2010 
Mean 
(SD) 
N % Median 
(IQR) 
Range Mean 
(SD) 
N % Median 
(IQR) 
Range 
Women  133 67.5    166 68.9   0.7598 
Age Y 50.6 
(10.5) 
  51 (13) 16-76 49.9 
(12.5) 
  51 (17) 17-76 0.6557 
Size ≥10mm  21 10.6    36 13.5   0.2980 
Neck >4mm  52 26.3    52 20.0   0.1129 
Anterior 
circulation 
 165 83.3    225 86.5   0.3392 
     ACA  78 39.4    102 39.2   0.9717 
     MCA  28 14.1    51 19.6   0.1244 
     ICA  59 29.8    72 27.7   0.6213 
Posterior 
circulation 
 33 16.7    35 13.5   0.3392 
 
Table 8.3 A summary of the characteristics of the two cohorts. ACA, anterior cerebral 
artery, ICA, interior carotid artery, MCA, middle cerebral artery. 
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Table 8.4 Comparison of aneurysms that exhibited re-opening versus those that did not 
within each cohort. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Cohort 1 Cohort 2 
No 
reopening 
All 
Reopening 
 No  
reopening 
All 
reopening 
 
 180 
patients 
with 182 
aneurysms 
Mean age 
50.8, SD 
10.5 
16 patients 
with 16 
aneurysms 
Mean age 
48.4, SD 
10.8 
230 patients 
with 248 
aneurysms 
Mean age 
49.7 SD 12.5 
11 patients 
with 12 
aneurysms 
Mean age 
51.1 SD 8.7 
 
 
 
        N % N % OR 95% 
conf 
int 
P N % N % OR 95% 
conf 
int 
P 
Women 12
3 
67.9 11 68.8 0.95 0.31-
2.85 
0.9237 157 68.3 9  2.09 0.44- 
9.93 
0.3527 
Size 
≥10mm 
16 8.8 5 31.3 4.72 1.46-
15.27 
0.0097 32 12.9 4 33.3 3.38 1.05-
12.51 
0.0474 
Neck 
>4mm 
46 25.3 6 37.5 1.77 0.61-
5.15 
0.2919 50 15.7 2 16.7 0.80 0.17- 
3.73 
0.7682 
ACA 71 39 6 37.5 0.94 0.33-
2.69 
 
0.9054 101 40.7 1 8.3 0.13 0.02- 
1.04 
0.0546 
MCA 28 15.4 0 00.0 0.16 0.01-
2.82 
0.2129 49 19.8 3 25.0 1.44 0.37- 
5.50 
0.5979 
ICA 53 29.1 6 37.5 0.56 0.15-
2.05 
0.3828 66 26.6 6 50.0 2.76 0.86- 
8.85 
0.0882 
-PCom 39 21.4 4 25.0 1.22 0.37-
4.00 
0.7401 (33) (13.3) (4
) 
(33.3) 3.29 0.94-
11.53 
0.0630 
Posterior 
circulation 
31 17.0 3 18.8 1.12 0.30-
4.18 
 
0.8615 19 7.7 2 16.7 2.54 0.52-
12.42 
0.2507 
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8.5 Discussion 
The results of this study suggest that the vast majority of patients with 
adequately coil-occluded cerebral aneurysms at initial follow-up of 6 months remain 
well occluded at long-term follow-up.  Overall the rate of any reopening was 6%, but 
the majority of these remained well occluded and only 2% showed significant 
deterioration to aneurysmal remnant.  Completely occluded aneurysms showed no 
cases of significant deterioration (5.5% showed mild deterioration but they remained 
well occluded), and the rate of significant deterioration in all adequately occluded 
aneurysms was lower in those aneurysms treated after 2006 with only one case in 
this cohort awaiting retreatment.  Our results are broadly in agreement with those of 
a recent investigation of 400 patients with 440 aneurysms followed for a mean 
period of 6 years (Ferns et al, 2011b).
  
This investigation found that the rate of 
aneurysm reopening after adequate initial occlusion identified at 6 months with 3 T 
TOF MRA was 2.6% (11 patients) and only three patients were retreated. In a series 
of 126 patients with fixed follow-up intervals of 6 and 18 months after coiling, all 
reopened aneurysms were found at 6-month angiography (Sluzewski et al, 2003). 
 
In 
another study, 111 aneurysms adequately occluded at 6 months underwent 3 T MRA 
5–11 years after coiling.  Three showed minor reopening and only one aneurysm, 
which initially contained intraluminal thrombus, showed major reopening (Sprengers 
et al, 2008).  
 
A difference between these studies and our own is that they included 
patients with both ruptured and unruptured aneurysms whereas we confined our 
analysis to ruptured aneurysms that, in theory, may be more prone to recurrence due 
to a thinner more friable wall and associated thrombus.  Our results suggest that this 
is not necessarily the case.  Likewise, a study by Gallas et al
 
(2005) reported that 
96% of ruptured aneurysms completely occluded at 1 year remained stable, with a 
mean follow-up period of 36 months.  They also reported that no patient with a 
completely occluded aneurysm at 2 years demonstrated recanalization at 3 years.  
Several studies (Cognard et al, 1999; Piotin et al, 2007; Campi et al, 2007; 
Wee et al, 2007)
 
have reached conclusions that contradict the findings of our study 
and that of Ferns et al (2011b). 
 
In these studies, prolonged imaging follow-up was 
recommended to detect more first-time recurrences, but the findings of these studies 
are hindered by wide variations in the time intervals of follow-up angiography; it is 
possible that initial reopening may have been identified sooner with earlier follow-
up.  When initial follow-up is fixed at 6 months, very few recurrences are first 
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recognised beyond the 6-month follow-up (Sluzewski et al, 2003; Ferns et al, 
2011b).  
Aneurysm rupture (Hope et al, 1999; Raymond et al, 2003; Tan et al, 2011),
 
larger aneurysm size (Hope et al, 1999; Raymond et al, 2003; Tan et al, 2011),
 
wide 
aneurysm neck (Hope et al, 1999; Raymond et al, 2003; Ries et al, 2007; Ferns et al, 
2009; Tan et al, 2011; Pierot et al, 2012a), posterior circulation location (Ferns et al, 
2009),
 
intraluminal thrombus (Sprengers et al, 2008),
 
low packing density 
(Sluzewski et al, 2004; Slob et al, 2005),
 
and initial incomplete occlusion (Piotin et 
al, 2007)
 
have previously been implicated in conferring a greater risk for aneurysm 
recurrence.  We found that large aneurysm size (≥10 mm) (p<0.001) and wide 
aneurysm neck (>4 mm) (p=0.0001) were significant risk factors for early 
recurrence.  We have also demonstrated that aneurysms of ≥10 mm size (p=0.0001) 
and neck width >4 mm (p=0.0017) are significant risk factors for significant late 
recurrence (reopening to residual aneurysm).  Any influence of aneurysm location on 
the predisposition to recurrence is more controversial (Cognard et al, 1999; Pierot et 
al, 2012a). 
 
We noted that the posterior communicating artery location tended to 
confer an increased risk, but this is of debatable significance.  
  Our results suggest that, for adequately occluded aneurysms, the rate of late 
recurrence was lower in those coiled between 2006 and 2010 than in those coiled 
between 1995 and 2005 (p<0.05).  We speculate that this coincided with the 
introduction of a biplane unit and 3D rotational angiography to our department that 
we feel has improved assessment of the aneurysm neck and local anatomy and also 
the introduction of next generation coil technology including 360 (Boston, now 
Stryker) and Axium 3D (eV3/Covidien) coils.  Although we did not formally assess 
packing density, complex-shaped platinum coils have been shown to increase 
packing density (Wakhloo et al, 2007). 
 
Nevertheless, we accept that there are 
multiple flaws in comparing the data of these two cohorts, not least that the imaging 
modalities used were different, that the missing data could have altered the results, 
and that attitudes to retreatment may have changed over time.  This therefore limits 
the conclusions that can be drawn.  
The results do indicate that, for adequately occluded aneurysms at 6 months, 
long-term follow-up may not be necessary for all aneurysms.  Patients with small 
narrow-necked aneurysms that are completely occluded at 6 months may not 
necessarily benefit from long-term follow-up.  Indeed, through evaluation of the 
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effects on mood and level of anxiety from long-term follow-up MRA in comparison 
to general population norms, aneurysm follow-up has been implicated in prolonging 
patient anxiety (Ferns et al, 2011a),
 
although there are no data about follow-up 
imaging and depression levels in a ruptured aneurysm population between those who 
underwent imaging and those who did not.  
The purpose of detecting recurrence is to identify those patients who may 
benefit from retreatment in order to reduce the risk of haemorrhage.  Although this is 
a well-accepted concept, only a small number of studies have related the degree of 
aneurysm coil occlusion to the subsequent risk of rehaemorrhage.  The CARAT 
investigators (Johnston et al, 2008)
 
demonstrated that the risk of rehaemorrhage in 
completely occluded aneurysms was 1.1%, but was as high as 17.6% for those with 
<70% occlusion.  Similarly, Sherif and colleagues
 
(2012) demonstrated that the risk 
of rebleeding ranged from 0% for completely occluded aneurysms to 16.7% for 
those with <70% occlusion.  Furthermore, the risk of rehaemorrhage is greatest in 
the first year following treatment (Johnston et al, 2008). 
 
Current evidence suggests 
that the risk of rehaemorrhage beyond the first year is low and lies between 0.11%
 
and 0.21% per year (Johnston et al, 2008; Molyneux et al, 2009).  The very low 
incidence of aneurysm rebleeding therefore questions the validity and cost-
effectiveness of performing routine long-term follow-up imaging of intracranial 
aneurysms completely obliterated after 6–12 months.  Indeed, in the International 
Subarachnoid Aneurysm Trial (ISAT), two of 988 patients had rehaemorrhage from 
an aneurysm that was completely occluded at 6-month follow-up angiography 
(Molyneux et al, 2005).
  
What confounds this argument is the effects of retreatment 
(7.7% in the first year and 4.5% in the second year
 
in CARAT (Johnston et al, 2008) 
and 17.4% overall in ISAT (Campi et al, 2007) that requires a robust follow-up 
system to guide the need for re-intervention.  In this study we specifically 
investigated those aneurysms that were adequately occluded at 6 months.  In ISAT, 
5.8% of 584 aneurysms that were well occluded at 6-month angiographic follow-up 
were retreated.  If retreatment is used as a surrogate measure of recurrence, this 
somewhat contradicts the findings of our study, particularly as the mean time to 
retreatment was 17 months, but what is difficult to quantify is the effect of 
retreatment in this group on the rate of rehaemorrhage.  It is noticeable that there 
may now be a trend to manage small recurrences or neck remnants more 
conservatively.  This trend may be reflected in the proportion of retreated patients in 
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the more recent Cerecyte (Molyneux et al, 2012)
 
and HELPS (HydroCoil 
Endovascular Aneurysm Occlusion and Packing Study)
 
(White et al, 2011)
 
trials 
compared with ISAT (5.5% and 3%, respectively, vs 17.4%).  
Some suggest that an additional reason for following patients with treated 
cerebral aneurysms is also to detect de novo aneurysms and to depict growth of 
untreated aneurysms.  This is an unresolved issue.  We have not detected any de 
novo aneurysms in our cohort of patients imaged using MRA (unpublished 
observations), nor have we observed the growth of additional small untreated 
aneurysms.  The results of previous large follow-up studies indicate that, in the first 
5 years after coiling (and probably also in the first 10 years), both the risk of de novo 
aneurysm formation and the risk of growth of existing untreated aneurysms is very 
low.  Gallas et al
 
(2009) found five de novo aneurysms in 731 patients over a 5-year 
period of follow-up and Sprengers et al
 
(2009) describe a 1.5% incidence after 5 
years.  The risk of subarachnoid haemorrhage from such aneurysms is extremely low 
(Wermer et al, 2005; Gallas et al, 2009; Sprengers et al, 2009).
  
There is no evidence 
that treatment of small unruptured aneurysms is beneficial.  Where appropriate at our 
institution, additional aneurysms are treated either at the time of the initial procedure 
or 3–6 months after the subarachnoid haemorrhage, following recovery.  
There are multiple problems with the methodology employed in this study 
and other retrospective observational studies that have reached similar conclusions 
(Sluzewski et al, 2003; Gallas et al, 2005; Sprengers et al, 2008; Ferns et al, 2011b).  
Each study has been relatively small and suffered from missing data.  This 
has previously been thoroughly critically appraised by Raymond (2009).
  
Grading of 
aneurysm occlusion was initially based on operator reports. It is well-accepted that 
there is wide variation in the reporting of aneurysm occlusion between operators and 
independent assessors (Nagarra et al, 2010; Daugherty et al, 2011; Tollard et al, 
2012).
  
We used different imaging modalities to follow patients (DSA prior to 2005 
and 1.5 T or 3 T TOF MRA for follow-up after 2005).  This could well have 
impacted on our comparison of the two cohorts.  It is generally accepted that DSA is 
the most sensitive method of detection for recurrence and therefore any differences 
in the rate of reported recurrence between the two cohorts should take into account 
the inherent differences in the sensitivity of DSA and MRA.  The evidence is 
conflicting with regard to the differences between 1.5 and 3 T MRA and is probably 
not significant (Kaufmann et al, 2010; Pierot et al, 2012c). 
 
The study could also 
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have been skewed by missing data.  A total of 122 patients were not followed up 
(11% of the overall population treated) and 303 patients with 306 aneurysms (27% 
of the overall population treated) had only 6-month follow-up available for review 
and were therefore not included in the primary study cohort, so limiting our ability to 
draw firm conclusions on the basis of the available data: we may have failed to 
capture all recurrences or alternatively, the rate of recurrence may have been 
overestimated since many of the aneurysms that underwent only 6-month follow-up 
were completely occluded at that stage.  An additional limitation is that long-term 
follow-up in most cases was limited to only 30 months.  It is possible that later 
reopening could have occurred but would not have been identified by the timing of 
our follow-up.  Significantly, however, no cases of rebleeding have occurred from 
the two cohorts of adequately coil-occluded aneurysms.  
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8.6 Conclusion 
This study concurs with others and proposes that most aneurysms adequately 
occluded at 6 months do not require further follow-up.  However, current data 
suggest that this policy should perhaps be reserved for small, narrow-necked and 
completely occluded aneurysms while large and wide-necked aneurysms are at 
greater risk of recurrence.  
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9.1 Introduction 
The findings of the investigations included in this thesis suggest that EVC is 
a suitable first line treatment for MCA aneurysms; that the injury sustained by brain 
regions heavily involved with cognition is significantly greater in patients with 
ACOM aneurysms treated with clipping; that clinical outcomes in patients with more 
severe physiological derangement are superior for coiled patients; that invasive 
imaging may be unnecessary in patients with PMSAH; that aggressive endovascular 
treatment of vasospasm results in low rates of cerebral infarction and may negate its 
clinical impact; and finally that long term follow-up of adequately occluded coiled 
aneurysms is probably not necessary. 
 
9.2 Treatment of middle cerebral and anterior communicating artery 
aneurysms 
Many critics of the ISAT study (Molyneux et al, 2002) state that a large proportion 
of the ruptured aneurysms encountered in routine practice are not characteristic of those 
included in the study in which equipoise for clipping or coiling was required. Although the 
BRAT study (McDougall et al, 2012), was designed to answer whether either modality 
was superior for all-comers the study design has been heavily criticised so this remains an 
area of controversy. 
The findings of this large case series of endovascularly treated MCA 
aneurysms suggest that the clinical results, anatomical occlusion rates and 
complication rates are similar to those for aneurysms at other locations.  
Furthermore, results are comparable to those published for the best surgical series 
and the endovascular results are reproducible. There will remain some doubt, 
however, from proponents of surgery and since surgery in many institutions is 
reserved for more anatomically challenging lesions, a trial of surgery versus 
endovascular treatment using adjunctive endovascular treatments may well be of use 
to the neurovascular team.  Balloon-assistance allows treatment of almost all 
ruptured cerebral aneurysms and current evidence suggests this can be achieved 
without a significant increased risk to the patient (Pierot et al, 2012b).  Balloon-
assistance was used in a handful of cases in the present series and very few of the 
ISAT cohort so a trial of balloon-assisted coiling versus surgery for more complex 
lesions is feasible.  Complex unruptured lesions can now be treated with stent-
assistance, flow diversion and the recent development of intra-aneurysmal flow 
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diverters.  An additional study that would therefore be useful is a trial of surgery 
versus newer flow-diverting techniques.   
The results of the present radiological observational study addressing rates of 
ischaemic injury following clipping or coiling of ACOM artery aneurysms 
demonstrated a marked predisposition to basal forebrain and septal/subcallosal 
region injury in the clipped patients.  These areas are heavily involved in cognition 
and it is likely that this injury is responsible for inferior cognitive outcomes 
following surgery.   Again, it could be argued by proponents of surgery that the more 
anatomically challenging lesions may require clipping for treatment but as the 
neurointerventionalist’s armamentarium increases, a trial of flow diversion/stent-
assisted coiling versus surgery would be fascinating.   
To improve the application of endovascular techniques in the context of 
subarachnoid haemorrhage, there is a need for development of stent devices that do 
not necessitate the use of dual anti-platelet therapy. 
 
 
9.3 Aneurysm treatment modality and physiological status 
The ISAT cohort was mostly of good clinical grade but we have no 
information on the physiological status of the patients.  The results of the present 
work suggest that there is a relationship between treatment modality, physiological 
status and outcome.  Clipping results in worse clinical outcomes in physiologically 
sicker patients.  Other work has suggested that clipping is associated with higher 
rates of medical and perioperative complications (Vergouwen et al, 2011c; Ayling et 
al, 2015).  Physiological information should probably be included in the data 
collection of trials designed to answer whether surgical or endovascular options are 
superior for different groups of patients that were less well represented in the ISAT 
trial including those with more complex aneurysms requiring adjunctive 
endovascular options including stents and intra-aneurysmal flow diverters or patients 
of poorer clinical grade. 
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9.4 Invasive imaging in patients with perimesencephalic haemorrhage 
The results of the present work suggest that DSA may not be required for 
investigation of perimesencephalic haemorrhage.  CT angiography may be a suitable 
definitive investigation.  Although other authors have reached similar conclusions, 
the validity of this investigation algorithm needs to be confirmed with higher level of 
evidence. A prospective study is probably required to achieve more universal 
acceptance.  The author is presently undertaking a prospective study investigating 
the clinical course in patients with perimesencephalic haemorrhage investigated with 
CT angiography alone read by two experienced neuroradiologists. 
 
 
9.5 Treatment of cerebral vasospasm using endovascular techniques 
The use of endovascular techniques to treat cerebral vasospasm and the role 
of cerebral vasospasm in delayed ischaemia remains controversial.  International 
guidelines state that it is reasonable to consider endovascular options in cases where 
medical therapy has failed (Bederson et al, 2009). The approach in the present 
studies was slightly different: endovascular treatment was started early in patients 
exhibiting significant angiographic vasospasm so as to prevent clinical deterioration.  
The adoption of this protocol will be limited in many health systems including that 
in the United Kingdom due to resource implications.  What would be more pertinent 
would be to address the efficacy of endovascular treatment options in situations in 
which maximal medical therapy has failed to show clinical improvement.  Many 
neurointerventionalists are reluctant to undertake balloon angioplasty for the risk of 
vessel rupture and in view of this, the use of intra-arterial vasodilators would seem a 
useful treatment option with relatively low risk. A multicentre trial comparing 
various intra-arterial vasodilators is in process (Chen, 2015). However, there is much 
work to be done on a basic science level.  For example, what is the dose-response for 
the various agents that are commonly in clinical use?  Furthermore, what is the effect 
of these agents on the other dominant mechanism of delayed ischaemia, spreading 
cortical depression?  The author is in the process of designing a study using electro-
encephalography to assess these interactions and also the interaction between both 
angiographic vasospasm and spreading cortical depression in order to fully elucidate 
the pathophysiology of this disease. 
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9.6 The necessity of long term follow-up of coiled cerebral aneurysms 
The present work also suggests that long term imaging follow up beyond 6 
months may not be necessary in patients with well coil-occluded cerebral aneurysms.  
However, this evidence was single-centre and of a retrospective nature.  For this 
notion to gain acceptance, the level of evidence needs to be greater. This would 
necessitate a multicentre, prospective study in which anatomical outcomes are 
independently assessed with long term follow-up beyond that of 2.5 years used in the 
present work.   
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APPENDIX 1 
SUPPLEMENTARY IMAGES FOR CHAPTER 5 
 
Figure A1 The definition of perimesencephalic haemorrhage:  Hemorrhage centered anterior 
to the midbrain and/or pons within the pre-pontine and interpeduncular cisterns (A, white 
arrow), with possible extension to the quadrigeminal or ambient cisterns (B, curved arrow). 
No deep extension into the anterior interhemispheric fissure (B, white arrow).  Possible 
extension into the basal parts of the sylvian fissures with no extension into the lateral sylvian 
fissures (B, black arrow). 4. Possible extension to the cisterna magna but not centered on the 
cisterna magna (C).  The latter feature was associated with a possible vertebral dissection in 
this study (see figure A2) and removal of this criterion resulted in a NPV of 100% for CTA, 
suggesting that cisterna magna haemorrhage should not be present if DSA is no be avoided. 
 
 
 
Figure A2 An abnormality beyond detection with CTA in a patient with a 
perimesencephalic pattern of haemorrhage with extension to the foramen magnum.  Non 
contrast CT (A and B) demonstrating a perimesencephalic pattern of SAH with extension to 
the foramen magnum. Coronal CTA (C) demonstrating minimal detectable abnormality of a 
hypoplastic V4 segment of left vertebral artery (black arrow). Oblique frontal projection 
DSA (D) demonstraing an irregular stenosis of the left vertebral artery (white arrow) 
interpereted as a potential  dissection at time of angiography. 
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Figure A3 A rare complication of cerebral angiography as a result of  
  possible contrast toxicity. A female patient presented with a small pre-pontine haemorrhage 
(A).  Shortly after cerebral angiography she developed a right hemiparesis with 
subsequent coma. Repeat angiography was normal. MRI performed within 3 hours 
showed minimal changes but a second MRI performed at 24 hours showed 
widespread, predominantly left hemisphere cortical and basal ganglia hyperintesity 
on T2-weighted and FLAIR sequences (B, C and D, arrows).  No diffusion 
restriction was evident suggesting that this was not a thrombo-embolic process 
(E, F).  The patient made a full recovery after supportive care. 
 
